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SUMMARY
Major depressive disorder (MDD) is among the most prevalent psychiatric 
disorders, with an immense socioeconomic burden, yet with unknown 
etiology. Although the cause(s) of MDD remain unknown, psychosocial 
stress is a major predisposing factor for the development of MDD. To date, 
the molecular and cellular substrates mediating persistent stress effects that 
contribute to the development of MDD are poorly understood, preventing 
the development of –highly needed– effective treatment strategies. 
Although MDD is well-known for its mood-related symptoms, cognitive 
dysfunction is a common and debilitating symptom of MDD. Importantly, 
cognitive symptoms often persist in remitted patients, and can sustain 
chronicity of MDD. Therefore, efficient treatment of cognitive impairment, 
together with mood-affecting symptoms, is imperative to gain full remission 
and to prevent MDD recurrence. Yet, deficits of the cognitive domain in 
MDD remain less studied and the underlying mechanisms are largely 
unexplored. 
In my PhD thesis, I specifically aimed to unravel the lasting effects 
of psychosocial stress, with an emphasis on its effects on cognition. 
Furthermore, I aimed to characterize the neurobiological mechanisms 
that underlie these long-lasting stress-induced cognitive deficits. In order 
to gain access to the molecular and cellular mechanisms driving chronic 
stress effects, I used social defeat, an animal model of psychosocial stress, 
both in rats and mice. 
In chapter 2, our unbiased proteomic study identified extracellular matrix 
(ECM) proteins to be regulated in SDPS (social-defeat induced persistent 
stress)-exposed rats during a depressive-like state, characterized by 
cognitive impairment and reduced social interest months after initial stress. 
This was accompanied with an increase in the number of perineuronal 
nets (PNNs) surrounding parvalbumin expressing (PV)-interneurons at 
the hippocampal CA1 subfield. Moreover, maintenance of LTP (long-term 
potentiation), together with reduced inhibitory neurotransmission was 
present during the depressive-like state. Importantly, enzyme-mediated 
normalization of hippocampal ECM levels reversed the SDPS-induced 
physiological and cognitive deficits. Taken together, these findings identified 
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hippocampal ECM as a novel substrate for hippocampal dysfunction during 
the sustained depressive-like state. 
In chapter 3, I characterized how the depressive-like state develops by 
assessing behavioral and ECM changes over the weeks and months after 
social defeat stress in rats. Temporal profiling of behavioral disturbances, 
including social withdrawal and hippocampal memory impairment, revealed 
major differences between early stress effects and the late-emerging 
depressive-like state. Cognitive function was disturbed immediately after 
stress, but this deficit subsided in the weeks after stress, and it re-emerged 
long after stress when the depressive-like state is established. Importantly, 
a divergent trajectory was observed for the affective deficit, which took 
weeks to develop and remained present for months once established. 
Temporal profiling of hippocampal ECM remodeling revealed a co-
occurrence with cognitive dysfunction; both showing a biphasic regulation 
after defeat stress. In particular, a decrease in perisynaptic ECM levels 
and in the number of PNNs was observed early after stress, accompanied 
by impaired short-term memory. After the initial post-stress phase, both 
the ECM levels and memory function normalized and remained intact 
over several weeks. Yet, following > 5 weeks post-stress, increased ECM 
levels, together with impaired memory, re-appeared. Taken together, these 
findings underscore a dichotomy in the effects of stress on the affective and 
cognitive domains. Furthermore, the biphasic regulation of hippocampal 
ECM and memory processing highlights the time-dependence of stress 
effects. Yet, the mechanisms driving these dynamic stress-induced 
changes on hippocampal ECM remain unknown.
Therefore, in chapter 4 I investigated the upstream mechanisms that could 
propel stress-induced ECM remodeling in the rat. In particular, I assessed 
the potential role of metalloproteinase-mediated regulation of ECM in 
driving the initial effects of stress. For this, I used IPR-179, an inhibitor 
of MMP-9, an enzyme known to degrade ECM proteins, in an attempt to 
prevent stress-induced ECM breakdown early on. I showed that systemic 
administration of IPR-179 before each daily defeat encounter prevented the 
early, defeat-induced memory impairment, suggesting that MMP-mediated 
mechanisms play a role in stress-induced cognitive deficits. Future work 
is needed to assess whether MMP inhibition-mediated reversal of early 
stress effects protects from the establishment of cognitive dysfunction in 
the long run. 
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In chapter 5, I aimed to set up a social defeat-based model for depression 
in mice, as the larger genetic toolbox available in this species allows for 
targeted circuit- and cell-specific interventions. For this, I developed a novel 
stress paradigm, in which physical social defeat is combined with vicarious 
defeat, i.e., witnessing the defeat of others, with the aim to intensify the 
psychological aspect of stress. Behavioral profiling of the effects of PVDPS 
(physical and vicarious defeat-induced persistent stress) demonstrated 
a temporal discrepancy in the development of cognitive and affective 
dysfunction, similar to our rat model. In mice, memory impairment was not 
present early after stress, and it only developed over the weeks following 
the defeat. On the contrary, social avoidance was present early after 
stress, but gradually dissipated over the weeks after defeat. Similar to our 
rat model, increased build-up of the ECM, together with aberrant inhibitory 
transmission at the CA1, coincided with hippocampal memory deficit 
evident weeks after stress. Taken together, these findings emphasize a 
temporal discrepancy in stress-induced cognitive and affective disturbances 
in mice, similar to what is observed in rats. Furthermore, fundamental 
differences between mice and rats in stress-driven adaptations related to 
affective behavior were revealed, which is an important consideration in 
study designs. Finally, this study further supports the important role of the 
hippocampal ECM in mediating persistent stress-induced memory deficits.
Together, my studies highlight the cross-species social defeat-induced 
persistent stress model as valuable tool to study depression-related 
pathology, as it recapitulates individual subdomains of depression, including 
affective and cognitive deficits. Importantly, temporal characterization of 
stress effects demonstrates stress recency as a crucial factor in determining 
the final stress-triggered outcome, both at the molecular and behavioral 
levels. Furthermore, my data suggest an important role for hippocampal 
ECM in mediating stress-induced memory impairments, as well as serving 
as a target for antidepressants. Thus, ECM-targeted interventions offer 
promising therapeutic strategies against MDD, including alleviation of 
MDD-associated cognitive symptoms.
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CHAPTER 1.  
General introduction
In part taken from: Incubation of depression: ECM assembly and 
parvalbumin interneurons after stress
S Spijker, MK Koskinen, D Riga 
Neurosci Biobehav Rev, 118, 65-79 (2020)
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INTRODUCTION TO MAJOR DEPRESSIVE DISORDER
Major depressive disorder (MDD) is amongst the most commonly diagnosed 
mood disorders, affecting almost 1 in 5 people at some point in their lifetime1. 
Low mood and reduced interest in everyday activities (anhedonia) are 
the core symptoms of depressive episodes and, when regularly present, 
form the basis of diagnosis1,2. Importantly, these affective symptoms only 
represent part of the disorder, as a plethora of other symptoms, including 
feelings of worthlessness and guilt, together with appetite and sleep 
disturbances, ranging from weight gain to weight loss and from insomnia 
to excessive sleep1,2, are common. Importantly, depression largely affects 
cognition, manifested in indecisiveness, concentration difficulties3, intrusive 
memories3,4, over-generalization of autobiographical memories5, as well 
as reduced cognitive flexibility and spatial memory deficits6,7. Altogether, 
depression embodies complex symptomatology that can significantly 
vary between patients8. As a result, patients with the same diagnosis 
can express a very different set of symptoms8,9. Furthermore, within an 
individual, the expression of symptoms can change between subsequent 
depressive episodes10. 
Considering the broad manifestations of MDD, it is likely that the disorder 
comprises a group of “endophenotypes” that vary with respect to etiology 
and pathophysiology11. As an example, affective symptoms and cognitive 
dysfunction may represent individual traits of MDD with distinct underlying 
biological mechanisms, although they may act interdependently. In support 
of this view, distinct depressive symptoms often develop and occur 
divergently. As an example, cognitive deficits are frequently reported even 
after affective symptoms have subsided12–14, underscoring the discrepancy 
of these traits of MDD. Furthermore, MDD is often co-morbid with other 
mental disorders15, such as anxiety disorders, making it difficult to uncover 
depression-specific mechanisms. 
The complex nature of MDD has halted understanding of depression 
neurobiology, and, subsequently, hampered the development of effective 
therapeutics. Consequently, treatment of depression still heavily relies 
on monoaminergic antidepressants that were serendipitously discovered 
more than 60 years ago16 and are only effective in a subset of patients, 
leaving up to 40% of patients non-responsive17,18. Therefore, there is an 
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urgent need for a better understanding of depression pathology that could 
pave the way for novel therapies. While genetic factors might render an 
individual prone to the development of MDD19,20, one of the most well-
described triggers of the disease is exposure to severe or chronic stress21. 
Whereas the adaptive stress response is essential for survival in changing 
environments, intense or chronic stress can trigger a cascade of events 
that increases vulnerability to psychiatric disorders22,23. Stress exposure 
initiates several neurobiological processes, including neuroendocrine 
responses, that aim at restoring the homeostatic state of an organism 
and to mediate proper behavioral adaptations. However, (chronic) stress 
can lead to a failure of these adaptive processes in vulnerable individuals. 
This can manifest as maladaptive stress responses, such as prolonged 
activation of stress systems or initiation of stress responses in the absence 
of a stressor24,25. 
Given the importance of the individual stress response on subsequent 
emergence of pathology26, rodent models were developed to study the 
underlying mechanisms. Over the years, different approaches have 
been adopted leading to behavioral assays that employ non-social (e.g., 
chronic mild stress, learned helplessness27,28) or social (e.g., maternal 
deprivation, early-life isolation, social defeat29–31) stressors for the induction 
of a depressive-like state. Collectively, these efforts have mainly focused 
on studying the behavioral, molecular and cellular effects of stress in the 
presence, or shortly after cessation, of the stressor. Less often, studies 
consider the perpetuating nature of the depressive state, given that in 
humans mood disorders may require months to develop32,33. Furthermore, 
a majority of patients diagnosed with MDD suffer from recurrent depressive 
episodes34, making it a lifelong condition for many patients. 
In an attempt to model depression in rodents, dissection of the depressive 
phenotype into its key components may help at understanding the 
molecular underpinnings of distinct domains affected in depression. In our 
studies, we have adopted this approach, in which we have characterized 
the development of two core depression-like symptoms, namely 
affective disturbances and cognitive dysfunction, following social stress. 
Importantly, in addition to studying initial stress effects we have focused 
on understanding the behavioral and cellular phenotypes that take time 
to develop and persist beyond the acute stress response. Unlike the 
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early stress responses, these endpoints are perhaps more pertinent to 
human depression. In particular, we have explored the persistent cellular 
and molecular mechanisms contributing to depression-related cognitive 
impairment, in order to increase our understanding of this less-studied 
aspect of the disorder. 
In the following paragraphs, I will first give an overview of MDD-associated 
cognitive impairments and the role of the hippocampus in mediating these 
disturbances, since these topics were addressed at large by my research. 
This is followed by an introduction to the brain extracellular matrix (ECM), 
as our studies provide evidence that the ECM serves as a crucial cellular 
substrate mediating stress-induced cognitive impairment. Lastly, I will give 
an overview of the common preclinical stress paradigms with an emphasis 
on the social defeat model that is employed in the studies presented in my 
thesis.   
Cognitive symptoms in 
depression and hippocampal dysfunction
As stated above, cognitive symptoms are common in patients with MDD 
and these often persist even after mood symptoms have subsided12–14. 
These lingering cognitive deficits have been associated with increased risk 
for subsequent depressive episodes and shown to impede remission35,36. 
Importantly, they negatively affect daily functioning, with immense 
impact on an individual’s quality of life and thus are considered a major 
determinant of functional recovery13,37. Yet, the cognitive hallmarks of MDD 
have received little attention and, to date, remain less studied. Although 
the pathophysiological underpinnings of cognitive symptoms in depression 
are poorly understood, hippocampal dysfunction is increasingly associated 
with MDD and related cognitive dysfunction38,39. The hippocampus is a 
highly stress-sensitive brain region40,41, and an important hub for learning 
and memory42,43. Indeed, hippocampal-dependent deficits, such as 
disturbed episodic5 and spatial memory6,44 are often present in patients 
with MDD. Furthermore, reduced hippocampal volume in patients with 
MDD is frequently reported and considered as a pathological hallmark 
of the disease45,46, although the underlying mechanism and functional 
implications are poorly understood. 
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The hypothalamus-pituitary-adrenal (HPA) axis is important in orchestrating 
physiological response to stress, ensuring adaptive actions to altered 
environmental demands promoting survival. Stress increases glucocorticoid 
levels in the brain, including the hippocampus, in which glucocorticoid 
receptors are abundant40,47. By providing feedback-inhibition to the 
hypothalamus, the hippocampus is crucial in dampening glucocorticoid-
mediated stress responses48, thereby ensuring homeostasis. However, 
prolonged or intense stress can disrupt the system, resulting in persistent 
glucocorticoid signaling. In the hippocampus, stress causes dendritic 
retraction49,50, impairs plasticity51,52 and reduces neurogenesis53,54, together 
providing cellular substrates for stress-induced hippocampal dysfunction. 
Glucocorticoid-mediated signaling plays an important role in triggering 
these stress effects that are apparent shortly after intense or chronic 
stress55,56. However, the molecular and cellular mechanisms mediating 
the cascading events that follow these initial stress responses, and hence 
sustain lasting hippocampal dysfunction similar to that observed in clinical 
depression are not well-understood. 
The classical monoaminergic deficiency hypothesis of depression, 
which posits that depressive symptoms result from an imbalance in 
brain monoamine levels57, is increasingly challenged. Indeed, this model 
alone does not explain why antidepressants, such as selective serotonin 
reuptake inhibitors (SSRIs), are only effective in subset of patients and 
take weeks to induce symptom remission58. Therefore, alternative, or rather 
complementary hypotheses have gained support. Accumulating evidence 
suggests that network dysfunction and compromised plasticity-related 
mechanisms, resulting in aberrant information processing in certain neural 
circuits, such as in the hippocampus, are involved in MDD pathology59,60.
Furthermore, the ability to enhance neural plasticity is increasingly 
attributed to the therapeutic effects of antidepressant61. As an example, 
antidepressants can reopen critical period-like plasticity in the adult 
brain62,63, thereby facilitating reorganization of neural circuits in response to 
environmental cues. However, the molecular mechanisms through which 
antidepressants increase plasticity are largely unknown. Identification of 
these plasticity-promoting effects of antidepressants, as well as mechanisms 
driving stress-induced plasticity deficits, is crucial for the development 
of novel treatment strategies. The brain extracellular matrix (ECM) is an 
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attractive substrate for lasting stress-triggered pathophysiology, given its 
well-known role in mediating several plasticity-related mechanisms. 
EXTRACELLULAR MATRIX 
ORGANIZATION AND FUNCTION
The brain ECM is increasingly acknowledged as an integral molecular 
substrate involved in the regulation of experience-dependent plasticity both 
in the developing and adult brain64,65. The extracellular space is occupied by 
a complex network of proteins, macromolecules such as proteoglycans and 
glycoproteins and cell-surface receptors, which combined, create a mesh-
like ECM assembly64. The brain’s ECM, rich in lecticans, like chondroitin 
sulphate proteoglycans (CSPGs), and ECM-tethering molecules including 
hyaluronic acid (HA) and proteins of the Tenascin family, surrounds both 
neurons and synapses. 
In the adult brain, the CSPGs Aggrecan, Brevican, Neurocan and Versican 
are core components of the ECM. The various CSPGs are attached to HA, 
the structural backbone of the ECM, via link proteins, including Hyaluronan 
and proteoglycan link protein (Hapln1). Furthermore, CSPGs are cross-
linked via Tenascin-R to form stable net-like structures66,67 (Fig. 1). CSPGs 
carry glycosaminoglycan (GAG) side chains of chondroitin sulfate (CS) that 
vary in numbers, length and sulfation patterns, and are critical determinants 
of the functional properties and heterogeneity of these proteoglycans68,69. 
ECM components are expressed and secreted both by neurons and glial 
cells in an activity-dependent manner70. In order to swiftly respond to 
changing external conditions, the ECM is under tight regulation enabling 
precise temporal and spatial remodeling. A key player in this process is 
proteolytic processing of the ECM by metalloproteinases (MMPs) and 
enzymes like a disintegrin and metalloproteinase with thrombospondin 
motifs (ADAMTS) that are produced by neurons and astrocytes alike71,72.
It has become increasingly evident that the ECM not only provides neurons 
with biochemical and structural support but critically modulates cell-to-cell 
communication. First, diffuse ECM encloses synapses, where it actively 
regulates synaptic transmission. For example, ECM around excitatory 
synapses regulates lateral mobility of a-amino-hydroxy-5-methyl-4-
isoxazolepropionic acid (AMPA) receptors, thereby altering short-term 
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synaptic plasticity73. Likewise, Brevican regulates localization of AMPA 
receptors and voltage-gated potassium channels in parvalbumin-expressing 
interneurons (PV+), thereby modulating connectivity and excitability of these 
interneurons74. These studies exemplify how perisynaptic ECM constitutes 
an integral part of the synaptic machinery, justifying the concept of the 
tetrapartite synapse75 (Fig. 1). Second, ECM assembles into dense net-
like structures, the perineuronal nets (PNNs), that envelope cell somas 
and proximal neurites76,77 (Fig. 1). PNN formation is linked to restricted 
plasticity, as PNNs act as a physical barrier that inhibits formation of novel 
synaptic contacts onto the surrounding cell, while providing structural 
support for the existing ones78,79. Importantly, by embedding numerous 
molecular cues onto their glycoproteins, PNNs can be either inhibitory or 
permissive, as the matrix forms a microenvironment that functions as a 
hub for signal detection and transmission, thereby actively participating in 
neuronal communication80,81.
PNNs often enwrap a specific subtype of interneuron, i.e. parvalbumin-
expressing (PV+) interneurons77,82, an abundant population of inhibitory 
cells that typically show fast-spiking properties83. PNN presence around 
other types of neurons, including excitatory cells, has been observed84,85. 
PV+-interneurons comprise around 20% and 40% of all GABAergic cells 
in the hippocampus and cortex, respectively83,86. Parvalbumin, a Ca2+ 
binding protein, regulates intracellular Ca2+ homeostasis and can therefore 
modulate many aspects of neuronal signaling87,88. Indeed, parvalbumin 
expression, measured as intensity of immunofluorescence, has been 
shown to correlate with GABA production89, and is often taken as a proxy 
of PV+ cell activity74,89. By innervating the soma and axon initial segment, 
PV+ basket cells exert powerful inhibitory control over their postsynaptic 
targets through feedforward and feedback inhibition83. This way, PV+ cells 
orchestrate the synchronization of network activity, especially in the theta 
and gamma frequency, crucial for cognitive processing90.
In the visual cortex, PNNs appear onto PV+ cells at the end of the critical 
developmental period, marking the maturation of the inhibitory network92. In 
a series of elegant experiments, Pizzorusso and colleagues demonstrated 
that targeting the ECM by chondroitinase ABC (chABC), an enzyme that 
catalyzes the removal of sulfate side chains of proteoglycans, jumpstarts 
a critical period-like plasticity in adulthood92. Similar to the visual cortex, in 
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the amygdala the appearance of PNNs coincide with a switch to an
Figure 1. Brain extracellular matrix (ECM). a) Schematic representation of 
diffuse perisynaptic ECM, which in the brain is enriched in chondroitin sulphate 
proteoglycans (CSPGs), in particular Brevican, and ECM-tethering molecules 
including hyaluronan link protein and tenascin-R. Together, pre- and post-synaptic 
terminals, astrocytic processes and perisynaptic ECM form the tetrapartite 
synapse75. b) ECM molecules assemble into dense mesh-like structures, the 
perineuronal nets (PNNs), which are enriched in aggrecan and preferentially 
surround Parvalbumin-expressing (PV+) interneurons. Wisteria floribunda 
agglutin (WFA)-labeled PNNs in the mouse hippocampus CA1 subfield. c) 
PNNs preferentially surround parvalbumin-expressing (PV+) interneurons in the 
hippocampus CA1 region. Example of Cat301-labeled PNNs, PV+ interneurons 
and nuclei (Dapi) in the CA1 pyramidal layer of the rat. Scale bar indicates 25 μm. 
Figure modified from Spijker et al. 202091.
adult-like state, after which fear memories become resilient to extinction93. 
In addition, degradation of amygdalar ECM renders acquired fear 
memories prone to erasure, similar to what observed in juvenile animals. 
These groundbreaking studies demonstrated the pivotal role of the ECM 
in controlling plasticity, and are increasingly accompanied by studies 
showcasing the critical involvement of the ECM in mediating experience-
dependent plasticity across brain regions94–97.
Increasing evidence points to the involvement of PV+ network dysfunction, 
as well as changes in PNN+/PV+ interneurons in the pathophysiology of 
several psychiatric diseases, in which stress acts as a major predisposing 
factor98,99. Post-mortem studies have demonstrated reduced PNN density 
in amygdala in patients with bipolar disorder100, while a variation in the 
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17
gene encoding for the proteoglycan Neurocan has been identified as a 
risk factor for the disease101. Furthermore, widespread reduction in PV+ 
neuron density and the ratio of PNN-ensheathed PV+ neurons is observed 
throughout the brain of patients with schizophrenic or bipolar disorder, 
including the entorhinal cortex102, dorsolateral PFC103 and thalamic reticular 
nucleus104, suggesting that PNN+/PV+ changes are common across brain 
regions in these psychiatric disorders. 
STRESS PARADIGMS IN PRECLINICAL MODELS
Exposure to physical and psychological stressors has been extensively 
used to examine both acute and long-term effects of stress on animal 
physiology and behavior in relation to hallmarks of psychiatric diseases, 
such as depression105,106. Such stressors span from social deprivation 
in critical periods, e.g., during development and adolescence, to social 
dominance in adulthood. 
One of the most widely used paradigms of stress exposure in rodents is 
the chronic mild stress (CMS) model, which is consisted of exposure to a 
series of moderate physical and psychosocial stressors, lasting up to 12 
weeks27. In its many variations, CMS animals are exposed to uncontrollable 
environmental stressors ranging from food and water deprivation to severe 
light and temperature changes. A social component is commonly added to 
the paradigm, where animals are subjected to overcrowded and/or isolated 
housing conditions. 
Other animal paradigms have focused exclusively on social deprivation 
as a source of stress during early life and adolescence, in an attempt 
to model environmental adversity. Limited maternal care or contact with 
conspecifics during early life have been extensively used and are linked to 
severe anxiety and depression-related phenotypes later in adulthood107,108. 
Deviations in these protocols concern the timing and duration of maternal 
deprivation or social isolation, with the latter being more detrimental when 
applied during critical neurodevelopmental periods, such as in early life or 
adolescence.
Finally, one of the most commonly used animal models of social stress is 
social defeat, which is based on the resident-intruder paradigm31,109. Social 
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defeat takes advantage of natural hierarchy and dominance/submission 
dynamics between male rodents and occurs when a larger territorial male 
(resident) physically defeats a smaller, submissive conspecific (intruder). 
Variations in social defeat procedure utilize differences in intensity (e.g., 
number of episodes, duration of physical contact, repetitions over time) 
to mimic stress-associated pathological states. In our studies, we have 
adopted the social defeat-induced persistent stress (SDPS) paradigm, a 
variation of the original resident-intruder protocol, to examine the enduring 
effects of an initial bout of social stress on affective and cognitive function. 
In addition, we have employed combination of physical and vicarious 
social defeat-induced persistent stress (PVDPS) to assess early and 
lasting effects of psychosocial stress in mice. SDPS and PVDPS utilize 
exposure to short-lived but severe physical stress, in the form of social 
defeat, mimicking adverse life events that are linked to the emergence 
of depression in humans. Defeat stress is then followed by exposure to 
prolonged social isolation110 in impoverished environments (non-enriched 
housing), emulating seclusion, and the lack of social support that depressed 
patients often experience. Previous studies in rats have demonstrated 
that the SDPS paradigm results in persistent affective (social withdrawal 
and anhedonia) and cognitive impairment (spatial memory)26,111,112 evident 
months after the last defeat exposure. Hence, the SDPS model offers an 
excellent tool to study cellular and molecular mechanisms related to a 
chronic depressive-like state in absence of immediate threat/stress. 
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AIMS OF THE THESIS
The overarching aim of this thesis was to understand the neural mechanisms 
that contribute to the pathophysiology of MDD. Specifically, I aimed to 
unravel mechanisms that mediate cognitive dysfunction associated with 
a depressive-like state. Although MDD is mainly associated with mood-
related symptoms, mild cognitive dysfunction is increasingly acknowledged 
as inherent to the disorder. However, the underlying molecular mechanisms 
are not well-understood. Notably, instead of solely focusing on acute stress 
responses, I considered and explored the lingering effects of stress on 
physiology and behavior.   
In chapter 2, the molecular and cellular mechanisms that underlie 
hippocampal-dependent memory deficits in chronic depression were 
explored. For this, the SDPS model was employed, together with molecular, 
cellular, electrophysiological and behavioral assays. Notably, an increased 
expression of ECM proteins in the perisynaptic fraction of the dorsal 
hippocampus in SDPS rats that showed memory deficit was found. This 
was accompanied with an increase in the number of PNNs surrounding 
PV-interneurons at the hippocampal CA1 subfield. Furthermore, 
electrophysiological assays demonstrated aberrant plasticity (long-
term potentiation) and reduced inhibitory neurotransmission in the CA1. 
Importantly, these studies demonstrated a causal relationship between 
ECM changes and impaired cognition, as enzyme-mediated normalization 
of the ECM levels rescued both the physiological deficits and the memory 
deficit in SDPS rats. Taken together, this study identified hippocampal ECM 
remodeling as a novel substrate for hippocampal dysfunction in sustained 
depressive-like state. 
In chapter 3, I aimed to explore how behavioral and ECM changes 
develop over time following social defeat stress. For this, I first temporally 
profiled behavioral disturbances, including affective dysfunction (social 
withdrawal) and hippocampal memory impairment following stress. This 
temporal profiling revealed fundamental differences between early stress 
and the later emerging depressive-like state. I observed an immediate 
effect of social defeat stress on cognition, that subsided in the weeks after 
stress, and re-emerged long after stress, when the depressive-like state 
is established. Importantly, the affective disturbances followed a different 
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trajectory, namely, they required weeks to develop and remained present 
for months once consolidated. In addition to behavioral profiling, I explored 
how hippocampal ECM remodeling develops following stress. I showed 
that cognitive dysfunction and ECM remodeling co-occur; both showing a 
biphasic regulation after stress. In particular, early after stress a decrease 
in perisynaptic ECM levels and in the number of PNNs was observed, 
accompanying spatial memory deficit. After this, both the ECM levels and 
memory function normalized and remained stable over several weeks. 
Only after > 5 weeks post stress increased ECM levels appeared, and the 
memory decline re-emerged. Altogether, this study highlighted a dichotomy 
in the effects of stress on the affective and cognitive domains. Moreover, 
the biphasic regulation of hippocampal ECM and function underscored the 
dynamic nature of stress effects and how stress recency plays an important 
role in determining the end molecular and behavioral phenotypes.
In chapter 4, I investigated the upstream mechanisms that could drive 
stress-triggered ECM remodeling. Specifically, in this exploratory study I 
assessed the role of metalloproteinase-mediated regulation of the ECM 
in driving stress effects. To test the hypothesis that stress-induced MMP-
mediated breakdown of ECM underlies hippocampal dysfunction, rats 
were administered a MMP inhibitor before each daily defeat encounter. 
Indeed, this intervention was effective against stress-induced hippocampal 
dysfunction. Yet, future work is needed to probe the underlying molecular 
mechanisms mediating these effects. 
In chapter 5, I aimed to set up a social defeat-based model for depression 
in mice, as the lager genetic toolbox available in this species allows for 
targeted circuit- and cell-specific interventions. For this aim, I developed a 
novel stress paradigm, in which physical social defeat was combined with 
vicarious defeat, witnessing the defeat of others, in order to strengthen the 
psychological aspect of stress. This paradigm, so forth termed “physical 
and vicarious social defeat-induced persistent stress (PVDPS)” induced 
persistent cognitive dysfunction, as assessed by spatial memory, up to 9 
weeks after stress. Notably, this deficit was not present early after stress 
as in the rat model, rather it only developed over the weeks following 
the last stress exposure. Conversely, affective disturbance, as assessed 
by social avoidance behavior, was present early after stress but did not 
persist. Similar to our rat model, we identified increased build-up of the 
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ECM, together with aberrant inhibitory transmission, that coincided with 
hippocampal memory deficit evident weeks after stress. Together, these 
findings highlighted a temporal disparity in stress-induced cognitive and 
affective disturbances in mice. Moreover, it highlighted fundamental 
differences between mice and rats in stress-driven adaptations related to 
affective behavior, which is an important consideration in study designs. 
Lastly, these findings provide further evidence for the crucial role of the 
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ABSTRACT
Patients with depression often suffer from cognitive impairments that 
contribute to disease burden. We used social defeat–induced persistent 
stress (SDPS) to induce a depressive-like state in rats and then studied 
long-lasting memory deficits in the absence of acute stressors in these 
animals. The SDPS rat model showed reduced short-term object location 
memory and maintenance of long-term potentiation (LTP) in CA1 
pyramidal neurons of the dorsal hippocampus. SDPS animals displayed 
increased expression of synaptic chondroitin sulfate proteoglycans in the 
dorsal hippocampus. These effects were abrogated by a 3-week treatment 
with the antidepressant imipramine starting 8 weeks after the last defeat 
encounter. Next, we observed an increase in the number of perineuronal 
nets (PNNs) surrounding parvalbumin-expressing interneurons and a 
decrease in the frequency of inhibitory postsynaptic currents (IPSCs) in 
the hippocampal CA1 region in SDPS animals. In vivo breakdown of the 
hippocampus CA1 extracellular matrix by the enzyme chondroitinase ABC 
administered intracranially restored the number of PNNs, LTP maintenance, 
hippocampal inhibitory tone, and memory performance on the object 
place recognition test. Our data reveal a causal link between increased 
hippocampal extracellular matrix and the cognitive deficits associated with 
a chronic depressive-like state in rats exposed to SDPS.
INTRODUCTION
Major depressive disorder (MDD) is a complex neuropsychiatric disorder 
that is characterized by persistent negative mood, a multifaceted anhedonic 
state, and impaired cognitive function113. MDD is considered one of the 
leading causes of disability worldwide, accounting for more lost productivity 
than any other psychiatric disorder113. A substantial part of this burden 
is attributed to the cognitive impairment that accompanies depression, 
including deficits in working and episodic memory6, which could persist 
beyond recovery from mood disturbances114. Despite compelling evidence 
linking these deficits to reduced hippocampal volume115 and impaired 
hippocampal function116, the molecular basis underlying the effects of MDD 
on cognition remains unclear. 
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Persistent stress responses, commonly triggered by stressful life events, 
are a potent causal factor in eliciting MDD21 and have major repercussions 
for hippocampal function117. In line with this, preclinical models of 
depression using acute stress consistently show hippocampal pathology, 
including reduced hippocampal long-term potentiation (LTP) and impaired 
hippocampus-mediated spatial learning60,118. In contrast, the chronic phase 
of depression in the months after initial stress exposure has only been 
scarcely explored, posing questions about the underlying neurobiological 
mechanisms. In an attempt to address this issue, we adopted the social 
defeat–induced persistent stress (SDPS) rat model in which a sustained 
depression-like state was elicited by exposure to five daily defeat episodes 
and individual housing for a period of 2 to 3 months in the absence of acute 
stressors111. Previously, the SDPS model has allowed us to investigate 
sustained affective and cognitive deficits on a variety of behavioral 
tests112,119. Here, we investigated the underlying mechanisms of cognitive 
dysfunction triggered by the chronic depressive-like state of rats exposed 
to SDPS112,119. 
RESULTS
SDPS induces imipramine-reversible 
deficits in hippocampus-mediated memory
We assessed the effects of a chronic depressive-like state on memory 
performance in rats exposed to the SDPS paradigm. We then examined 
the potentially restorative action of the tricyclic antidepressant drug 
imipramine (Fig. 1A). First, we confirmed that physiological (corticosterone) 
and behavioral adaptations (body weight and food intake) in response to 
acute social stress had completely subsided 8 weeks after the last defeat 
exposure (fig. S1)120. We then evaluated cognitive capacity using the object 
place recognition (OPR) test and novel object recognition (NOR) test, 
which assess short-term object location (spatial) and recollection memory, 
respectively121,122. SDPS impaired the retention of spatial information 
[P=0.044 versus vehicle-treated (H2O) control] expressed as reduced 
exploration of the displaced object during the test phase of the OPR task 
(Fig. 1B). Vehicle-treated control animals displayed a clear preference for 
the displaced object [control-H2O, P=0.041 versus a fictive control showing 
no discrimination (exploration index 0.50), while retaining the variation of 
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the tested sample ]123. In contrast, SDPS rats displayed no such preference 
(SDPS-H2O, P=0.478 versus fictive control), indicating a reduced ability to 
retain short-term memories. Oral imipramine administration during the last 
3 weeks of the SDPS paradigm (Fig. 1A), previously shown to ameliorate 
SDPS-induced hippocampal pathology120,124, normalized performance on 
the OPR test [two-way analysis of variance (ANOVA), group × treatment 
interaction effect, P=0.014; post hoc SDPS-H2O versus control-H2O, 
P=0.044; SDPS-imipramine versus control-imipramine, P=0.122; SDPS-
H2O versus SDPS-imipramine, P=0.010] (Fig. 1B). SDPS had no effect 
on the performance on the NOR test (P=0.819 versus control-H2O); both 
groups showed a preference for the novel object (control-H2O, P=0.005; 
SDPS-H2O, P=0.005 versus fictive control) (Fig. 1C). Similarly, treatment 
with the antidepressant imipramine did not affect the performance on the 
NOR test in either group (two-way ANOVA, group × treatment, P=0.379) 
(Fig. 1C). 
Given that the optimal performance on the OPR test requires an intact 
dorsal hippocampus125, we assessed the effects of the SDPS paradigm on 
synaptic plasticity in the dorsal hippocampus. SDPS reduced maintenance 
of LTP in the hippocampal CA1 subfield (0.8-fold; P=0.001 versus control-
H2O; fig. S2), and imipramine treatment reversed this effect (P=0.937 
versus control-imipramine), as previously reported124. Thus, the SDPS 
paradigm promoted an enduring depressive-like state in rats that was 
characterized by a reduction in hippocampal plasticity and deficits in 
short-term object location memory; these deficits were ameliorated by 
antidepressant treatment. Notably, individual housing alone devoid of 
the social defeat stress component did not affect the performance on the 
OPR test or LTP maintenance (fig. S2), indicating that SDPS specifically 
affected hippocampal function.
SDPS induces an imipramine-reversible 
increase in synaptic chondroitin sulfate proteoglycans
We next investigated SDPS-induced changes in the dorsal hippocampal 
synaptic proteome that might underlie the observed perturbations in 
plasticity and memory. These effects were not mediated by changes in 
the expression of AMPA or NMDA receptors126 in the synaptic membrane 
fraction or by global changes in the number of glutamatergic or GABAergic 
synapses, as reflected by no change in PSD-95 or gephyrin expression (fig. 
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S3). Therefore, we examined whether SDPS induced unique imipramine-
reversible changes in protein expression in the rat hippocampus. For 
this, we used an unbiased differential proteomics analysis of the dorsal 
hippocampal synaptic membrane fraction (n=5).
Figure 1. SDPS induces imipramine-reversible deficits in spatial memory. 
A) Rats underwent the SDPS paradigm, consisting of 5 daily defeat episodes and 
~3 months of individual housing. Pharmacotherapy (IMI; or control (H2O)) was 
applied only during the last three weeks of the isolation period, until behavioral 
assessment (object place recognition (OPR; B), novel object recognition (NOR; C). 
B) Exploration index during the test phase of the OPR task. SDPS impaired object 
location memory retention, and imipramine reversed this effect, with no effect 
in controls. C) Exploration index during the test phase of the NOR task. Neither 
SDPS nor IMI treatment affected recognition performance. Dotted line represents 
exploration at chance level (0.50); n=number of animals; *P<0.05. 
From a total of 519 proteins identified by mass spectrometry (≥2 distinct 
peptides; confidence interval, ≥95%), 37 proteins were significantly 
regulated by SDPS (P<0.05; adjusted for multiple testing)127. The 
expression of a subset of 18 proteins was restored by imipramine 
treatment. Overrepresentation analysis using gene ontology (GO) 
annotation128 revealed a large contribution of extracellular matrix proteins 
both in the total set (adjusted P=0.039; Fig. 2A) and among proteins whose 
expression was rescued by imipramine (adjusted P=0.025; Fig. 2B) (table 
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control showing no discrimination (exploration index 0.50), while 
retaining the variation of the tested sample] (16). In contrast, SDPS 
rats displayed no such preference (SDPS-H2O, P = 0.478 versus fic-
tive control), indicating a reduced ability to retain short-term mem-
ories. Oral imipramine administration during the last 3 weeks of the 
SDPS paradigm (Fig. 1A), previously shown to ameliorate SDPS- 
i duced hippocamp l pathology (13, 17), normalized performance 
on the OPR test [two-way analysis of variance (ANOVA), group × 
treatment interaction effect, P = 0.014; post hoc SDPS-H2O versus 
control-H2O, P = 0.044; SDPS-imipramine versus control-imipramine, 
P = 0.122; SDPS-H2O versus SDPS-imipramine, P = 0.010] (Fig. 1B). 
SDPS had no effect on the performance on the NOR test (P = 0.819 
versus control- H2O); both groups showed a preference for the novel 
object (control- H2O, P = 0.005; SDPS-H2O, P = 0.005 versus fictive 
control) (Fig. 1C). Similarly, treatment with the antidepressant imip-
ramine did not affect the performance on the NOR test in either 
group (two-way ANOVA, group × treatment, P = 0.379) (Fig. 1C).
Given that the optimal performance on the OPR test requires an 
intact dorsal hippocampus (18), we assessed the effects of the SDPS 
paradigm on synaptic plasticity in the dorsal hippocampus. SDPS re-
duced maintenance of LTP in the hippocampal CA1 subfield (0.8-fold; 
P = 0.001 versus control-H2O; fig. S2), and imipramine treatment 
reversed this effect (P = 0.937 versus control- imipramine), as previous-
ly reported (17). Thus, the SDPS paradigm promoted an enduring 
depressive-like state in rats that was characterized by a reduction in 
hippocampal plasticity and deficits in short- term object location 
memory; these deficits were ameliorated by antidepressant treatment. 
Notably, individual housing alone devoid of the social defeat stress 
component did not affect the performance on the OPR test or LTP 
maintenance (fig. S2), indicating that SDPS specifically affected hippo-
campal function.
SDPS induces an imipramine-reversible increase in synaptic 
chondroitin sulfate proteoglycans
We next investigated SDPS-induced changes in the dorsal hippo-
campal synaptic proteome that might underlie the observed pertur-
bations in plasticity and memory. These effects were not mediated 
by changes in the expression of AMPA or NMDA receptors (19) in 
the synaptic membrane fraction or by global changes in the number 
of glutamatergic or GABAergic synapses, as reflected by no change 
in PSD-95 or gephyrin expression (fig. S3). Therefore, we examined 
whether SDPS induced unique imipramine-reversible changes in pro-
tein expression in the rat hippocampus. For this, we used an unbiased 
differential proteomics analysis of the dorsal hippocampal synaptic 
membrane fraction (n = 5).
From a total of 519 proteins identified by mass spectrometry 
(≥2 distinct peptides; confidence interval, ≥95%), 37 proteins were 
significantly regulated by SDPS (P < 0.05; adjusted for multiple testing) 
(20). The expression of a subset of 18 proteins was restored by imi p-
ra mine treatment. Overrepresentation analysis using gene ontology 
(GO) annotation (21) revealed a large contribution of extracellular 
matrix proteins both in the total set (adjusted P = 0.039; Fig. 2A) and 
among proteins whose expression was rescued by imipramine (ad-
justed P = 0.025; Fig. 2B) (table S1). In particular, SDPS increased the 
expression of chondroitin sulfate proteoglycans (CSPGs; table S1), 
glycosaminoglycan- carrying lecticans that are considered to be major 
constituents of adult brain extracellular matrix (22). CSPGs reside 
in the perisynaptic space at contact sites with astrocytes, actively con-
tributing to the tetrapartite synaptic complex (23, 24). CSPGs assem-
ble into pericellular netlike formations that envelop interneurons, 
the so-called perineuronal nets (PNNs) (25).
In an independent group of animals (n = 4 to 5), we investigated 
the expression of seven core components of adult brain extracellu-
lar matrix, namely, the CSPGs aggrecan, brevican, neurocan, phos-
phacan, and versican. We also looked at the expression of the proteins 
tenascin-R a d hyaluronan and proteoglycan link protein 1 (HPLN1), 
which contribute to the assembly of PNNs, in the synapse-enriched 
fraction of the dorsal hippocampus. Quantitative immunoblotting 
confirmed the SDPS-induced increase in the expression of brevican 
(twofold; P = 0.016), neurocan (twofold; P = 0.001), phosphacan 
(1.9-fold; P = 0.010), and HPLN1 (1.8-fold; P = 0.009), compared to 
vehicle-treated control rats (Fig. 2, C to F, and fig. S4). SDPS had a 
modest but nonsignificant effect on the expression of tenascin-R 
(1.8-fold; P = 0.068), aggrecan (1.5-fold; P = 0.139), and versican 
(1.3-fold; P = 0.181) (Fig. 2, G and H, and fig. S4). Imipramine treat-
ment reversed SDPS-induced changes in CSPG expression and no 
significant differences between the two imipramine-treated groups 
(control-imipramine versus SDPS-imipramine) were detected (brevican, 
P = 0.230; neurocan, P = 0.443; phosphacan, P = 0.284; HPLN1, P = 
0.251) (Fig. 2, C to F). Aberrant CSPG expression was specific to the 
hippocampal synaptic membrane fraction because no increase in 
CSPG expression was detected in the tissue lysates collected before 
isolation of synaptic membranes (fig. S5). Together, these data es-
tablish that SDPS specifically alters the composition of perisynaptic 











































































































Fig. 1. SDPS induces deficits in rat spatial memory that are reversed by imip-
ramine. (A) Rats were exposed to the social defeat–induced persistent stress (SDPS) 
paradigm, consisting of five daily social defeat episodes and ~3 months of individual 
housing. Pharmacotherapy with imipramine (IMI) or vehicle (H2O) as control was ap-
plied during the last 3 weeks of the isolation period in both groups. Rats underwent 
behavioral assessment using the object place recognition (OPR) test (B) or the novel 
object recognition (NOR) test (C). (B) Exploration index during the test phase of the 
OPR task. SDPS impaired memory retention of the object location; imipramine re-
versed this deficit but had no effect on control animals. (C) Exploration index during 
the test phase of the NOR task. Neither SDPS nor imipramine treatment affected rec-
ognition performance. Dotted line represents exploration at chance level (0.50); n = 
number of animals; two-way ANOVA; post hoc Fisher’s LSD; *P < 0.05 (see table S2). 
†Significant memory retention (I) for P < 0.05, and #trend for P < 0.2 by unpaired t test.
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S1). In particular, SDPS increased the expression of chondroitin sulfate 
proteoglycans (CSPGs; table S1), glycosaminoglycan-carrying lecticans 
that are considered to be major  constituents of adult brain extracellular 
matrix64. CSPGs reside in the perisynaptic space at contact sites with 
astrocytes, actively contributing to the tetrapartite synaptic complex75,129. 
CSPGs assemble into pericellular netlike formations that envelop 
interneurons, the so-called perineuronal nets (PNNs)77. 
In an independent group of animals (n=4–5), we investigated the 
expression of seven core components of adult brain extracellular matrix, 
namely, the CSPGs aggrecan, brevican, neurocan, phosphacan, and 
versican. We also looked at the expression of the proteins tenascin-R and 
hyaluronan and proteoglycan link protein 1 (HPLN1), which contribute 
to the assembly of PNNs, in the synapse-enriched fraction of the dorsal 
hippocampus. Quantitative immunoblotting confirmed the SDPS-induced 
increase in the expression of brevican (twofold; P=0.016), neurocan 
(twofold; P=0.001), phosphacan (1.9-fold; P=0.010), and HPLN1 (1.8-fold; 
P = 0.009), compared to vehicle-treated control rats (Fig. 2, C–F, and fig. 
S4). SDPS had a modest but nonsignificant effect on the expression of 
tenascin-R (1.8-fold; P=0.068), aggrecan (1.5-fold; P=0.139), and versican 
(1.3-fold; P=0.181) (Fig. 2, G and H, and fig. S4). Imipramine treatment 
reversed SDPS-induced changes in CSPG expression and no significant 
differences between the two imipramine-treated groups (control-imipramine 
versus SDPS-imipramine) were detected (brevican, P = 0.230; neurocan, 
P=0.443; phosphacan, P=0.284; HPLN1, P=0.251) (Fig. 2, C-F). Aberrant 
CSPG expression was specific to the hippocampal synaptic membrane 
fraction because no increase in CSPG expression was detected in the 
tissue lysates collected before isolation of synaptic membranes (fig. S5). 
Together, these data establish that SDPS specifically alters the composition 
of perisynaptic extracellular matrix in the dorsal hippocampus and that 
imipramine reverses this effect. 
SDPS increases the number of PNNs and decreases
inhibitory transmission in the hippocampal CA1 region
We next examined whether SDPS affected the organization of CSPG-rich 
PNNs in the dorsal hippocampus67. Immunohistochemical analysis (Fig. 
3A and fig. S6) showed that the number of PNN-coated neurons was 
increased after SDPS (1.6-fold; P=0.032 versus control), specifically in 
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the CA1 subfield of the dorsal hippocampus (Fig. 3B). Characterization of 
these PNN-coated neurons in an independent set of animals revealed that 
this increase was unique to parvalbumin-expressing interneurons located 
in the CA1 stratum pyramidale of the hippocampus (1.4-fold; P=0.044 
versus control; Fig. 3C and fig. S7), where the vast majority (>90%) of 
PNN-associated cells are parvalbumin-positive (fig. S8). This was in 
the absence of changes in the overall intensity of PNN immunostaining 
(Fig. 3D and fig. S7). No group difference in the number of PNN-
coated parvalbumin-negative neurons (P=0.146) was detected (Fig. 
3C). SDPS had no effect on the number of PNNs located in the stratum 
oriens, where a much lower percentage (~50%) of PNN-coated parvalbumin-
positive interneurons was identified (fig. S8). Finally, in accordance with 
our behavioral data showing an absence of SDPS effects on the NOR test 
(Fig. 1C), we detected no SDPS-induced changes in the number of PNN-
coated neurons in the perirhinal cortex (fig. S9)130. 
PNNs are known to alter the structural and physiological properties of 
parvalbumin-positive neurons131,132. Therefore, we examined the effects 
of SDPS on CA1 stratum pyramidale interneuron morphology and their 
excitatory synaptic input. SDPS did not affect the total number of PNN-
coated parvalbumin-positive interneurons (P=1.00; Fig. 4A) but increased 
the intensity of parvalbumin immunoreactivity in these neurons (8%; 
P=0.008; Fig. 4B). A significant reduction (−10% versus control; P=0.043) 
in the fraction of cells with intermediate-low parvalbumin expression was 
observed after SDPS, which coincided with an increase in the fraction of 
interneurons with high expression of parvalbumin (17% versus control; 
P=0.002; Fig. 4, C and D). Notably, this intensity shift was not observed 
in parvalbumin-positive neurons that were not PNN-coated (Fig. 4D). 
Increased parvalbumin immunostaining has been associated with reduced 
structural synaptic plasticity in the hippocampus and a subsequent 
decrease in experience-dependent learning89. Therefore, we analyzed 
the density of bassoon-positive synaptic puncta in single confocal planes 
along the cell bodies of PNN-coated parvalbumin-positive interneurons. 
We found no between-group differences in perisomatic excitatory input 
onto these interneurons (Fig. 4, E and F). Overall, parvalbumin-positive 
PNN-free neurons received more excitatory input compared to their PNN-
coated counterparts, as indicated by increased bassoon-positive puncta 
(control, 12%; P=0.007). This increase in excitatory input onto parvalbumin-
positive PNN-free versus PNN-coated neurons was more pronounced in 
rats exposed to SDPS (24%; P=0.005; Fig. 4F).
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Figure 2. SDPS induces an imipramine-reversible increase of perisynaptic 
CSPGs in the dHPC. A,B) Proteomic analysis (iTRAQ) on dHPC synaptic 
membrane fraction at 3 months after the last defeat episode revealed 37 SDPS-
regulated proteins (adjusted P<0.05; A), and a subset of 18 imipramine-rescued 
proteins (IMI; adjusted P<0.1, SDPS-IMI vs. SDPS-H2O; A), in which extracellular 
matrix (ECM), and in particular chondroitin sulphate proteoglycans (CSPGs), were 
overrepresented (B). C-F) Independent immunoblot analysis revealed that SDPS 
increased the synaptic expression of several CSPGs (Brevican, C; Neurocan, D; 
Phosphacan, E) and PNN backbone (Hapln1, F) proteins, and that imipramine 
treatment reversed this effect. G,H) Immunoblots for TenascinR (160 and 180 kDa, 
G), Aggrecan and Versican (H) showed moderate effects of SDPS (0.05<P<0.20). 
I) Example blots of the SDPS-effect and imipramine-treatment show the 
specific protein band (apparent molecular weight); total protein loading used for 
normalization can be found in Fig. S4. n=number of samples; *P<0.05; **P<0.01.
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Fig. 2. SDPS induces increased perisynaptic CSPG expression in the dorsal hippocampus that is reversed by imipramine. (A and B) Proteomic analysis using iTRAQ 
of the dorsal hippocampal synaptic membrane fraction at 3 months after the last social defeat episode. The results revealed 37 SDPS-regulated proteins (adjusted P < 
0.05) (A). Expression of 18 of these proteins was rescued by treatment with imipramine (IMI; adjusted P < 0.1, SDPS-IMI versus SDPS-H2O) (A). Extracellular matrix (ECM) 
proteins, in particular, chondroitin sulfate proteoglycans (CSPGs), were overrepresented in both groups of 37 and 18 differentially expressed proteins (B). (C to F) Inde-
pendent immunoblot analysis revealed that SDPS increased the synaptic expression of several CSPGs, including brevican (C), neurocan (D), phosphacan (E), and the PNN 
backbone protein hyaluronan and proteoglycan link protein 1 (HPLN1) (F). Imipramine (IMI) treatment reversed this effect. (G and H) Immunoblots for tenascin-R (160 
and 180 kDa) ( ), aggrecan and versican (H) showed a moderate effect of SDPS on expression (0.05 < P < 0.20). (I) Representative example blots showing the effect of SDPS 
on protein expression and that imipramine treatment reversed this effect. The apparent molecular mass is indicated for the specific protein band; total protein loading 
used for normalization can be found in fig. S4. n = number of samples; PLGEM (A and B), one-way ANOVA (C, D, and F to H), Mann-Whitney (E); *P < 0.05 and **P < 0.01 
(see table S2).
31
Figure 3. SDPS increases CSPG-rich PNNs enwrapping CA1 parvalbumin-
expressing interneurons. A) PNN-coated cells and PV+ interneurons of the dHPC 
subfields were quantified in control vs. SDPS animals at 2 months after the last 
defeat (PNNs, Cat-301 antibody). PNN+ PV+ interneurons in CA1 are indicated by 
an arrowhead in the 40x magnification. B) SDPS increased the number of PNN+ 
cells in the CA1 region, but not in CA2/3 or the dentate gyrus (DG). C,D) The 
increase in PNN number was specific to PV+ interneurons of the CA1 stratum 
pyramidale (C), and was not accompanied by an alteration in PNN intensity (D). 
Scale bars (A) indicate 75 μm, or 25 μm (40x); n=number of animals; N=number 
of sections; *P<0.05.
Given the larger number of PNN-coated parvalbumin-positive neurons in 
SDPS rats versus controls (Fig. 3C), our data suggested that there could 
be changes in the inhibitory output of parvalbumin-positive interneurons, 
contributing to the memory deficits observed after SDPS133. To test this, 
we recorded spontaneous inhibitory postsynaptic currents (sIPSCs) in 
hippocampal CA1 pyramidal neurons and found that SDPS reduced their 
frequency (SDPS, 4.56 ±0.6 Hz; control, 6.67 ± 0.9 Hz; P=0.018; Fig. 4, 
G and H), without affecting their amplitude (P=0.229; Fig. 4H). Together, 
our data establish that SDPS increased the number of CSPG-rich PNN-
coated parvalbumin-expressing interneurons, which received reduced 
excitatory perisomatic synaptic input. Furthermore, pyramidal neurons in 
the hippocampal CA1 subfield of SDPS animals showed reduced inhibitory 
input. 
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SDPS increases the number of PNNs and decreases 
inhibitory transmission in the hippocampal CA1 region
We next examined whether SDPS affected the organization of CSPG-
rich PNNs in the dorsal hippocampus (26). Immunohistochemical 
analysis (Fig. 3A and fig. S6) showed that the number of PNN-coated 
neurons was increased after SDPS (1.6-fold; P = 0.032 versus con-
trol), specifically in the CA1 subfield of the dorsal hippocampus 
(Fig. 3B). Characterization of these PNN-coated neurons in an in-
dependent set of animals revealed that this increase was unique to 
parvalbumin-expressing interneurons located in the CA1 stratum 
pyramidale of the hippocampus (1.4-fold; P = 0.044 versus control; 
Fig. 3C and fig. S7), where the vast majority (>90%) of PNN-associated 
cells are parvalbumin-positive (fig. S8). This was in the absence of 
changes in the overall intensity of PNN immunostaining (Fig. 3D and 
fig. S7). No group difference in the number of PNN-coated 
parvalbumin-negative neurons (P = 0.146) was detected (Fig. 3C). 
SDPS had no effect on the number of PNNs located in the stratum 
oriens, where a much lower percentage (~50%) of PNN-coated 
parvalbumin-positive interneurons was identified (fig. S8). Finally, 
in accordance with our behavioral data showing an absence of SDPS 
effects on the NOR test (Fig. 1C), we detected no SDPS-induced 
changes in the number of PNN-coated neurons in the perirhinal cor-
tex (fig. S9) (27).
PNNs are known to alter the structural and physiological prop-
erties of parvalbumin-positive neurons (28, 29). Therefore, we ex-
amined the effects of SDPS on CA1 stratum pyramidale interneu-
ron morphology and their excitatory synaptic input. SDPS did not 
affect the total number of PNN-coated parvalbumin-positive inter-
neurons (P = 1.00; Fig. 4A) but increased the intensity of parvalbu-
min immunoreactivity in these neurons (8%; P = 0.008; Fig. 4B). A 
significant reduction (−10% versus control; P = 0.043) in the fraction 
of cells with intermediate-low parvalbumin expression was observed 
after SDPS, which coincided with an increase in the fraction of in-
terneurons with high expression of parvalbumin (17% versus con-
trol; P = 0.002; Fig. 4, C and D). Notably, this intensity shift was not 
observed in parvalbumin-positive neurons that were not PNN-coated 
(Fig. 4D). Increased parvalbumin immunostaining has been associ-
ated with reduced structural synaptic plasticity in the hippocampus 
and a subsequent decrease in experience-dependent learning (30). 
Therefore, we analyzed the density of bassoon-positive synaptic 
puncta in single confocal planes along the cell bodies of PNN-coated 
parvalbumin-positive interneurons. We found no between-group 
differences in perisomatic excitatory input onto these interneurons 
(Fig. 4, E and F). Overall, parvalbumin-positive PNN-free neurons 
received more excitatory input compared to their PNN-coated coun-
terparts, as indicated by increased bassoon-positive puncta (control, 
12%; P = 0.007). This increase in excitatory input onto parvalbumin- 
positive PNN-free versus PNN-coated neurons was more pronounced 
in rats exposed to SDPS (24%; P = 0.005; Fig. 4F).
Given the larger number of PNN-coated parvalbumin-positive 
neurons in SDPS rats versus controls (Fig. 3C), our data suggested 
that there could be changes in the inhibitory output of parvalbumin- 
positive interneurons, contributing to the memory deficits observed 
after SDPS (31). To test this, we recorded spontaneous inhibitory 
postsynaptic currents (sIPSCs) in hippocampal CA1 pyramidal neu-
rons and found that SDPS reduced their frequency (SDPS, 4.56 ± 
0.6 Hz; control, 6.67 ± 0.9 Hz; P = 0.018; 
Fig. 4, G and H), without affecting their 
amplitude (P = 0.229; Fig. 4H). Together, 
our data establish that SDPS increased 
the number of CSPG-rich PNN-coated 
parvalbumin-expressing interneurons, 
which received reduced excitatory peri-
somatic synaptic input. Furthermore, py-
ramidal neurons in the hippocampal CA1 
subfield of SDPS animals showed reduced 
inhibitory input.
Extracellular matrix reorganization 
ameliorates SDPS-induced deficits 
in hippocampal memory
To assess whether the altered inhibitory 
tone after SDPS was causally linked to syn-
aptic up-regulation of CSPG expression 
and the ensuing rise in the number of 
PNNs, we enzymatically digested CSPGs 
by intrahippocampal application of chon-
droitinase ABC (Fig. 5A). Penicillinase- 
treated rats were used to control for the 
stereotactic injection because this enzyme 
has no endogenous substrate (32). We pro-
ceeded with cellular, physiological, and 
behavioral assessments of the effects of 
chondroitinase ABC at ~2 weeks after 
administration. This time point was se-
lected to allow for a partial recovery of 







































































































































ig. 3. SDPS increases the number of PNN-coated parvalbumin-expressing interneurons in the hippocampus. 
(A) PNN-coated (PNN+) parvalbumin-positive (PV+) interneurons of the dorsal hippocampal subfields w re quanti-
fied for control ve sus SDPS rats at 2 months after the last defeat. Double-immunopositive interneurons (PNN+ PV+) 
in the hippocampus A1 region are indicated by white arrows in the 40× magnification images. (B) SDPS increased 
the number of PNN+ cells in the CA1 region but not in CA2/3 or the dentate gyrus (DG) regions of the hippocampus. 
(C and D) The increase in PNN number was specific for PV+ interneurons of the hippocampal CA1 stratum pyramidale 
region (C) and was not accompanied by an alteration in PNN intensity (D). Scale bars (A), 75 or 25 mm (40×); n = num-
ber of animals; N = number of sections; one-way ANOVA (B and C); paired t test (D); *P < 0.05 (see table S2).
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Extracellular matrix reorganization ameliorates 
SDPS-induced deficits in hippocampal memory
To assess whether the altered inhibitory tone after SDPS was causally 
linked to synaptic up-regulation of CSPG expression and the ensuing 
rise in the number of PNNs, we enzymatically digested CSPGs by 
intrahippocampal application of chondroitinase ABC (Fig. 5A). Penicillinase-
treated rats were used to control for the stereotactic injection because 
this enzyme has no endogenous substrate92. We proceeded with cellular, 
physiological, and behavioral assessments of the effects of chondroitinase 
ABC at ~2 weeks after administration. This time point was selected to 
allow for a partial recovery of the extracellular matrix, as reflected by a 
postadministration increase in the number of PNNs in control animals 
and an increase in the expression of synaptic CSPGs in SDPS animals 
(fig. S10). After the intracranial administration of chondroitinase ABC, 
the SDPS-induced alteration of the extracellular matrix was normalized 
(one-way ANOVA; group, P=0.008), as shown by the decreased 
number of PNNs in the SDPS-chondroitinase group (post hoc SDPS-
penicillinase versus control-penicillinase, P=0.026; SDPS-chondroitinase 
versus control-chondroitinase, P=0.281; SDPS-penicillinase versus 
SDPS-chondroitinase, P=0.007) (Fig. 5, B and C). Chondroitinase ABC 
treatment decreased the number of PNNs in control rats (fig. S10) (control-
chondroitinase versus control-penicillinase, P=0.040). 
The chondroitinase ABC-induced reorganization of the extracellular matrix 
normalized the hippocampal inhibitory tone in SDPS rats (one-way ANOVA; 
group, P=0.035; Fig. 5, D and E). First, we confirmed that SDPS reduced 
the frequency of sIPSCs onto pyramidal neurons of the hippocampal CA1 
region (control-penicillinase, 5.04±0.49 Hz; SDPS-penicillinase, 3.36±0.41
Hz; P=0.031). Next, we showed that chondroitinase ABC treatment 
reversed this effect (SDPS-chondroitinase versus control-chondroitinase, 
P=0.683; SDPS-chondroitinase versus SDPS-penicillinase, P=0.008), 
with sIPSC frequency returning to control values (control-chondroitinase, 
5.06±0.61 Hz; SDPS-chondroitinase, 5.37±0.58 Hz; P=0.979). No effect 
on sIPSC amplitude was detected (fig. S11).
In independent groups of animals, chondroitinase-induced reorganization 
of the extracellular matrix rescued the impaired hippocampal plasticity after 
SDPS (one-way ANOVA; group, P=0.040; Fig. 5, F and G). The robust 
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Fig. 4. SDPS alters parvalbumin-positive interneuron properties and decreases 
inhibitory transmission in the hippocampus. (A and B) In the hippocampal CA1 
stratum pyramidale, SDPS did not affect the total number of parvalbumin-positive 
interneurons having a PNN coat (PNN+ PV+) (A) but did cause a moderate (7.8±1.0%) 
increase in the intensity of parvalbumin immunoreactivity in SDPS versus control 
animals (B). (C and D) Representative examples of labeling of hippocampal CA1 
parvalbumin- positive interneurons in SDPS and control animals (high intensity, 
white arrowheads; intermediate-low intensity, yellow arrowheads) (C). (D) Within Riga et al., Sci. Transl. Med. 9, eaai8753 (2017)     20 December 2017































































































































































































































































Fig. 4. SDPS alters parvalbumin-positive interneuron properties and decreases inhibitory transmission in the hippocampus. (A and B) In the hippocampal CA1 
stratum pyramidale, SDPS did not affect the total number of parvalbumin-positive interneurons having a PNN coat (PNN+ PV+) (A) but did cause a moderate (7.8 ± 1.0%) increase 
in the intensity of parvalbumin immunoreactivity in SDPS versus control animals (B). (C and D) Representative examples of labeling of hippocampal CA1 parvalbumin- 
positive interneurons in SDPS and control animals (high intensity, white arrowheads; intermediate-low intensity, yellow arrowheads) (C). (D) Within double-immunopositive 
(PNN+ PV+) interneurons, SDPS decreased the fraction of intermediate-low parvalbumin– xpressing cells (control, 22.1%; SDPS, 11.8%) and increa ed the fraction of 
high parvalbumin–expressing interneurons (control, 26.2%; SDPS, 44.1%) (D, left). No difference in the fraction of low or intermediate-high parvalbumin–expressing 
interneurons was observed. No intensity shift was observed in PNN-free parvalbumin-positive (PNN− PV+) interneurons (D, right). (E and F) Quantification of bassoon-positive 
(Bs+) puncta showed no effect of SDPS on perisomatic excitatory input onto PNN+ PV+ interneurons [representative example (E)]. In control and SDPS animals alike, PNN− PV+ 
interneurons showed increased density of Bs+ puncta versus PNN+ PV+ cells (F). AU, arbitrary units. (G) Example traces of whole-cell patch-clamp recordings (5 s) of hippo-
campal CA1 pyram idal neurons. (H) SDPS reduced sIPSC frequency (left) while leaving amplitude unaffected (right). Scale bars, 50 mm (C) or 20 mm (E); str.or, stratum 
oriens; str.pyr, stratum pyramidale; str.rad, stratum radiatum; n = number of animals; N = number of sections/slices; Mann-Whitney (A and F); paired t test (B and F); one-way 
ANOVA (D and F); *P < 0.05 and **P < 0.01 (see table S2).
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double-immunopositive (PNN+ PV+) interneurons, SDPS decreased the fraction 
of intermediate-low parvalbumin–expressing cells (control, 22.1%; SDPS, 11.8%) 
and increased the fraction of high parvalbumin–expressing interneurons (control, 
26.2%; SDPS, 44.1%) (D, left). No difference in the fraction of low or intermediate-
high parvalbumin–expressing interneurons was observed. No intensity shift was 
observed in PNN-free parvalbumin-positive (PNN− PV+) interneurons (D, right). 
(E and F) Quantification of bassoon-positive (Bs+) puncta showed no effect of 
SDPS on perisomatic excitatory input onto PNN+ PV+ interneurons [representative 
example (E)]. In control and SDPS animals alike, PNN− PV+ interneurons showed 
increased density of Bs+ puncta versus PNN+ PV+ cells (F). AU, arbitrary units. 
(G) Example traces of whole-cell patch-clamp recordings (5 s) of hippo-campal 
CA1 pyramidal neurons. (H) SDPS reduced sIPSC frequency (left) while leaving 
amplitude unaffected (right). Scale bars, 50 mm (C) or 20 mm (E); str.or, stratum 
oriens; str.pyr, stratum pyramidale; str.rad, stratum radiatum; n=number of animals; 
N=number of sections/slices; Mann-Whitney (A and F); paired t test (B and F); one-
way ANOVA (D and F); *P<0.05 and **P<0.01 (see table S2).
reduction in LTP maintenance (0.9-fold; SDPS-penicillinase versus control-
penicillinase, P=0.037) was absent in chondroitinase ABC–treated rats 
(SDPS-chondroitinase versus control-chondroitinase, P=0.287; SDPS-
chondroitinase versus SDPS-penicillinase, P=0.007). LTP normalization 
after chondroitinase ABC treatment could be measured for up to 3 weeks 
after treatment. Given the concordant restoration of LTP and sIPSCs after 
chondroitinase ABC administration, we next examined whether restoration 
of the hippocampal network coincided with improved short-term object 
location memory (Fig. 5, H and I). SDPS-induced deficits on performance 
on the OPR test were abrogated after chondroitinase ABC administration 
(two-way ANOVA; group × treatment, P=0.012; post hoc, SDPS-
penicillinase versus control-penicillinase, P=0.053; SDPS-chondroitinase 
versus control-chondroitinase, P=0.044; SDPS-penicillinase versus SDPS-
chondroitinase, P=0.004). Notably, whereas object location memory was 
absent in penicillinase-treated SDPS rats (P=0.477 versus fictive control), 
chondroitinase-treated SDPS rats displayed intact object location memory 
(P=0.001 versus fictive control), similar to that of penicillinase-treated 
con-trol rats (P=0.012 versus fictive control). In addition, chondroitinase 
ABC treatment attenuated the debilitating effects of SDPS on social 
recognition memory based on the performance in a social recognition 
test using a juvenile conspecific (fig. S12). Together, these data show that 
chondroitinase ABC reversed the SDPS-evoked increase in the number of 
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PNN-coated parvalbumin-positive interneurons in the hippocampal CA1 
region and restored sIPSC frequency, LTP, and object location and social 
recognition memory.
DISCUSSION
Cognitive impairment  associated with MDD has been well 
characterized134–136. This includes deficits in declarative and spatial 
memory137,138, supporting a role for hippocampus-mediated dysfunction 
and other related (endo)phenotypes, for example, decreased hippocampal 
volume, in MDD39. However, the molecular mechanisms underlying this 
association remain to be elucidated. Here, we used a preclinical rat 
model that induces several long-lasting depressive-like behaviors112,119 to 
investigate the connection between hippocampal pathology and cognitive 
deficits. Our data indicate a causal relationship between aberrant synaptic 
CSPG expression, alterations in the number of PNNs, and dysregulation 
of the hippocampal network that, together, mediate cognitive impairments 
in our rat model.
Collectively, our data highlight the dorsal hippocampus as a 
principal mediator of cognitive deficits in the SDPS paradigm. At the 
behavioral level, SDPS impaired short-term object location memory, 
as assessed by the OPR test121, a task that necessitates recollection 
of spatial cues and uses the dorsal hippocampus for optimal 
performance125. SDPS did not affect object recognition in the NOR test, 
which evaluates the novelty of an object independent of its spatial location 
and remains intact after loss of most of dorsal hippocampal volume125.
At the physiological level, SDPS reduced the plasticity potential of the dorsal 
hippocampus, as reflected by decreased LTP maintenance, as reported 
previously124. This synaptic plasticity phenotype correlates with the location 
memory deficit we observed because it was shown that interference 
with hippocampal CA1 LTP affects spatial memory performance139,140. 
Important for the predictive validity of our observations was the finding 
that antidepressant treatment given months after the last exposure to 
social stress reversed this cognitive phenotype both at the behavioral and 
physiological level in our SDPS rat model. 
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Fig. 5. Intrahippocampal chondroitinase ABC administration restores PNNs, 
hippocampal function, and memory recall after SDPS.
(A) After exposure to SDPS or no exposure (control), animals received either 
intrahippocampal administration of chondroitinase ABC (ChABC) or penicillinase 
(Peni) as a control. Performance on the object place recognition (OPR) test 
Riga et al., Sci. Transl. Med. 9, eaai8753 (2017)     20 December 2017

































































































































































































































































































Fig. 5. Intrahippocampal chondroitinase ABC administration restores PNNs, hippocampal function, and memory recall after SDPS. (A) After exposure to SDPS or 
no exposure (control), animals received either intrahippocampal administration of chondroitinase ABC (ChABC) or penicillinase (Peni) as a control. Performance on the 
object place recognition (OPR) test was assessed 12 days after administration (H and I) and was followed by LTP measurements at 12 to 24 days after treatment (F and 
G). Immunohistochemistry (B and C) and sIPSC recordings (D and E) were performed at 12 to 14 days after treatment. (B and C) SDPS increased the number of double- 
immunopositive (PNN+ PV+) interneurons [representative example, (C)], and treatment with chondroitinase ABC reversed this effect. Chondroitinase ABC treatment reduced 
the number of PNN+ PV+ neurons co pared to penicillinase treatment. (D and E) Frequency of sIP Cs [representative example traces, (D)] was reduced after SDPS, and 
chondroitinase ABC treatment rescued this effect. Chondroitinase ABC treatment had no effect on sIPSC frequency in control rats. (F and G) Maintenance of LTP, expressed 
as fEPSP slope, was decreased in SDPS rats and restored after chondroitinase ABC treatment. Chondroitinase ABC treatment had no effect on LTP maintenance in control 
animals. (G) Representative example of placement on the MED-64 grid with fEPSP traces before and after (gray/black, respectively) high-frequency stimulation to induce 
LTP. (H and I) Rats exposed to the SDPS paradigm showed impaired object location memory on the OPR test, and chondroitinase ABC reversed this effect. (H) Representative 
example of animal movements during the OPR test. Yellow squares represent the displaced object. Scale bar (C), 25 mm. Dotted line represents baseline fEPSP slope before high- 
frequency stimulation (F) or exploration at the chance level (0.50) (I); n = number of animals; N = number of cells/sections; one-way ANOVA and post hoc Fisher’s LSD (B, E, and F); 
two-way ANOVA and post hoc Fisher’s LSD (I); *P < 0.05 and **P < 0.01 (see table S2). †Significant memory retention (I) for P < 0.05, and #trend for P < 0.2 by unpaired t test.
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was assessed 12 days after administration (H and I) and was followed by LTP 
measurements at 12 to 24 days after treatment (F and G). Immunohistochemistry 
(B and C) and sIPSC recordings (D and E) were performed at 12 to 14 days after 
treatment. (B and C) SDPS increased the number of double-immunopositive 
(PNN+ PV+) interneurons [representative example, (C)], and treatment with 
chondroitinase ABC reversed this effect. Chondroitinase ABC treatment reduced 
the number of PNN+ PV+ neurons compared to penicillinase treatment. (D and 
E) Frequency of sIPSCs [representative example traces, (D)] was reduced after 
SDPS, and chondroitinase ABC treatment rescued this effect. Chondroitinase ABC 
treatment had no effect on sIPSC frequency in control rats. (F and G) Maintenance 
of LTP, expressed as fEPSP slope, was decreased in SDPS rats and restored after 
chondroitinase ABC treatment. Chondroitinase ABC treatment had no effect on 
LTP maintenance in control animals. (G) Representative example of placement on 
the MED-64 grid with fEPSP traces before and after (gray/black, respectively) high-
frequency stimulation to induce LTP. (H and I) Rats exposed to the SDPS paradigm 
showed impaired object location memory on the OPR test, and chondroitinase ABC 
reversed this effect. (H) Representative example of animal movements during the 
OPR test. Yellow squares represent the displaced object. Scale bar (C), 25 mm. 
Dotted line represents baseline fEPSP slope before high- frequency stimulation (F) 
or exploration at the chance level (0.50) (I); n = number of animals; N = number 
of cells/sections; one-way ANOVA and post hoc Fisher’s LSD (B, E, and F); two-
way ANOVA and post hoc Fisher’s LSD (I); *P<0.05 and **P<0.01 (see table S2). 
†Significant memory retention (I) for P < 0.05, and #trend for P<0.2 by unpaired 
t-test.
At the molecular level, analysis of the dorsal hippocampus synaptic proteome 
in SDPS rats implicated proteins of the extracellular matrix, and in particular, 
CSPGs, in the observed cognitive impairment and its subsequent rescue 
by the antidepressant drug imipramine. These changes were most likely 
occurring in glutamatergic synapses by virtue of the biochemical isolation 
of the synaptic membrane fraction141. The brevican-rich perisynaptic 
extracellular matrix142 acts as a diffusion barrier for AMPA receptor lateral 
mobility, locally altering short-term synaptic plasticity73. Bidirectional 
alterations in the composition of CSPG-rich extracellular matrix, driven 
both by genetic143–146 and by pharmacological manipulations147–150, impair 
hippocampal LTP and hippocampal-mediated memory processes. Thus, it 
is possible that the robust synaptic up-regulation of CSPGs observed after 
SDPS affects plasticity at the tetrapartite synapse151, disrupts incoming 
local and distal excitatory signaling, and thereby impairs hippocampal 
physiology and memory formation and recall. Indeed, changes in matrix 
metalloproteinase activity, which regulate extracellular matrix proteolysis, 
have been reported to drive stress- induced CA1-mediated cognitive 
deficits152.
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At the cellular level, SDPS-induced effects on PNNs were linked to 
interneurons of the CA1 stratum pyramidale that expressed parvalbumin. 
In particular, we showed that SDPS induced an increase in the number 
of parvalbumin-expressing interneurons coated by PNNs. This was in 
parallel with increased expression of parvalbumin selectively in PNN-
coated interneurons that received less excitatory perisomatic synaptic 
input compared to their PNN-free counterparts. PNN organization is 
critical for the intrinsic structural and functional properties of parvalbumin-
expressing neurons153–155, including regulation of their excitability131. 
Notably, the presence of PNNs has been reported to correlate directly with 
the expression of parvalbumin132,156, which is a hallmark of cellular activity89.
Our data argue that SDPS-induced adaptations in PNN-coated parvalbumin-
positive neurons of the hippocampus CA1 region, together with the observed 
increase in perisynaptic extracellular matrix, may elicit a reduction in the 
inhibitory output of parvalbumin-positive interneurons, leading to decreased 
sIPSC frequency in hippocampal CA1 principal neurons. Supporting this 
notion, after chronic mild stress, an antidepressant-reversible reduction 
in sIPSC frequency has been associated with decreased GABA release 
probability in the hippocampus dentate gyrus157. Likewise, an imipramine-
induced increase in sIPSC frequency was accompanied by altered GABA 
presynaptic release in the hippocampus CA1 region158.
Although sIPSCs represent the combined diverse inhibitory inputs 
that characterize the hippocampal network159, we hypothesized that 
the observed effect of decreased inhibitory input is driven by reduced 
parvalbumin-dependent perisomatic inhibition, which is the predominant 
inhibitory input onto hippocampus CA1 pyramidal cells160,161. We show that 
in rats exposed to the SDPS paradigm and treated with chondroitinase ABC, 
there was a restoration of the number of PNN-coated parvalbumin-positive 
interneurons and a rescue of the sIPSC phenotype. Chondroitinase-
mediated PNN removal has been reported to increase the excitability 
of parvalbumin-positive neurons in vitro131, indicating that an aberrant 
increase in extracellular matrix could lead to a reduction in interneuron 
excitability and a subsequent decrease in sIPSC frequency. Our data 
showing reduced excitatory puncta in PNN-coated parvalbumin-positive 
neurons support this hypothesis.
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Parvalbumin-positive neurons are essential for proper functioning of the 
hippocampal network through their direct effects on hippocampal CA1 
principal neurons162,163 and subsequent modulation of hippocampal gamma 
oscillations164,165. We demonstrated that restoration of the number of PNN-
coated parvalbumin-positive neurons by intrahippocampal administration 
of chondroitinase ABC coincided with improved hippocampal inhibitory tone 
(sIPSC frequency) and plasticity (LTP maintenance). We propose that there 
may be a common extracellular matrix–associated molecular mechanism 
that drives hippocampal pathology after SDPS. In line with this, transgenic 
mice deficient in the TnR gene, which show reduced perisomatic inhibition, 
display a metaplastic increase in LTP induction threshold166 , indicating 
interdependence between extracellular matrix, inhibitory transmission, 
and plasticity in the hippocampus. Furthermore, chondroitinase ABC 
administration rescued SDPS-induced cognitive deficits on object location, 
suggesting that impaired hippocampus-mediated memory function is due 
to extracellular matrix changes at both the perisynaptic (that is, CSPGs) 
and the pericellular (that is, PNN) levels.
An attractive hypothesis is that the presence of PNNs92,132, similar 
to increased expression of parvalbumin89, marks the maturation of 
parvalbumin-positive interneurons. Thereafter, these cells participate 
in a network configuration that is characterized by low plasticity used to 
maintain already established behavioral patterns167,168. In our rat model 
that shows a sustained depressive-like state, elevated synaptic CSPG 
expression, and the increased number of PNN-coated parvalbumin-positive 
interneurons in the hippocampus CA1 region may have contributed to 
reduced hippocampal plasticity, promoted the embedding of maladaptive 
memories, and hindered the (re)consolidation of (updated) information, as 
shown previously63,93. The extracellular matrix reorganization after either 
chronic imipramine treatment or a single chondroitinase ABC treatment 
could act to boost hippocampal plasticity and subsequently memory 
function in rats exposed to the SDPS paradigm. Supporting this notion, 
chronic fluoxetine treatment in mice was reported to reduce the number 
of PNN-coated parvalbumin-positive neurons in hippocampal CA1 and 
in the amygdala, rendering parvalbumin-positive neurons in a state of 
dematuration63. This effect was associated with a reactivation of juvenile 
plasticity that facilitated memory processes, including memory overwrite 
and incorporation of updated information63,93.
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There are a number of limitations to our study. Although we found evidence 
for extracellular matrix–associated alterations in the cognitive component 
associated with depressive-like behavior, what drives these changes 
remains to be understood. Future studies will need to examine the role 
of cell-type specific contributions to synthesis, release, and degradation 
of extracellular matrix proteins in the SDPS model. Likewise, it would be 
useful to examine whether extracellular matrix–related changes are seen 
in different brain areas (for example, cortical areas) known to be associated 
with cognitive deficits in depression169. Moreover, it will be of interest to 
investigate whether the antidepressant effects of chondroitinase ABC 
on cognitive behavior last beyond 3 weeks and, if so, how the interplay 
between extracellular matrix production and breakdown is regulated in the 
long term.
Preclinical data in animal models, such as our SDPS rat model showing 
several depressive-like behaviors, need to be interpreted with caution. Our 
data would be strengthened by clinical evidence of extracellular matrix–
related changes in postmortem brain tissue from MDD patients, as has 
been shown for schizophrenia170. Moreover, although SDPS affects both 
object place and social recognition memory119 and both are ameliorated by 
chondroitinase ABC treatment, future studies will need to investigate other 
type of cognitive behaviors.
Our data indicate that components of the extracellular matrix contribute 
to reduced plasticity potential and impaired memory processes in the 
SDPS rat model. Our study suggests that translational strategies aimed at 
restoring altered extracellular matrix organization, PNN integrity, or related 
inhibitory network function171 deserve further exploration as potential 
targets for alleviating cognitive deficits in MDD.
MATERIALS AND METHODS
Study design
The present study consists of a series of experiments using multiple 
molecular (biochemical assays and proteomics), cellular (immuno-
histochemistry and electrophysiology), and behavioral techniques to 
examine sustained depressive-like behavior in the SDPS rat model. 
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Independent groups of animals were used for each technique and to 
cross-validate results [for example, isobaric tags for relative and absolute 
quantitation (iTRAQ)–based proteomics versus proteomic analysis using 
immunoblots] or to investigate treatment effects (for example, the effect 
of chondroitinase ABC treatment on sIPSCs). Groups were randomly 
assigned, except for intervention experiments (Fig. 5), in which groups 
were balanced using baseline OPR test results. When applicable (Fig. 5, F 
to I), experiments were carried out using independent batches of animals 
yet combining experiments with low impact and carryover to adhere to the 
3-R principle of ethical use of experimental animals. No between-batch 
differences were observed. In all experiments, researchers were blinded 
to the group or treatment protocol when measurements were being taken 
and upon initial analysis of between group effects. 
Animals
Male Wistar rats (Harlan) aged 6 to 8 weeks were habituated after arrival 
to housing, handling, and reversed day/night cycle (2 weeks). Rats were 
exposed to the SDPS paradigm120, starting with five single daily exposures 
to social defeat stress. From the first defeat episode onward, SDPS rats 
(≥9 weeks old) were single-housed, deprived from standard home-cage 
enrichment. Control rats were pair-housed and daily handled and/or 
exposed to an empty social defeat apparatus during the defeat exposure 
of the SDPS group. Individually housed controls were isolated for a period 
of 2 to 3 months, devoid of defeat. Animals were housed in temperature-
controlled rooms (21±1 °C). Long-Evans male rats (Charles River, UK) 
were used as residents for social defeat120. Residents were pair-housed 
with age-matched sterilized females in plastic cages (defeat apparatus: 
63 x 25 x 33 cm, transparent) located in a separate room. Defeat was 
conducted as previously described119. In brief, Wistar rats were placed 
inside the defeat apparatus for a total of 15 minutes with a pre-fight and 
a post-fight phase of 5 minutes in which they were separated from the 
resident by a perforated Plexiglas wall. The partition wall was removed for 
a 5-minute fight-phase, during which Wistars were attacked and forced to 
submission. After the defeat, Wistar rats returned to their own cage, located 
in a room different from the room the Long-Evans rats were housed. All 
experimental manipulations were conducted during the dark phase (activity 
period) under a dim red light. Food and water were available ad libitum.
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Whenever applicable, the antidepressant imipramine (20 mg/kg per 
0.5 ml of water; Sigma-Aldrich) was orally (gavage or via water bottle) 
administrated during the last 3 weeks of the social isolation period. All 
behavioral, electrophysiological, and molecular analyses were performed 
at the end of treatment/after intervention in independent groups of rats 2 
to 3 months after the last defeat, unless stated otherwise. All experiments 
were approved by the Animal Users Care Committee of the VU University 
Amsterdam and were performed in accordance with the relevant guidelines 
and regulations.
Behavioral assessment
Habituation to testing arenas
All animals were habituated to the testing arenas (79 x 57 x 42 cm, plastic, 
opaque) before they were subjected to any behavioral experiments. 
Habituation consisted of daily transport to the video-recording room and 
free exploration of the empty testing arenas for at least 10 minutes during 
the 3 days prior to behavioral readouts. Furthermore, all animals were 
allowed 5 minutes of habituation to the empty arenas before the start of 
each task for OPR, NOR, SR and SAA.
object place recognition (opr) task
Hippocampal-dependent short-term object location memory was determined 
with the OPR test121 using a 15-min retention interval. Discrimination 
between spatial locations of objects was used as measurement for spatial 
memory [exploration index = time spent in active zone (novel location)/
total exploration time (novel + familiar location)] in a 4-min test. The 
configuration of the object’s novel place was counterbalanced such that 
on each trial, a different corner was used as a familiar and novel location. 
Objects were randomly assigned between groups to avoid the development 
of preference. 
novel object recognition (nor) task
Short-term recognition memory was determined with the NOR test 
using a 15-min retention interval. Discrimination between objects was 
estimated on the basis of preference for the novel object [exploration 
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index = time spent in active zone (novel object)/total exploration time 
(novel + familiar object)]. Objects were randomly assigned between 
groups to avoid development of preference.
social approacH avoidance (saa) task 
SDPS-induced deficits in social behavior were determined by the SAA test, 
using an unfamiliar Long-Evans adult male rat (i.e., an SDPS-resident that 
the Wistar rat did not encounter before). SAA was conducted as described 
previously119. In brief, animals were given a 5-minute sampling phase, 
during which they were allowed to freely explore two empty target boxes 
(TBs, perforated, transparent, plastic, 23× 11 × 34 cm) placed on opposite 
arena walls. During the test phase (5 minutes), the resident was introduced 
to one TB; Approach-avoidance behavior (interaction index) was calculated 
as time spent in active zone (resident zone)/total interaction time (resident 
+ neutral zone). Active and inactive zones were randomly assigned to 
avoid development of preference. 
social recognition task 
SDPS-induced deficits in long-term social memory were determined by the 
SR test, using two Wistar juvenile rats (4–6 weeks old) as social targets. 
SR was conducted as described previously119. In brief, animals were given 
a 5-minute sampling phase, during which they were allowed to freely 
interact with the social target. After a 24-h memory retention interval, rats 
were placed back to the arena, and a second, novel social target was 
introduced. During the test phase (5 minutes), discrimination between 
familiar (inactive zone) and novel (active zone) social targets was used as 
measurement of SR. Interaction index was calculated as time spent in the 
active zone (novel target) / total interaction time (familiar+ novel target). 
Active and inactive zones were randomly assigned to avoid development 
of a preference.
video recordings & tracking 
Each session was recorded by a video camera suspended above the 
arenas and interfaced with a computerized tracking system using the 
‘Viewer2’ software package (BIOBSERVE, GmbH, Bonn, Germany). 
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Exploration of the objector interaction with the target were defined as the 
time spent within 2 cm from the designated active / inactive zones, with the 
nose of the rat serving as reference point. Exploration/ interaction indices 
were calculated based on the 1st minute of the test phase of each task, 
during which the natural propensity of animals to novelty is more robust125.
Blood corticosterone assay
Corticosterone concentration was measured as previously described120. In 
short, trunk blood samples were collected via decapitation between 9:00 
AM and 11:00 AM. Samples were collected into a 7-mL heparin-coated tube 
(Greiner Bio-One, Monroe, North Carolina) and kept on ice. The samples 
were centrifuged at 1,000x g for 10 min. Plasma was decanted and stored 
at −80 °C until the assay was used. Plasma corticosterone concentration 
was assessed using a rat Glucocorticoid (GC) ELISA kit (Cusabio Biotech 
Co., LTD), according to the manufacturer’s instructions. Independent sets 
of animals were used for each time-point and treatment group (Fig.S1): 
Acute, n=8 per group, Long-term, n=6 per group, Imipramine, n=6 per 
group, Single-housing, n=10–12 per group. 
Chondroitinase ABC administration
SDPS and control rats received a single infusion of 0.03 U per side of 
chondroitinase ABC (C3667, Sigma-Aldrich) or penicillinase (P0389, 
Sigma-Aldrich) in a 0.5-ml volume in the dorsal hippocampus (bregma: 
−3.8 anterior-posterior, ±2.1 medial-lateral, and −2.9 dorso-ventral) 
>2 months after the last social defeat trial. Chondroitinase ABC effects 
in SDPS (OPR, PNNs, and e-phys) were assessed at ≥2 weeks after 
administration using two batches of animals. The first batch was used for 
OPR test and LTP measurements. All animals received chondroitinase ABC 
or penicillinase treatment, and OPR memory was tested at 12 days after 
the operations. Thereafter, LTP was analyzed between 16 and 24 days 
after chondroitinase ABC application (see Fig. 5A). The second batch was 
used for PNN quantification and for sIPSC recordings. Similar to the first 
batch, all animals received chondroitinase ABC or penicillinase and were 
subjected to the OPR task at 10 to 12 days after administration. Thereafter, 
all animals were decapitated, and sIPSC recordings were obtained 24 to 
96 hours after the OPR test. For PNNs, animals were perfused 24 to 48 
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hours after the OPR test.
iTRAQ-based Proteomics
To analyze differential expression of hippocampal synaptic membrane 
proteins between experimental groups, quantitative iTRAQ proteomics 
was performed in 5 biologically independent replicates. To this end, tissue 
preparation, iTRAQ labeling, two-dimensional liquid chromatography, 
MS⁄MS and protein identification and quantification were performed as 
previously described94,172.
tissue preparation
Following decapitation, brains were removed and rapidly frozen in ice-cold 
isopentane and stored at –80 °C until further use. The dorsal hippocampus 
(Bregma: 2.56–5.30) was dissected freehand at –20 °C from 1-mm thick 
slices. Synaptic membrane fractions, known to be enriched in pre-and 
postsynaptic proteins141, were isolated for every hippocampus following 
sucrose gradient-assisted biochemical fractionation. Protein concentrations 
were determined using a Bradford assay (Bio-Rad, Hercules, CA, USA). 
For each sample, 75 μg of protein was used for iTRAQ labeling and 
subsequent MS measurements (see Supplementary information), and 
synaptic membrane fractions were dried in a SpeedVac overnight.
itraQ-based proteomics tissue preparation
Samples were homogenized in ice-cold 0.32 M sucrose (5% of homogenate 
was collected as total cell lysate) and then centrifuged at 1,000 x g for 
10 minutes. The supernatant was loaded on top of a sucrose gradient 
consisting of 0.85 and 1.2 M sucrose. After centrifugation at 100,000 x g 
for 2 h, the synaptosome fraction at the interface of 0.85⁄1.2 M sucrose 
was collected and then lysed in hypotonic solution. The resulting synaptic 
membrane fraction was recovered by centrifugation using the sucrose step 
gradient as described above. iTRAQ labeling–Synaptic membranes were 
resuspended in 28 μL of dissolution buffer and 2 μL of cleavage reagent 
[iTRAQ reagent kit, with 0.85% RapiGest (Waters Associates, Milford, 
MA, USA)] to solubilize synaptic membranes. After incubation for 1 h, 1 
μL of cysteine blocking buffer (Applied Biosystems, Carlsbad, CA, USA) 
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was added and vortexed for 20 minutes. Next, 10 μL of trypsin (Promega) 
dissolved in water was added and incubated overnight at 37 °C. Trypsinized 
peptides from each experimental group were then tagged with iTRAQ 
reagents (113, Con H2O; 114, Con Imi; 115, Con BT; 116, SDPS H2O; 
117, SDPS Imi; 118, SDPS BT) dissolved in 80 μL ethanol. After incubation 
for 3 h, the six samples were pooled and acidified with 10% trifluoroacetic 
acid (TFA) to pH 2.5–3.0. After 1 h, the final sample was centrifuged and 
the supernatant dried overnight in a SpeedVac.
two-dimensional liQuid cHromatograpHy
The dried iTRAQ sample was dissolved in 300 μL of loading buffer (20% 
acetonitrile, 10 mM KH2PO4, pH 2.9) and loaded onto apolysulfoethyl A 
column (PolyLC, Columbia, MD, USA). Peptides were eluted with a linear 
gradient of 0–500 mM KCl in 20% acetonitrile, 10 mM KH2PO4pH 2.9, 
over 25 minutes at a flow rate of 50 μL⁄minute. Fractions were collected 
at 1-minute intervals. In the second-dimensional liquid chromatography 
separation, peptides were delivered with a Famos autosampler (Dionex 
Corp., Sunnyvale, CA) at 30 μL⁄minute to a C18 trap column (1 mm x 300 
μm i.d. column) and separated on an analytical capillary C18 column (150 
mm x 100 μm i.d. column) at 400 nL⁄minute using the LC-Packing Ultimate 
system. Peptides were separated using a linearly increasing concentration 
of acetonitrile from 5 to 50% in 45 minutes, and to 90% in 5 minutes. The 
eluent was mixed with matrix (7 mg a-cyano-hydroxycinnaminic acid in 1 
mL of 50% acetonitrile, 0.1% TFA, 10 mM dicitrate ammonium) delivered at 
a flow rate of 1.5 μL⁄minute and deposited off-line to the Applied Biosystems 
metal target every 15 s for a total of 192 spots using a robot (Dionex, 
Sunnyvale, CA, USA).
mass spectrometry
The Matrix-assisted laser desorption/ionization (MALDI) plates were 
analyzed on a 4800 proteomics analyzer (Applied Biosystems) and 
peptide collision induced dissociation (CID) was performed at 2 kV with 
nitrogen collision gas. MS⁄MS spectra were collected from 2500 laser 
shots. Peptides with a signal-to-noise ratio above 50 at the MS mode were 
selected for MS⁄MS, at a maximum of 25 MS⁄MS per spot. The precursor 




Experiment-level MS/MS spectra were annotated against a 
concatenated target-decoy database of rat sequences in the UniprotKB/
Swiss-Prot database (version 07/2012) using Mascot Server software 
(version 2.3.01, MatrixScience). Database searches were performed 
with trypsin/P specificity allowing up to two missed cleavages. iTRAQ 
modifications on lysine residues and N-termini, and methylthio-
modifications on cysteine residues were set as fixed modification. 
iTRAQ modifications on tyrosine residues, and oxidation of methionine 
residues were allowed as variable modification. Mass tolerance was 
200 ppm for precursor ions, and 0.4 Da for fragment ions. For each 
spectrum, the best scoring peptide sequence was selected as spectrum 
annotation. Protein inference was performed globally (on spectra from all 
experiments simultaneously) using in-house modified Isoform Resolver 
software173 (software available on request) aiming for consistent protein 
assignment of peptides across experiments. False discovery rate 
(FDR) for peptide and protein identification were established using 
Mayu software174. FDR of protein identification was based on ‘unique’ 
(assigned to a single globally inferred protein) spectra exclusively.
protein Quantification
For protein quantification only unique spectra that were within 5% peptide 
identification FDR were used. In case of multiple spectra assigned to the 
same peptide sequence in an experiment, only the spectrum with the highest 
ions score was used for quantification. Spectra with very low iTRAQ reporter 
signals (maximum intensity of any of the reporter ions less than 100) were 
removed. Only proteins with a minimum of two unique peptides in each 
experiment that pass the above criteria and that were within 5% protein 
level FDR were considered for quantification. After correction for isotope 
impurities, iTRAQ reporter ions were log2-transformed, error-corrected 
and normalized by variance stabilizing normalization implemented in the 
VSN r-package175. Normalized log2-transformed iTRAQ reporter intensities 
of each spectrum were centered to the average intensity of all iTRAQ 
reporter ions in the respective spectrum. Sample-level protein abundance 
was determined by taking the average centered iTRAQ reporter intensities 
of the respective iTRAQ reporters of all spectra assigned to that protein. 
Statistical evaluation of protein abundance differences was performed with 
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the PLGEM R-package127. For presentation of differential expression of 
synaptic proteins between groups, regulation was calculated by subtracting 
the average log2-transformed protein abundance of groups of interest
Immunoblotting
Total homogenate (fig. S5) and synaptic membranes of the dorsal 
hippocampus (Fig. 2) were isolated from independent groups of animals. 
For CSPGs immunoblotting, samples were treated [chondroitinase ABC, 
90 min at 37 °C using 0.002 U/ml in NaAc (pH 8.0)] before SDS-gel 
separation. Samples (10 mg) were lysed in Laemmli lysis buffer, separated 
by electrophoresis on gradient precast gels (4 to 20%; Criterion TGX stain-
free, Bio-Rad), and blotted to polyvinylidene difluoride membrane (Bio-
Rad). Primary antibodies used were rabbit anti-aggrecan (1:700; AB1031, 
Millipore), guinea pig anti-brevican (1:2000; provided by C. I. Seidenbecher, 
Magdeburg), mouse anti-neurocan (1:1000; N0913, Alpha Diagnostics), 
mouse anti-phosphacan (1:1000; 3F8, Developmental Studies Hybridoma 
Bank), mouse anti-versican (1:1000; 75-324, NeuroMab), mouse anti–
tenascin-R (1:2000; mTN-R2, Acris Antibodies), and rabbit anti-HPLN1 
(1:1000; ab98038, Abcam). After incubation with horseradish peroxidase–
conjugated secondary antibody (1:10,000; Dako) and visualization with 
Femto Chemilu-minescent Substrate (Thermo Fisher Scientific), blots were 
scanned using the LI-COR Odyssey Fc and analyzed with Image Studio (Li-
COR). Total protein was visualized using trichloroethanol staining, scanned 
using a Gel Doc EZ imager (Bio-Rad), and analyzed with Image Lab (Bio-
Rad) to correct for input differences per sample because this is a reliable 
method that is not dependent on a single protein for normalization94. Water- 
and imipramine-treated samples were run on separate gels. All samples 
(SDPS-H2O, Con-imipramine, and SDPS- imipramine) were run adjacent 
to Con-H2O samples; thus, all values are expressed as fold change from 
control. In Fig. 2, the mean of two SDPS samples was each time quantified 
versus their adjacent control sample.
Immunohistochemistry
Rats were perfused with 4% paraformaldehyde (PFA) pH 7.4. Brains 
were fixed overnight in 4% PFA and subsequently transferred to a 30% 
sucrose solution. Series of coronal hippocampal sections were cut at 30 
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μm in a freezing cryostat (–18 °C). From every animal, every 7th slice of 
the dorsal hippocampus (AP –2.40 to –4.56) was collected in the same 
container for labeling and PNNs, parvalbumin-positive (PV+) cells and 
bassoon-positive (Bs+) puncta quantification. From each animal, 3 slices, 
ranging from –2.40 to –3.72 (AP), were used for immunohistochemical 
analysis. Free-floating sections were blocked for 1 h with 5% normal goat 
serum, 2.5% bovine serum albumin and 0.2% Triton X-100 in PBS and 
incubated overnight with primary antibodies. Goat anti-mouse Alexa Fluor 
488-conjugate (1:400, A11001, Life Technologies), goat anti-rabbit Alexa 
Fluor 568-conjugate (1:400, A11011, Life Technologies), donkey anti-rabbit 
Alexa-647-conjugate (1:400, 711-605-152, Bio-connect), donkey anti-
mouse DyLight 550-conjugate (1:250, ab96876, Abcam), donkey anti-goat 
DyLight 488-conjugate (1:400, ab96931, Abcam) were used as secondary 
antibodies. Sections were cover-slipped using VECTASHIELD mounting 
medium with DAPI (H-1500, Vector Laboratories). Sections obtained from 
SDPS animals and controls (Figs. 3–5; Figs. S7–9) were imaged in pairs. 
Only intact sections were included in the analyses. PNN-enwrapped cells 
in the hippocampus were identified and quantified using an anti-CSPG 
primary antibody (Cat-301153) that is known to label CSPGs expressed in 
the extracellular surface of cell bodies, allowing for visualization of CSPG-
rich PNNs176. Whereas Wisteria Floribunda Agglutinin or Lectin (WFA-WFL) 
are often used as a tool for PNN labeling and ChABC effects in mice, in rat 
slice preparations this yields a diffuse staining pattern177 that prevents PNN 
quantification in the hippocampus(Fig. S6). In contrast, Cat-301 gives solid, 
sharp PNN patterns that are consistently co-localized with Aggrecan, a core 
component of CSPC-rich PNNs (Fig. S7). For Bs+puncta, sections were 
imaged using an oil-immersion 63x/1.4 NA objective. Maximum-intensity 
projection images were acquired from 20 confocal images collected at a 
1-μm interval along the z-axis under the same conditions for all groups. For 
quantification using FIJI178, PNNs were initially identified with the “Triangle” 
auto-threshold, followed by application of Gaussian Blur (sigma=2). 
A second round of identification by the “Li” auto-threshold was run and 
particles of 60–6000 size and 0–1.00 circularity were finally identifiedas 
PNN+. PV+ cells were identified by setting “Max Entropy” followed by 
“Intermodes” auto-thresholds. Following smoothing of the images and 
application of Gaussian Blur (sigma=2) particles of 60–6,000 size and 
0–1.00 circularity were finally identifiedas PV+. Using the automated script, 
number of cells, intensity and double immunoreactivity between PNN+ and 
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PV+ cells were established in an unbiased manner.Manual inspection and 
exclusion of false-positive identification was performed. Bassoon-positive 
puncta (particle size 0.1-10) onto PV+ interneuron cell bodies were identified 
by setting “Renyi Entropy Dark” threshold, following the identification of 
PV+ somas (Gaussian Blur (sigma=2), particle size 100-infinity). Within the 
ROI (PV+ cell-bodies) the intensity from IR-channel (Aggrecan) was taken 
into account for identification of PV+/PNN+ cells.
Electrophysiology
wHole-cell patcH-clamp recordings (ipscs)
Slicing methods for adult animals were adapted from Ting et al., 2014179. 
Animals were swiftly decapitated, and brains were extracted and placed 
for up to 10 minutes in iced-cold oxygenated ‘slicing solution’ containing 
(in mM): 93 N-methyl-d-glucamine, 2.5 KCl, 1.2 NaH2PO4.H2O, 30 
NaHCO3, 20 HEPES, 25 Glucose, 5 Na-Ascorbate, 2 Thio-urea, 3 Na-
Pyruvate, 12 N-acetyl-L-cysteine, 10 MgSO4.7H2O, 0.5 CaCl2.2H2O; pH 
7.4, 305 mOsm, perfused with carbogen (95% O2, 5% CO2). Horizontal 
hippocampal slices (300 μm) were acquired, using a vibrating-blade 
microtome (HM-650V, Thermo Scientific), in ice-cold carbogen-perfused 
‘slicing solution’. Upon slicing, each slice was left to recover for 2 minutes 
at 32 °C in carbogen-perfused ‘slicing solution’. Subsequently, slices 
were placed in room temperature ‘holding solution’ containing (in mM): 92 
NaCl, 2.5 KCl, 1.2 NaH2PO4.H2O, 30 NaHCO3, 20 HEPES, 25 Glucose, 
5 Na-Ascorbate, 2 Thio-urea, 3 Na-Pyruvate, 12 N-acetyl-L-cysteine, 2 
MgSO4.7H2O, 2 CaCl2.2H2O; pH 7.4, 305 mOsm, perfused with carbogen. 
Individual slices were transferred to a submerged recording chamber, and 
left to equilibrate for 10 minutes, under continuous perfusion, at a rate 
of 2 mL/minute, with room temperature ‘recording solution’ containing (in 
mM); 124 NaCl, 3 KCl, 1 NaH2PO4.H2O, 26 NaHCO3, 10 Glucose, 1 
MgSO4.7H2O, 2 CaCl2.2H2O; pH 7.4, 305 mOsm, perfused with carbogen. 
Subsequently, hippocampal CA1 pyramidal neurons were visualized under 
differential interference contrast microscopy, and selected based on 
their morphology and basic cell firing properties. Whole-cell patch-clamp 
configuration was achieved using standard borosilicate glass pipettes 
(~3.0 MΩ resistance) filled with intracellular solution containing (in mM): 
70K-Gluconate, 70 KCl, 10 HEPES, 4 ATP-Mg, 4 K2-Phosphocreatine, 0.4 
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GTP; 0.5% Biocytin, pH 7.35, 290 mOsm. Upon achieving a stable whole-
cell patch-clamp configuration, ‘recording solution’ was supplemented with 
10 μM 6-cyano-7nitroquinoxaline-2,3-dione (CNQX), 50 μM DL-2-Amino-
5-Phosphonopentanoic acid (DL-APV), and 4 μM (2S)-3-[[(1S)-1-(3,4-
Dichlorophenyl)ethyl]amino-2hydroxypropyl](phenylmethyl) phosphinic 
acid hydrochloride (CGP55845) in order to block AMPA, NMDA, and 
GABAB receptor-mediated currents respectively. Subsequently, 3x5-
minute voltage-clamp gap-free recordings were acquired with pClamp 
software (Molecular Devices), using a Multiclamp 700Bamplifier (Molecular 
Devices), sampled at 10 kHz, low-pass filtered at 3 kHz, and digitized 
with an AxonDigidata 1440A (Molecular Devices). Series resistance was 
monitored online in between each gap-free recording, and only cells 
exhibiting less than a 20% change were used for subsequent analysis. The 
last 2x5-minute gap-free recordings were merged and used for analyzing 
sIPSC properties with Mini-Analysis software (Synaptosoft).
long-term potentiation (ltp) measurements
Rats were decapitated and brains were rapidly removed, and placed in ice-
cold slicing buffer (in mM: NaCl 124, KCl 3.3, KH2PO41.2, MgSO47, CaCl2 
0.5, NaHCO3 20 and Glucose 10, constantly gassed with 95% O2/5% CO2). 
Coronal hippocampal slices were cut on a vibrating microtome (400 μm) and 
then placed in a submerged-style holding chamber in artificial cerebrospinal 
fluid aCSF (in mM: NaCl 124, KCl 3.3, KH2PO41.2, MgSO41.3, CaCl2 
2.5, NaHCO3 20 and Glucose 10, constantly gassed with 95% O2, 5% 
CO2). Slices were allowed to recover for 1 hour following slicing. A planar 
multi-electrode recording setup (MED64 system, Alpha Med Sciences Co., 
Ltd, Tokyo, Japan) was employed to record field excitatory post-synaptic 
potential (fEPSP) in aCSF in the presence of 10 μM Glycine, and to study 
LTP. This methodology has been described in detail elsewhere180. Briefly, 
hippocampal slices were placed on special probes that were fabricated with 
8 x 8 electrode arrays and pre-coated with polyethylenimine (PEI, Sigma). 
The multi-electrode array was then placed in a chamber saturated with 
humidified carbogen gas for at least 1 h before recording. P5155 probes 
(Alpha Med Sciences) with an inter-electrode distance of 150 μm were 
used. Correct placement of the electrodes at the CA3–CA1 region was 
done manually, assisted by microscope monitoring (MIC-D, Olympus Ltd., 
Japan). During recording, each slice was perfused with oxygenated aCSF 
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at a flow rate of 2 mL/minute at room temperature. The chosen stimulating 
electrode (Fig. S2) from the array was in the Schaffer collateral pathway. 
In order to obtain more robust LTP measurements (Fig. 5F,G), fEPSP 
activity was stimulated with an external electrode in the Schaffer collateral 
pathway, using a 440b isolator bipolar current stimulator. Based on the 
stimulus–response curve, we chose a stimulation intensity that evoked the 
fEPSPs with a magnitude of 50% of the maximum response. We found 
that this setting was suitable for the induction of LTP in healthy slices in the 
setup. After allowing a stable baseline of 10 minutes, an induction protocol 
(tetanus stimulation) that evoked LTP was applied, which consisted of 2 
trains of 100 Hz stimulus that lasted for 1 s, separated by 15 s. The field 
potential response was recorded for 1 h after the tetanusstimulation. The 
fEPSPs were recorded from multiple electrodes in the dendritic layer of 
CA1 neurons. LTP measured in all electrodes within the CA1 region was 
averaged, binned per 1 minute, and analyzed for the interval between 
40–50 minutes after induction of LTP. Recording electrodes that showed 
no induction of LTP during the first 10 minutes were excluded from this 
analysis. Only healthy slices (stable base-line), without visual damage 
from the injector were included in the analyses.
Statistical analysis
Memory retention in the OPR test, NOR test (Figs. 1 and 5), and social 
recognition memory task, as well as approach behavior in the social 
approach avoidance task (fig. S12), was statistically tested by comparing 
the data (Student’s t test) to a fictive control, as reported previously123. 
The ratio of exploration or interaction, based on the time spent exploring 
an object or interacting with a social target, was 0.5 for the fictive control, 
representing task performance at chance levels while retaining a similar 
distribution and within-sample variation as the original data. This stringent 
approach gives a more realistic comparison with higher statistical power 
than performing a single-sample t-test123. For the iTRAQ-based proteomics, 
multiple comparisons correction was carried out using the power law global 
error model (PLGEM) (20) or using the WebGestalt GO enrichment analysis. 
For all other data, statistical analysis was performed using SPSS21.0. The 
effects of SDPS and of treatments were assessed with one-way or two-
way ANOVA, followed by Fisher’s least significant difference (LSD) post 
hoc analyses. Mann-Whitney nonparametric test was used in cases of 
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non-normal data distribution. Paired sample t tests were used for within-
group comparisons. Testing was two-sided, unless the initial experiment 
(proteomics to immunoblot, CA1 to CA1 layers, and OPR test performance 
at the intervention experiment) directed follow-up studies. All results are 
expressed as group mean ± SEM. Statistical outliers were excluded 
only in the case of a value exceeding 2× standard deviation of the group 
average on multiple parameters, leading to the exclusion of the following 
data: immuno-blotting, n=1 for control-H2O; electrophysiology (sIPSC 
frequency), n=1 for the SDPS group and n=1 for the SDPS-penicillinase 
group. All statistical tests performed are summarized in table S2.
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SUPPLEMENTARY FIGURES AND TABLES
Figure S1. The SDPS paradigm elicits physiological stress responses that 
subside after several weeks. Physiological parameters, i.e., corticosterone 
concentration (A) body weight (B) and food intake (C), were measured in the 
weeks after animals were exposed to social defeat, and/or subjected to social 
isolation (single-housing). (A) Acutely following five social defeat sessions, animals 







Figure S1. he SDPS paradigm elicits physiological stress responses that subside after several weeks. 
Physiological parameters, i.e., corticosterone concentration (A) body weight (B) and food intake (C), were 
measured in the weeks after animals were exposed to social defeat, and/or subjected to social isolation (single-
housing). (A) Acutely following five social defeat sessions, animals showed a significant (P<0.05) increase in 
blood corticosterone concentration vs. controls and this difference was normalized at the long term (2–3 
months after last defeat encounter). Three weeks of imipramine (IMI) treatment did not affect blood 
corticosterone concentration (left panel). Likewise, prolonged (2–3 months) social isolation without prior 
social defeat had no effect on basal corticosterone concentration (right panel). The significant (P<0.05) 
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controls and this difference was normalized at the long term (2–3 months after 
last defeat encounter). Three weeks of imipramine (IMI) treatment did not affect 
blood corticosterone concentration (left panel). Likewise, prolonged (2–3 months) 
social isolation without prior social defeat had no effect on basal corticosterone 
concentration (right panel). The significant (P<0.05) increase in basal corticosterone 
concentration in the long-term vs. the acute group is probably due the age difference 
in these animals (up to 24 vs.10–12 weeks of age, respectively), as aging has 
been shown to increase corticosterone concentration181,182.Note that the correlation 
of variation is similar between groups (0.35 acute; 0.32 long-term), excluding 
confounding factors between age groups. (B,C) Body weight normalized around 
the fourth week (B, day 24) and food consumption around the third week (C, day 
17) following the last defeat encounter. ***P<0.001, **P<0.01, *P<0.05
Figure S2. SDPS triggers imipramine-reversible reduction in LTP maintenance; 
SDPS effects on behavior and plasticity are not seen after individual housing 
without prior defeat. LTP measurements performed 2–3 months after the last 






i S2. The SDPS paradig  triggers imipramine-reversible reductio  in LTP maintenance. LTP 
measurements performed 2–3 months after the last defeat session confirmed that SDPS leads to imipramine- 
reversible reduction in maintenance of LTP (A-C), as reported before (10). (A) Data presented in a time 
course of change in fEPSP slope measured before and after high frequency stimulation (2 trains of 100 Hz at 
time point 0). Inset: representative traces from one experiment recorded before (gray) and after (black) LTP 
induction. (B) SDPS suppressed CA1 LTP, expressed as change in fEPSP slope at 40–50 minutes after LTP 
induction (One-way ANOVA, F1,9=21.28, P=0.001), and late imipramine (IMI) treatment normalized this 
effect (One-way ANOVA, F1,9=0.01, P=0.937). (C,D) In independent groups of animals, OPR performance 
(C) and fEPSP slope (D) were analyzed in rats that were pair- or single-housed for 3 months. C) Exploration 
index during the test phase of an OPR task. Individually housed rats showed similar memory performance 
compared with control pair-housed rats (One-way ANOVA; F1,48=0.78, P=0.383). Both groups showed 
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maintenance of LTP (A-C), as reported before111. A) Data presented in a time course 
of change in fEPSP slope measured before and after high frequency stimulation (2 
trains of 100 Hz at time point 0). Inset: representative traces from one experiment 
recorded before (gray) and after (black) LTP induction. B) SDPS suppressed CA1 
LTP, expressed as change in fEPSP slope at 40–50 minutes after LTP induction 
(One-way ANOVA, F1,9=21.28, P=0.001), and late imipramine treatment normalized 
this effect (One-way ANOVA, F1,9=0.01, P=0.937). C,D) In independent groups of 
animals, OPR performance (C) and fEPSP slope (D) were analyzed in rats that 
were pair- or single-housed for 3 months. C) Exploration index during the test phase 
of an OPR task. Individually housed rats showed similar memory performance 
compared with control pair-housed rats (One-way ANOVA; F1,48=0.78, P=0.383). 
Both groups showed preference for the displaced object: Pair-housed, P<0.001; 
Individually-housed, P=0.011 vs. fictive control123. D) At 40–50 minutes following 
LTP induction, slices obtained from pair-housed and single-housed animals showed 
a similar change in fEPSPs slope (One-way ANOVA; F1,22=1.22, P=0.281). Dotted 
lines (A,B,D) represent baseline fEPSP slope before tetanic stimulation; n=number 
of animals; N=number of slices; **P<0.01.
Figure S3. Expression of synaptic proteins following SDPS. Quantitative 
immunoblot analysis of expression of glutamate receptor subunits and scaffold 
proteins in the synaptic membrane fraction of the dHPC. A, B) Long-term after 
social defeat (3 months), expression of AMPA (A) and NMDA (B) receptors subunits 
was similar between control and SDPS rats (One-way ANOVA, GluA1, F1,8=0.43, 





Figure S3. Expression of synaptic proteins following SDPS. Quantitative immunoblot analysis of 
expression of glutamate receptor subunits and s affold proteins in the synaptic membrane fraction of the 
dorsal hippocampus. (A, B) Long-ter  after social defeat (3 months), expression of AMPA (A) and NMDA 
(B) receptors subunits was similar between control and SDPS rats (One-way ANOVA, GluA1, F1,8=0.43, 
P=0.528; GluA2, F1,8=2.01, P=0.194; P=0.194; GluN1, F1,8=0.05, P=0.826; GluN2A, F1,8=1.38, P=0.274; 
GluN2B, F1,8=0.01, P=0.913). (C) Absence of regulation of PSD-95 and Gephyrin (GPHN) in the synaptic 
membrane fraction after SDPS provides no indication for global changes in the abundance of glutamatergic or 
GABAergic synapses (One-way ANOVA, PSD-95, F1,8=0.01, P=0.915; GPHN, F1,10=0.08, P=0.788). (D) 




F1,8=1.38, P=0.274; GluN2B, F1,8=0.01, P=0.913). C) Absence of regulation of PSD-
95 and Gephyrin (GPHN) in the synaptic membrane fraction after SDPS provides 
no indication for global changes in the abundance of glutamatergic or GABAergic 
synapses (One-way ANOVA, PSD-95, F1,8=0.01, P=0.915; GPHN, F1,10=0.08, 
P=0.788). D) Example blots of control vs. SDPS show the specific protein band 
(apparent molecular weight). n=number of animals.
Figure S4. Representative immunoblots and corresponding loading 
control. For immunoblots presented in Figure 2, we performed normalization of 
loading differences based on trichloroethanol-assisted total protein staining of 
the respective gel. The representative protein bands and corresponding loading 
controls for water- (left column) or imipramine- (right column) treated control and 






Figure S4. Representative immunoblots and corresponding loading control. For immunoblots presented 
in Figure 2, we performed normalization of loading differences based on trichloroethanol-assisted total protein 
staining of the respective gel. The representative protein bands and corresponding loading controls for water- 
(left column) or imipramine- (right column) treated control and SDPS samples are shown.  
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Figure S5. Overall CSPG expression is not affected by SDPS. A) Quantitative 
immunoblot analysis of CSPG expression in total cell homogenate revealed that 
none of the CSPGs that were upregulated in the synaptic membrane fraction 
(cf. Fig. 2) was increased in the corresponding homogenates of the dHPC (One-
way ANOVA, Brevican (Bcan), F1,7=0.24, P=0.636; Neurocan (Ncan), F1,7=0.34, 
P=0.580; Phosphacan (Phcan), F1,7=1.28, P=0.296). The lack of CPSG regulation 
at the total homogenate vs. the synaptic fraction could indicate a reduction of 
extra-synaptic CPSGs expression. Alternatively, it could result from reduced 
synaptic release of ECM degrading proteases, leading to targeted synaptic CSPG 
upregulation. B) Example blots of control vs. SDPS show the specific protein band 
(apparent molecular weight), with trichloroethanol-assisted total protein staining of 






Figure S5. Overall CSPG expression is not affected by SDPS. (A) Quantitative immunoblot analysis of 
CSPG expression in total cell homogenate revealed that none of the CSPGs that were upregulated in the 
synaptic membrane fraction (cf. Fig. 2) was increased in the corresponding homogenates of the dorsal 
hippocampus (One-way ANOVA, Brevican (Bcan), F1,7=0.24, P=0.636; Neurocan (Ncan), F1,7=0.34, 
P=0.580; Phosphacan (Phcan), F1,7=1.28, P=0.296). The lack of CPSG regulation at the total homogenate vs. 
the synaptic fraction could indicate a reduction of extra-synaptic CPSGs expression. Alternatively, it could 
result from reduced synaptic release of extracellular matrix degrading proteases, leading to targeted synaptic 
CSPG upregulation. (B) Example blots of control vs. SDPS show the specific protein band (apparent 
molecular weight), with trichloroethanol-assisted total protein staining of the SDS-PAGE gel for 
normalization. n=number of animals. 
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Figure S6. Cat-301 recognizes a CSPG-rich PNN population in hippocampus. 
A) Sections from naïve rats were stained with fluorescein-conjugated WFL (green) 
and the anti-CSPG (red; Cat-301) antibody, together with DAPI (blue). WFL labeled 
structurally intact PNNs in the primary somatosensory cortex (left panels), which 
were not recognized by Cat-301. In contrast, in the hippocampus (right panels), 
CSPG-rich PNNs were only identified by the Cat-301 antibody, whereas WFL gave 
a diffuse pattern of staining and PNN-like aggregations were seen only rarely. B) 
Sections from the CA1 subfield in the hippocampus of naïve rats were stained 
with anti-Aggrecan or the anti-CSPG (Cat-301) antibody, together with other ECM 
proteins, such as Neurocan (Ncan, CSPG, upper panels), and the PNN-assembling 
proteins Tenascin-R (TnR, middle panels) and hyaluronan and proteogycan 
link protein 1 (Hapln1, lower panels). Although all antibodies recognized PNN 
structures, as visible from the overlap (merge), these antibodies were not suitable 
for PNN quantification in the rat hippocampus. CA1 layers are indicated; str.or: 
stratum oriens; str.pyr: stratum pyramidale; str.rad: stratum radiatum. Scale bars 






Figure S6. Cat-301 recognizes a CSPG-rich PNN population in hippocampus. (A) Sections from naïve 
rats were stained with fluorescein-conjugated WFL (green) and the anti-CSPG (red; Cat-301) antibody, 
together with DAPI (blue). WFL labeled structurally intact PNNs in the primary somatosensory cortex (left 
panels), which were not recognized by Cat-301. In contrast, in the hippocampus (right panels), CSPG-rich 
PNNs were only identified by the Cat-301 antibody, whereas WFL gave a diffuse pattern of staining and 
PNN-like aggregations were seen only rarely. (B) Sections from the CA1 subfield in the hippocampus of 
naïve rats were stained with anti-aggrecan or the anti-CSPG (Cat-301) antibody, together with other 
extracellular matrix (ECM) proteins, such as neurocan (Ncan, CSPG, upper panels), and the PNN-assembling 
proteins tenascin-R (TnR, middle panels) and hyaluronan and proteogycan link protein 1 (Hapln1, lower 
panels). Although all antibod es recognized PNN structures, s visible from the overlap (merge), these 
tibodies were not suitable for PNN quantifica ion in the rat hippocampus CA1 yers are indicated; str.or: 
stratum oriens; str.pyr: stratum pyramidale; str.rad: stratum radiatum. Scale bars indicate 75 µm (10x), 50 µm 






Figure S6. Cat-301 recognizes a CSPG-rich PNN population in hippocampus. (A) Sections from naïve 
rats were stained with fluorescein-conjugated WFL (green) and the anti-CSPG (red; Cat-301) antibody, 
together with DAPI (blue). WFL labeled structurally intact PNNs in the primary somat sensory cortex (left 
panels), which were not recognized by Cat-301. In contrast, in the hippocampus (right panels), CSPG-rich 
PNNs were only identified by the Cat-301 antibody, whereas WFL gave a diffus  patter of staining and 
PNN-like aggregations were seen only rarely. (B) Sections from the CA1 subfield in the hippocampus of 
naïve rats were stained with anti-aggrecan or the anti-CSPG (Cat-301) antibody, together with other 
extracellular matrix (ECM) proteins, such as neurocan (Ncan, CSPG, upper panels), and the PNN-assembling 
proteins tenascin-R (TnR, middle panels) and hyaluronan and proteogycan link protein 1 (Hapln1, lower 
panels). Although all antibodies recognized PNN structures, as visible from the overlap (merge), these 
antibodies were not suitable for PNN quantification in the rat hippocampus. CA1 layers are indicated; str.or: 
stratum oriens; str.pyr: stratum pyramidale; str.rad: stratum radiatum. Scale bars indicate 75 µm (10x), 50 µm 
(20x) and 25 µm (40x). 
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Figure S7. Cat-301 recognizes aggrecan-rich PNNs, which are increased 
following SDPS. A) Sections from naïve rats were stained with the Cat-301 
antibody (green), the PNN marker aggrecan (Acan, red) and DAPI (blue) in the 
hippocampus CA1. B, C) Quantification of double-immunoreactive cells showed 
an almost complete overlap between Acan+ cells in the total of CSPG+ neurons 
(98.2% ± 2.6) (B) and vice-versa (95.8% ± 2.4) (C). D-F) Quantification of Acan+ 
PNNs in control vs. SDPS rats revealed a significant increase in PNN-coated PV-
expressing interneurons of the CA1 stratum pyramidale (paired t-test, t4=-3.59, 
P=0.023; E) in absence of an overall increase in Acan+ PNN intensity (paired t-test, 
t4=-0.78, P=0.480; F). Scale bar indicates 50 μm (20x) and 25 µm (40x); n=number 







Figure S7. Cat-301 recognizes aggrecan-rich PNNs, which increase after SDPS. (A) Sections from naïve 
rats were stained with the Cat-301 antibody (green), the PNN marker aggrecan (Acan, red) and DAPI (blue) in 
the hippocampus CA1. (B, C) Quantification of double-immunoreactive cells showed an almost complete 
overlap between Acan+ cells in the total of CSPG+ neurons (98.2% ± 2.6) (B) and vice-versa (95.8% ± 2.4) 
(C). D-F) Quantification of Acan+ PNNs in control vs. SDPS rats revealed a significant increase in PNN-
coated parvalbumin-expressing (PV+) interneurons of the CA1 stratum pyramidale (paired t-test, t4=-3.59, 
P=0.023; E) in absence of an overall increase in Acan+ PNN intensity (paired t-test, t4=-0.78, P=0.480; F). 








Figure S7. Cat-301 recognizes aggrecan-rich PNNs, which increase after SDPS. (A) Sections from naïve 
rats were stained with the Cat-301 antibody (green), the PNN marker aggrecan (Acan, red) and DAPI (blue) in 
the hippocampus CA1. (B, C) Quantification of double-immunoreactive cells showed an almost complete 
overlap between Acan+ cells in the total of CSPG+ neurons (98.2% ± 2.6) (B) and vice-versa (95.8% ± 2.4) 
(C). D-F) Quantification of Acan+ PNNs in control vs. SDPS rats revealed a significant increase in PNN-
coated parvalbumin-expressing (PV+) interneurons of the CA1 stratum pyramidale (paired t-test, t4=-3.59, 
P=0.023; E) in absence of an overall increase in Acan+ PNN intensity (paired t-test, t4=-0.78, P=0.480; F). 
Scale bar indicates 50 µm (20x) and 25 µm (40x); n=number of animals; N=number of sections; *P<0.05. 
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Figure S8. CSPG-rich PNNs characterization in dHPC CA1 layers. A) Example 
IHC labeling of CSPG-rich (Cat-301) PNNs and PV-expressing interneurons 
in the layers of the hippocampal CA1 subfield in control and SDPS rats. White 
arrows indicate PNN-free PV+ cells; yellow arrows indicate double-immunoreactive 
cells (PNN+/PV+); scale bar indicates 50 μm. B) Unlike at the stratum pyramidale 
(cf. Fig. 3C), quantification of PNNs at the stratum oriens revealed no between-
groups difference in the number of PNNs for either PV+ (One-way ANOVA, 
F1,6=0.24, P=0.640) or PV
- cells (One-way ANOVA, F1,6=0.94, P=0.370) cells. C) 
Quantification of double-immunoreactive cells showed that in stratum pyramidale 
the vast majority of PNN-coated cells express PV (yellow; control, 90.1% ± 2.8; 
SDPS, 95.4% ± 1.1). In contrast, only half of the PNN-coated cells were PV+ in 
stratum oriens (green; control, 56.9% ± 4.1; SDPS, 50.1% ± 3.4). str.or: stratum 







Figure S8. CSPG-rich PNN characterization in dorsal hippocampus CA1 layers. (A) Example IHC 
labeling of CSPG-rich (Cat- ) P Ns and PV-expressing (PV+) interneurons in the layers of the 
hippocampal CA1 subfiel  in control and SDPS rats. White arrows indicate PNN-free PV+ cells; yellow 
arrows indicate double-immunoreactive cells (PNN+ PV+); scale bar indicates 50 µm. (B) Unlike at the 
stratum pyramidale (cf. Fig. 3C), quantification of PNNs at the stratum oriens revealed no between-groups 
difference in the number of PNNs for either PV+ (One-way ANOVA, F1,6=0.24, P=0.640) or PV- cells (One-
way ANOVA, F1,6=0.94, P=0.370) cells. C) Quantification of double-immunoreactive cells showed that in 
stratum pyramidale the vast majority of PNN-coated cells express PV (yellow; control, 90.1% ± 2.8; SDPS, 
95.4% ± 1.1). In contrast, only half of the PNN-coated cells were PV+ in stratum oriens (green; control, 56.9% 
± 4.1; SDPS, 50.1% ± 3.4). str.or: stratum oriens; str.pyr: stratum pyramidale; str.rad: stratum radiatum; 
n=number of animals; N=number of sections. 
  
62
Figure S9. SDPS does not affect PNN number in the perirhinal cortex. A) 
Example (5x magnification) of IHC labeling of Acan+ PNNs and PV-expressing 
interneurons in the perirhinal cortex (left), as outlined by dashed lines in the red 
box (schematic drawing of brain; right). The white box indicates the enlarged area 
visible in the 20x magnification. White arrows indicate PNN-free PV+ cells; yellow 
arrows indicate double-immunoreactive cells (PNN+/PV+); scale bars indicate 250 
μm (5x) and 50 µm (20x). B) Quantification of Acan+ PNNs in control vs. SDPS rats 
showed no significant group differences (One-way ANOVA, F1,10=1.96, P=0.192); 





   
 
Figure S9. SDPS does not affect PNN number in the perirhinal cortex. (A) Example (5x magnification) of 
IHC labeling of Acan+ PNNs and PV-expressing (PV+) interneurons in the perirhinal cortex (left), as outlined 
by dashed lines in the red box (schematic drawing of brain; right). The white box indicates the enlarged area 
visible in the 20x magnification. White arrows indicate PNN-free PV+ cells; yellow arrows indicate double-
immunoreactive cells (PNN+ PV+); scale bars indicate 250 µm (5x) and 50 µm (20x). (B) Quantification of 
Acan+ PNNs in control vs. SDPS rats showed no significant group differences (One-way ANOVA, F1,10=1.96, 
P=0.192); n=number of animals; N=number of sections. 
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Figure S10. Spread of ChABC effect and CSPGs, PNN recovery at week 2 post-
administration. A, B, C) Sections from naïve animals, obtained at ~12 days after 
ChABC administration were labeled for CSPG-rich PNNs (Cat-301, red). ChABC or 
Penicilinase was injected bilaterally aimed at the CA1 (coordinates: –3.8 AP, ±2.1 
ML, and –2.9 DV). The spread of PNN degradation was estimated based on the 
number of CSPG-rich PNNs detected at the three subfields of the hippocampus. 
A) At coordinates AP –2.52 from Bregma, no difference in the number of PNNs 
detected in ChABC- and Peni-treated sections was observed: CA1, P=0.954; 
CA2/3, P=0.384; and DG, P=0.394. B) At coordinates AP –3.12 from Bregma, a 
significant decrease in the number of CSPG+ cells was observed after ChABC 
that was limited to the CA1 (P=0.016 vs. Peni). No between-group differences in 
PNNs numbers in CA2/3 and DG were seen: CA2/3, P=0.757; and DG, P=0.563. 
C) At coordinates AP –3.84 from Bregma, ChABC effects were broadly spread, with 
a significant reduction in PNN counts both at the CA1 (P=0.047) and the CA2/3 
(P=0.030) subfields. A moderate reduction in the DG was observed, but this did 
not reach statistical significance (P=0.141 vs. Peni). The number of CSPG+ cells 





 Figure S10. The effects of chondroitinase ABC on CSPGs and PNN recovery 2 weeks after 
administration. (A,B,C) Sections from naïve animals, obtained at ~12 days after chondroitinase ABC 
(ChABC) administration were labeled for CSPG-rich PNNs (Cat-301, red). ChABC or penicillinase (Peni) 
was injected bilaterally aimed at the CA1 (coordinates: –3.8 AP, ±2.1 ML, and –2.9 DV). The spread of PNN 
degradation was estimated based on the number of CSPG-rich PNNs detected at the three subfields of the 
hippocampus. (A) At coordinates AP –2.52 from Bregma, no difference in the number of PNNs detected in 
ChABC- and Peni-treated sections was observed: CA1, P=0.954; CA2/3, P=0.384; and DG, P=0.394. (B) At 
coordinates AP –3.12 from Bregma, a significant decrease in the number of CSPG+ cells was observed after 
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For each coordinate example IHC stainings and representative diagrams183 are 
included. Scale bar indicates 500 μm. The spread of ChABC effects is indicated 
in light red color (B,C). D) The temporal profile of ECM re-organization following 
intra-hippocampal ChABC administration was examined in naïve animals at 24 
h, 2 weeks and 4 weeks post-administration. Representative images from each 
time point indicate a complete loss of WFL staining (green) acutely after ChABC 
injection (upper right), which is partially restored at 2 weeks (lower left) and back 
to normal levels at 4 weeks (lower right) post-administration. Scale bar indicates 
250 μm. E) Quantitative immunoblot analysis of CSPGs expression in the 
synaptic membrane fraction of the dHPC of SDPS animals at ~12 days following 
Penicilinase (Peni) or ChABC administration. At this time point, ChABC-treated 
samples showed considerably reduced levels of CSPGs, comparable to the PNN 
recovery rate (One-way ANOVA, Brevican (Bcan), F1,10=2.50, P=0.145, ~30% 
reduction; Neurocan (Ncan), F1,10=0.74, P=0.410, ~28% reduction; and Versican 
(Vcan), F1,10=3.95, P=0.078, ~45% reduction). Similar results were obtained for 
the PNN backbone protein Hapln1 (One-way ANOVA, F1,10=2.94, P=0.117, ~45% 
reduction). F) Example blots of SDPS Peni vs. ChABC show the specific protein 
band (apparent molecular weight). n=number of animals; N=number of sections; 
*P<0.05.
Figure S11. ChABC does not affect IPSC amplitude. Whole cell patch-clamp 
recordings at the CA1 pyramidal neurons (cf. Fig. 5) revealed that neither SDPS nor 
ChABC affected sIPSCs amplitude significantly, as recorded at 2 weeks following 
local dHPC application (One-way ANOVA (F3,57=2.43, P=0.074); n=number of 






Figure S11. Chondroitinase ABC does not affect sIPSC amplitude. Whole cell patch-clamp recordings at 
the CA1 pyramidal neurons (cf. Fig. 5) revealed that neither SDPS nor chondroitinase ABC (ChABC) affected 
sIPSCs amplitude significantly, similar values as in penicillinase-treated (Peni) animals, as recorded at 2 
weeks following local dorsal hippocampus application (One-way ANOVA (F3,57=2.43, P=0.074); n=number 
of animals; N=number of sections.  
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Figure S12. ECM re-organization reversed SDPS-induced deficits in social 
recognition and mildly attenuated social withdrawal. A) Time-line of experimental 
manipulations. Rats were exposed to the SDPS paradigm. Animals were then 






Figure S12. Extracellular matrix re-organization rescues SDPS-induced deficits in social recognition 
and mildly attenuates social withdrawal. (A) Time-line of experimental manipulations. Rats were exposed 
to the SDPS paradigm. Animals were then administered chondroitinase ABC (ChABC) or penicillinase (Peni) 
locally at the dorsal hippocampus (Bregma: –3.8 AP, ±2.1 ML, and –2.9 DV) and allowed to recover for 2 
weeks. SDPS and treatment effects on social behavior were assessed using the social recognition (SR) (B,D) 
and the social approach-avoidance (SAA) (C,E) tasks, in two independent sets of animals. (B) Two-way 
ANOVA revealed a group x treatment interaction (F1,25=6.19, P=0.020), in absence of a group (F1,25=1.76, 
P=0.196) or treatment effect (F1,25=0.23, P=0.633), as ChABC had an opposite effect in long-term social 
recognition memory in SDPS vs. control rats. In particular, ChABC-treated controls displayed impaired 
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±2.1 ML, and –2.9 DV) and allowed to recover for 2 weeks. SDPS and treatment 
effects on social behavior were assessed using the social recognition (SR) (B,D) 
and the social approach-avoidance (SAA) (C,E) tasks, in two independent sets of 
animals. B) Two-way ANOVA revealed a group x treatment interaction (F1,25=6.19, 
P=0.020), in absence of a group (F1,25=1.76, P=0.196) or treatment effect (F1,25=0.23, 
P=0.633), as ChABC had an opposite effect in long-term social recognition memory 
in SDPS vs. control rats. In particular, ChABC-treated controls displayed impaired 
memory retention (P=0.295 vs. fictive), performing similar to untreated SDPS rats 
(P=0.219 vs. SDPS Peni), and showed significantly decreased interaction with the 
novel social target as compared with the two other groups (P=0.011 vs. SDPS 
ChABC; P=0.049 vs. control Peni). ChABC-treated SDPS rats and Peni-treated 
controls showed intact memory retention, spending significant time interacting 
with the novel target (SDPS ChABC, P=0.005; control Peni, P=0.044 vs. fictive). 
Peni-treated SDPS rats showed impaired memory retention (P=0.330 vs. fictive), 
confirming the limiting effects of the depressive-like state on cognitive function119. 
Together, ChABC reversed SDPS-induced deficits in social recognition, whereas 
it disrupted memory retention in controls. It is known that optimal social memory 
performance depends on activity level of CA2 pyramidal neurons. This decrease 
in social recognition in control rats might thus in part be explained by spillover 
effects of ChABC on PNNs of the most posterior part of the CA2 subfield (cf. Fig. 
S10), thereby altering inhibitory control of CA2 pyramidal neurons. Furthermore, 
because we have no evidence that PNNs are increased in the CA2 area of SDPS 
rats, the improvement of social recognition in SDPS rats cannot be attributed to 
a role of CA2 PNNs. Rather these data indicate that this improvement relies on 
restoring the affected hippocampal network (cf. Fig. 5), which was imposed on 
SDPS animals by the increase in CA1 ECM levels. C) Two-way ANOVA revealed 
a trend for a main group effect (F1,26=4.13, P=0.052), in absence of treatment 
effect (F1,26=0.24, P=0.628) or group x treatment interaction (F1,26=1.77, P=0.195). 
Controls, independently of treatment, showed a clear preference for the social 
target (control Peni, P=0.011; control ChABC, P=0.034 vs. fictive), indicating intact 
social behavior. Similarly, ChABC-treated SDPS rats showed a trend for control-
level interaction index (SDPS ChABC, P=0.064 vs. fictive). In contrast, Peni-
treated SDPS animals did not show a preference for the social target (SDPS Peni, 
P=0.142 vs. fictive), as shown previously119. Together, ChABC administration mildly 
ameliorated the SDPS-induced social withdrawal, without a major ChABC effect 
in controls as observed for object place (cf. Fig. 5) and social memory (C). D,E) 
Individual performance at the social recognition (D) and social approach-avoidance 
(E) tasks. Vertical lines represent group means. Dotted lines represent interaction 
at chance levels (0.50); $significant memory retention (B) and social interaction (C) 
for P<0.05, and trend #P<0.1; *P<0.05; **P<0.01.
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Table S1. SDPS-induced changes in dHPC synaptic protein levels and 
rescue by Imipramine. From the total of 519 proteins identified, 37 proteins were 
significantly regulated 3 months after social defeat in the SDPS paradigm (log2; 
P-value<0.05 after adjustment for multiple hypothesis-testing using PLGEM). The 
rescue by Imipramine (Imi; 18 proteins) is indicated (P-value<0.1 vs. SDPS H2O 
after adjustment for multiple hypothesis-testing using PLGEM; indicated in bold) as 
expression in SDPS Imi vs. expression in SDPS H2O. CSPGs and ECM proteins 









symbol Protein description 
Regulation by 
SDPS (log2) P-value 
Rescue by 
IMI (log2) P-value 
EAA2 Slc1a2 Excitatory amino acid transporter 2 0.124 0.004 -0.145 0.001 
ANXA6 Anxa6 Annexin A6 0.160 0.004 -0.236 0.000 
G3P Gapdh Glyceraldehyde-3-phosphate dehydrogenase 0.128 0.005 -0.089 0.006 
DHPR Qdpr Dihydropteridine reductase -0.144 0.008 0.050 0.227 
MAG Mag Myelin-associated glycoprotein -0.098 0.010 -0.086 0.142 
HBB2 Hbb2 Hemoglobin subunit beta-2 -0.119 0.013 0.034 0.140 
PCP4 Pcp4 Purkinje cell protein 4 -0.166 0.015 0.036 0.847 
AT1B1 Atp1b1 
Sodium/potassium-transporting ATPase 
subunit beta-1 0.091 0.015 -0.129 0.007 
UCHL1 Uchl1 
Ubiquitin carboxyl-terminal hydrolase 
isozyme L1 0.065 0.016 -0.019 0.171 
NCAN Ncan Neurocan core protein 0.082 0.017 -0.022 0.085 
SYPH Syp Synaptophysin 0.082 0.018 -0.135 0.001 
CSPG2 Vcan Versican core protein (Fragments) 0.074 0.018 -0.050 0.029 
HBB1 Hbb Hemoglobin subunit beta-1 -0.128 0.018 0.148 0.746 
EAA1 Slc1a3 Excitatory amino acid transporter 1 0.111 0.020 -0.120 0.014 
HPLN1 Hapln1 Hyaluronan and proteoglycan link protein 1 0.100 0.021 -0.033 0.224 
PPIB Ppib Peptidyl-prolyl cis-trans isomerase B 0.129 0.021 -0.102 0.070 
GBG7 Gng7 
Guanine nucleotide-binding protein 
G(I)/G(S)/G(O) subunit gamma-7 0.087 0.022 -0.075 0.009 
KAPCA Prkaca 
cAMP-dependent protein kinase catalytic 
subunit alpha 0.160 0.022 -0.101 0.008 
CXA1 Gja1 Gap junction alpha-1 protein 0.114 0.027 0.014 0.866 
GLNA Glul Glutamine synthetase 0.112 0.031 -0.046 0.093 
NFL Nefl Neurofilament light polypeptide -0.083 0.032 -0.012 0.528 
LAT1 Slc7a5 
Large neutral amino acids transporter small 
subunit 1 0.087 0.033 -0.076 0.043 
GRM1 Grm1 Metabotropic glutamate receptor 1 0.080 0.035 -0.014 0.179 
TXTP Slc25a1 
Tricarboxylate transport protein_ 
mitochondrial -0.080 0.035 -0.018 0.152 
NFM Nefm Neurofilament medium polypeptide -0.106 0.036 -0.019 0.504 
CN37 Cnp 2'_3'-cyclic-nucleotide 3'-phosphodiesterase -0.085 0.036 -0.084 0.033 
B3AT Slc4a1 Band 3 anion transport protein -0.150 0.037 0.086 0.855 
CRYM Crym Thiomorpholine-carboxylate dehydrogenase -0.081 0.037 0.066 0.202 
KCNQ2 Kcnq2 
Potassium voltage-gated channel subfamily 
KQT member 2 0.082 0.039 -0.055 0.063 
GNAI2 Gnai2 
Guanine nucleotide-binding protein G(i) 
subunit alpha-2 0.068 0.039 -0.057 0.026 
LPP3 Ppap2b Lipid phosphate phosphohydrolase 3 0.120 0.039 -0.045 0.096 
AQP4 Aqp4 Aquaporin-4 0.212 0.040 0.009 0.557 
MYPR Plp1 Myelin proteolipid protein -0.053 0.044 -0.154 0.001 
ACBP Dbi Acyl-CoA-binding protein 0.079 0.044 -0.069 0.023 
MOG Mog Myelin-oligodendrocyte glycoprotein -0.043 0.045 -0.037 0.370 
SPTN2 Sptbn2 Spectrin beta chain brain 2 -0.065 0.047 -0.011 0.688 
CD166 Alcam CD166 antigen 0.091 0.048 -0.073 0.066 
 
Table S1. SDPS-induced changes in dorsal hippocampus synaptic protein expression and rescue by the 
antidepressant imipramine. From the total of 519 proteins identified, 37 proteins were significantly regulated 3 
months after social defeat in the SDPS paradigm (log2; P-value<0.05 after adjustment for multiple hypothesis-
testing using PLGEM). The rescue by Imipramine (IMI; 18 proteins) is indicated (P-value<0.1 vs. SDPS-H2O after 
adjustment for multiple hypothesis-testing using PLGEM; indicated in bold) as expression in SDPS-IMI vs. 
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Table S2. Overview of statistical tests in main figures. Indicated are: 
Corresponding figure panels, type of test performed, F- and t-statistical values, 




Figure Test Statistics P-value 
1B Two-way ANOVA Group; F1,33=0.10 
Treatment; F1,33=1.44 




 Fisher’s LSD Control H2O vs. SDPS H2O 
Control Imi vs. SDPS Imi 
Control H2O vs. control Imi 





1C Two-way ANOVA Group; F1,34=3.11 
Treatment; F1,34=2.67 




2C One-way ANOVA H2O-treated; F1,7=9.65 
IMI-treated; F1,6=0.62   
0.009* 
0.230* 







IMI-treated; F1,6=0.36  
0.016* 
0.284* 


































4A Mann-Whitney U=9.00 1.000 
4B Paired t-test t3=-6.21 0.008 























5B One-way ANOVA F3,11=6.74 0.008 
 Fisher’s LSD Control Peni vs. SDPS Peni 
Control ChABC vs. SDPS ChABC 









SDPS Peni vs. SDPS ChABC 0.007 
5E One-way ANOVA F3,57=3.06 0.035 
 Fisher’s LSD Control Peni vs. SDPS Peni 
Control ChABC vs. SDPS ChABC 
Control Peni vs. control ChABC 





5F One-way ANOVA F3,36=3.08 0.040 
 Fisher’s LSD Control Peni vs. SDPS Peni 
Control ChABC vs. SDPS ChABC 
Control Peni vs. control ChABC 





5I Two-way ANOVA Group, F1,32=0.05 
Treatment, F1,32=3.12 




 Fisher’s LSD Control Peni vs. SDPS Peni 
Control ChABC vs. SDPS ChABC 
Control Peni vs. control ChABC 
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type of test performed, F- and t-statistical values, and α-level of significance (P-value), with * representing 1-
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ABSTRACT
Stress can predispose to depressive episodes, yet the molecular 
mechanisms regulating the transition from the initial stress response to 
a persistent pathological depressive state remain poorly understood. We 
profiled the development of an enduring depressive-like state by assessing 
affective behavior and hippocampal function during the 2 months following 
social-defeat stress. We measured remodeling of hippocampal extracellular 
matrix (ECM) during this period, as we recently identified ECM changes to 
mediate cognitive impairment during the sustained depressive-like state. 
Affective disturbance and cognitive impairments develop disparately after 
social stress with gradual emerge of affective deficits. In contrast, spatial 
memory impairment was present both early after stress and during the late-
emerging chronic depressive-like state, while intact in-between. Similarly, 
we observed a biphasic regulation of the hippocampal ECM coinciding 
with hippocampus-dependent memory deficits. Together our data 1) 
reveal a dichotomy between affective and cognitive impairments similar 
to that observed in patients, 2) indicate different molecular processes 
taking place during early stress and the chronic depressive-like state, and 
3) support a role of the ECM in mediating long-lasting memory-effects. 
From a translational point of view, it is important to prioritize on temporal 
phenotypic aspects in animal models to elucidate underlying mechanisms 
of depression.
INTRODUCTION
Major depressive disorder (MDD) is a highly prevalent and debilitating 
neuropsychiatric disorder with a complex set of symptoms and high rates of 
relapse1. MDD is characterized by persistent disturbances in the affective 
domain, including depressed mood and anhedonia1. In addition to these 
well-characterized affective symptoms, cognitive dysfunction is prominent 
among depressed patients, affecting multiple domains, such as executive 
function, attention, memory and learning184,185. Despite the high occurrence 
and disabling effects on everyday life of patients, cognitive dysfunction in 
depression has received little attention and therapeutic strategies against 
depression are mainly aimed at alleviating its mood-related symptoms. 
This poses serious limitations as residual cognitive symptoms often persist 
after improvement of mood symptoms and prevent functional recovery of 
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patients13,35. Moreover, these residual symptoms are associated with an 
increased risk of relapse and recurrence of depressive episodes13. Taken 
together, increasing data suggest that rather than being an epiphenomenon 
of affective symptoms, cognitive dysfunction represents a core trait of the 
disease that is necessary to tackle in order to reach full recovery and 
prevent relapse. 
Although the etiology of MDD remains elusive, stressful life experiences 
have been strongly linked to the development of depression and other 
neuropsychiatric disorders21. The hippocampus is highly susceptible to 
the effects of stress and given its critical involvement in cognitive function 
(e.g., spatial and temporal order processing), stress-induced hippocampal 
abnormalities appear to have a strong contribution to the cognitive deficits 
associated with MDD41,51. For example, attenuated hippocampal activity 
during hippocampus-dependent tasks has been demonstrated in MDD 
patients38,135, underscoring the potentially causal relation between deficits 
in recollection and declarative memory and hippocampal atrophy. Similarly, 
in chronically stressed animals, hippocampal memory deficits are present 
alongside structural changes and altered activity of hippocampal neurons186. 
Despite the vast data describing these stress-induced depression-
related changes, the neural substrates and mechanisms that underlie the 
transition from initial stress exposure to a pathological depressive state 
remain elusive. In particular, the molecular mechanisms that propel these 
enduring effects of stress are poorly characterized as preclinical studies 
have largely focused on the short-lasting effects of acute and/or chronic 
stress. 
Recently, we employed the social defeat-induced persistent stress (SDPS) 
model in rats to investigate the molecular mechanisms that underlie 
hippocampus-dependent cognitive dysfunction during a sustained 
depressive-like state187. In this preclinical model, brief social defeat stress 
is combined with a prolonged social isolation period that together result in 
enduring affective deficits and cognitive dysfunction, thereby recapitulating 
the core depression symptoms. Importantly, these deficits are prominent 
months after the last social defeat stress exposure, reminiscent of the 
human depressive state that can emerge and persist long after a stressful 
period32,33. As a novel pathological mechanism, we identified changes in 
hippocampal extracellular matrix (ECM), which mediate these cognitive 
impairments during the sustained depressive-like state187.
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The brain ECM is a heterogeneous molecular network that forms a scaffold 
around neurons and synapses, supporting structural stability and regulating 
plasticity64,188. The pivotal role for ECM in mediating experience-dependent 
plasticity in the adult brain has become increasingly apparent. In particular, 
perineuronal nets (PNNs), lattice-like matrix structures predominantly 
coating parvalbumin-expressing interneurons77, have been shown to gate 
the closure of critical periods92, to sustain fear memories93 and to regulate 
addiction-related memories189. Furthermore, increasing evidence supports 
the involvement of abnormal ECM in diseases with disturbed cognitive 
processing, as diverse as schizophrenia190 and Alzheimer’s disease191.
In the present study, we studied the development of SDPS-induced 
depressive-like state by assessing affective behavior, as well as cognitive 
function during the days and weeks following social defeat stress. In 
addition to this temporal profiling of the core depressive-like symptoms, 
we characterized ECM remodeling over this same timeframe in order to 
understand how aberrant ECM that underlies the cognitive deficit at the 
late state develops following initial social defeat stress. 
 
RESULTS
Affective dysfunction and cognitive impairment 
develop disparately following social defeat stress
To characterize the development of depressive-like symptoms following 
a stressful experience, we performed a temporal analysis and assessed 
affective behavior and cognitive function at several time-points (24 h / 48 h, 
2, 4 and 8 weeks) following the last social defeat encounter (Fig. 1a). The 
effect of SDPS on affective behavior was tested by the social approach 
avoidance (SAA) test, where interaction towards an unfamiliar Long-
Evans rat is used to measure motivation for social interaction. Cognitive 
function was assessed by the object place recognition (OPR) test with 
a 15-minute retention interval. This test measures short-term spatial 
memory and is heavily dependent on hippocampal function. In order to 
avoid carryover effects from repeated testing, independent groups of 
animals were used for each time-point. In addition, these low-stress tests 
allowed analysis of ECM expression in absence of stress-by-test-induced 
effects.  As others192 and we187 have previously shown, social isolation 
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Figure 1. Affective deficit and cognitive impairment develop disparately after 
social defeat stress (a) Adult rats were subjected to the SDPS (social defeat-
induced persistent stress) paradigm; a 5-day social defeat paradigm followed by an 
8-week period of individual housing. Control rats were not exposed to social defeat 
and remained pair-housed throughout the experiment. Behavior was assessed 
with social approach avoidance (SAA) and object place recognition (OPR) tests at 
four different time points: 24 h/48 h, 2 weeks, 4 weeks and 8 weeks after the last 
social defeat session. (b) Affective deficits emerged gradually following SDPS. At 
24 h after the last social defeat session, no difference in approach towards a social 
target between SDPS and control groups was present. At week 2 post-defeat and 
thereafter decreased approach towards a social target was observed in the SDPS 
group (c) SDPS impaired spatial memory in a temporally dynamic manner. SDPS 
rats failed to discriminate between a stable and relocated object both shortly (48 h) 
after social defeat stress and at the chronic depressive state (week 8), whereas 
at week 2 and 4 post-defeat the SDPS rats showed intact spatial memory, similar 
to the control group. Behavior at each time point was assessed in an independent 
group of SDPS and control rats. Student’s t-test or Mann–Whitney U test were used 
to test statistical significance between SDPS and control group at each time point. 
#P < 0.05 compared to a fictive group with a mean of 0.5 and equal variation123; 
*P < 0.05; **P < 0.01. Data are expressed as mean ± SEM.
employed during and after social defeat is an intricate part of the SDPS 
paradigm and serves as a subthreshold stressor that contributes to the 
incubation of a chronic depressive-like state. In adult males, prolonged 
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Notably, all animals were defeated by the same group of residents in a span of 4 weeks, ensuring no between-
batch differences in the quantity or quality of received aggression that could explain these behavioral differences. 
In support, we did not observe differences in stress-induced arrest in weight gain among batches (Supplementary 
Fig. S2; P = 0.129).
Taken together, the current data show that hippocampal function is restored for a limited period of time after 
the short-term str ss effects subside and before the long-term depression-related changes e anate. No significant 
correlation between SAA and OPR behavior was observed in any of the time points studied (Supplementary 
Fig. S3), indicating a degree of independence between these two behavioral domains, as shown  previously30.
Cognitive impairment coincides with dysregulation of hippocampal extracellular matrix. Our 
previous study identified increased levels of hippocampal ECM during the depressive-like state evident months 
after the last social defeat  exposure13. Specifically, SDPS increased the number of PNN-coated PV-expressing 
interneurons in the dorsal CA1 hippocamp l ubregion, but not in CA2/3 or  DG13, together with an increase in 
the expression of perisynaptic ECM proteins in the dorsal hippocampus. Moreover, we showed that enzymatic 
disruption of CA1-ECM could restore the number of PNNs and, importantly, rescue the SDPS-induced 
Figure 1.  Affective and cognitive impairments develop disparately after social defeat stress. (a) Adult rats 
were subjected to the SDPS (social defeat-induced persistent stress) paradigm; a 5-day social defeat paradigm 
followed by an 8-week period of individual housing. Control rats were not exposed to social defeat and 
remained pair-housed throughout the experiment. Behavior was assessed with social approach avoidance (SAA) 
and object place recognition (OPR) tests at four different time points: 24 h/48 h, 2 weeks, 4 weeks and 8 weeks 
after the last social defeat session. (b) Affective deficits emerged gradually following SDPS. At 24 h after the 
last social defeat session, no difference in approach towards a social target between SDPS and control groups 
was present. At week 2 post-defeat and thereafter decreased approach towards a social target was observed 
in the SDPS group (c) SDPS impaired spatial memory in a temporally dynamic manner. SDPS rat  failed to 
discriminate between a stable and relocated object both shortly (48 h) after social defeat stress and at the chronic 
depressive state (week 8), whereas at week 2 and 4 post-defeat the SDPS rats showed intact spatial memory, 
similar to the control group. Behavior at each time point was assessed in an independent group of SDPS and 
control rats. Student’s t-test or Mann–Whitney U test were used to test statistical significance between SDPS and 
control group at each time point. #P < 0.05 compared to a fictive group with a mean of 0.5 and equal  variation29; 
*P < 0.05; **P < 0.01. Data are expressed as mean ± SEM.
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social isolation alone does not lead to alterations in behavior (Supplementary 
Fig.1), hippocampal plasticity or corticosterone levels187.
A day after (24 h) the last social defeat exposure, control and SDPS animals 
showed similar interaction time spent in the SAA test (control vs. SDPS, 
P=0.935), indicating that recent stress does not affect approach behavior 
towards an unfamiliar social target (Fig. 1b). At 2 weeks post-defeat, 
the SDPS group displayed decreased time spent with the social target 
(control vs. SDPS, P=0.028), demonstrating the emergence of diminished 
motivation for social interaction and exploration. Similarly, at week 4 and 
8 post-defeat, the SDPS rats showed decreased interaction ratios (control 
vs. SDPS, week 4 P=0.023; week 8 P=0.026). Taken together, these 
results demonstrate a gradually developing, yet persistent, effect of SDPS 
on affective behavior as observed previously26,187. 
The next day (48 h after the last social defeat session), the SDPS group 
showed a deficit in the OPR test, assessing short-term spatial memory. 
A significant group effect was found (control vs. SDPS, P=0.041), as the 
SDPS rats spent significantly less time exploring the relocated object when 
compared with the control group, thereby demonstrating an impairment 
in hippocampus-dependent spatial memory. Furthermore, whereas the 
control group showed a preference for the relocated object (control, 
P=0.029 vs. a fictive control with a mean of 0.5 and equal variation123), the 
SDPS group failed to perform this task by showing an OPR discrimination 
index around chance levels (SDPS, P=0.908 vs. a fictive control) (Fig. 
1c). Surprisingly, at week 2 post-defeat, the SDPS group displayed normal 
short-term memory retention (SDPS, P=0.003 vs. a fictive control) similar 
to the control group (control, P=0.008 vs. a fictive control), while no 
between group differences were found (control vs. SDPS, P=0.298). Also, 
at week 4 post-defeat both groups showed a preference for the relocated 
object (control, P=0.018 vs. a fictive control; SDPS, P<0.001 vs. a fictive 
control; and control vs. SDPS, P=0.789). In accordance with our previous 
study187, 8 weeks after the last social defeat stress encounter, SDPS rats 
showed impaired memory function as indicated by decreased exploration 
of the relocated object compared with the control group (control vs. SDPS, 
P=0.002) and a loss of preference for the displaced object (SDPS, P=0.067 
vs. a fictive control), whereas the control group retained information over 
the object’s location (control, P<0.001 vs. a fictive control).  
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Notably, all animals were defeated by the same group of residents in a 
span of 4 weeks, ensuring no between-batch differences in the quantity 
or quality of received aggression that could explain these behavioral 
differences. In support, we did not observe differences in stress-induced 
arrest in weight gain among batches (Supplementary Fig. 2; P = 0.129).
Taken together, the current data show that hippocampal function is 
restored for a limited period of time after the short-term stress effects 
subside and before the long-term depression-related changes emanate. 
No significant correlation between SAA and OPR behavior was observed 
in any of the time-points studied (Supplementary Fig. S1), indicating a 
degree of independence between these two behavioral domains, as shown 
previously26. 
 
Cognitive impairment coincides with 
dysregulation of hippocampal extracellular matrix
Our previous study identified increased levels of hippocampal ECM at the 
depressive-like state evident months after the last social defeat exposure187. 
Specifically, SDPS induced an increase in the number of PNN-coated PV-
expressing interneurons in the dorsal CA1 hippocampal subregion, but not 
in CA2/3 or DG187, together with an increase in the expression of ECM 
proteins in the synaptic membrane fraction of the dorsal hippocampus. 
Moreover, we showed that enzymatic disruption of CA1-ECM could 
restore the number of PNNs and, importantly, rescue the SDPS-induced 
hippocampal memory deficits, thereby demonstrating a causal relationship 
between hippocampal ECM dysregulation and cognitive dysfunction during 
the sustained depressive-like state. However, at what moment after the 
defeat stress this ECM increase emerged was not clear.
To unravel the progression of SDPS-induced dysregulation of hippocampal 
ECM, in the present study we profiled temporal changes in the ECM at 
72 h, 2, 4 and 8 week social defeat stress. We quantified the number of 
the PNN+/PV+-cells in the dorsal CA1 region (Fig. 2a). Early after social 
defeat stress (72 h), a reduced number of PNN+/PV+-cells was found in 
the SDPS animals compared with the control group (control vs. SDPS, 
P=0.030). This shows that social defeat stress induces an immediate ECM 
remodeling resulting in decreased number of PNN+/PV+-cells. At week 2 
and 4 post-social defeat, no difference in the number of PNN+/PV+- cells 
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between the control and SDPS groups was present (week 2, control vs. 
SDPS, P=0.941; week 4, control vs. SDPS, P=0.196), revealing a recovery 
of the perisomatic ECM after the cessation of acute stress. Moreover, as 
shown previously187, an increased number of PNN+/PV+-cells was present 
8 weeks following stress, characterizing the sustained depressive-like 
state (week 8, control vs. SDPS, P=0.021) (Fig. 2b,c). The density of 
PV+ interneurons was not affected in any of the time points studied (72 h, 
control vs. SDPS, P=0.977; week 2 control vs. SDPS, P=0.155; week 4 
control vs. SDPS, P=0.110; week 8 control vs. SDPS, P=0.333; Fig. 2d), 
indicating a specific regulation of PNNs by SDPS both early after stress 
and at the phase when the depressive-like state appears (cf. Fig. 1).
Apart from the perisomatic PNNs surrounding PV-interneurons, perisynaptic 
extracellular space is enriched with ECM proteins that are vital for synaptic 
function64,167. Therefore, we also investigated the expression of ECM 
proteins in the synaptic dorsal hippocampus fraction 72 h and 2 weeks 
following social defeat stress (Fig. 3a). We found the expression of the 
perisynaptic ECM to follow an identical pattern with that of PNNs. Namely, 
early after stress we found decreased expression of ECM proteins, followed 
by a transient recovery period during which perisynaptic ECM regulation 
was absent, before increasing at the long-term (Fig. 3b,d). Specifically, 
at the early time-point (72 h), synaptic expression of several chondroitin 
sulfate proteoglycans (CSPG) from the lectican family, including brevican 
(Bcan), neurocan (Ncan) and phosphacan (Phcan) was reduced in the 
SDPS group (vs. control: Bcan, P=0.039; Ncan, P=0.029; Phcan, P=0.022; 
Acan, P=0.450). Similarly, the expression of the link-proteins Tenascin-R 
(TnR) and Hyaluronan and proteoglycan link protein 1 (Hapln1) was 
decreased shortly after social stress in the SDPS group (vs. control: TnR160, 
P=0.007; TnR180, P=0.047; Hapln1, P=0.021) (Fig. 3c,d). At week 2 post-
defeat, no difference in the expression of synaptic ECM proteins between 
the control and SDPS groups was present (vs. control: Bcan, P=0.993; 
Ncan P=0.760; Phcan, P=0.671; Acan, P=0.300; TnR160, P=0.327; TnR180, 
P=0.629; Hapln1, P=0.491), illustrating a transient recovery of perisynaptic 
ECM protein levels, similar to what was observed for the number of PNNs. 
Taken together, this temporal profile of hippocampal ECM organization 
shows that social defeat stress induces a persistent, yet dynamic ECM 
remodeling both at the perisynaptic, as well as at the pericellular level.
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Figure 2. SDPS induces a temporally dynamic regulation of CA1 perineuronal 
nets (a,b) The number of chondroitin sulfate proteoglycan (CSPG+)-rich 
perineuronal nets (PNNs; green) and parvalbumin-expressing (PV+, red) 
interneurons were quantified with immunohistochemical (IHC) analysis at four time 
points: 72 h, 2 weeks, 4 weeks and 8 weeks after the last social defeat session 
(n = 3–5 animals per group; based on 2–3 sections per animal). Examples of 
staining for each time point is shown. Scale bar (75 µm) is indicated. (c) Decreased 
number of CSPG+PV+ -cells was present at 72 h after stress in the SDPS group. 
At week 2 and 4 no difference in the number CSPG+PV+-cells was observed. At 
the chronic depressive state (week 8) an increased number of CSPG+PV+-cells 
was found in the SDPS group, revealing a biphasic regulation of PNNs in response 
to SDPS. (d) SDPS did not alter the total number of PV-expressing cells in any of 
the time points studied. Student’s t-test was used to test statistical significance 
between SDPS and control group at each time point. *P < 0.05. Data are expressed 
as mean ± SEM.
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Figure 3. SDPS induces a biphasic regulation of perisynaptic extracellular 
matrix a) Immunoblot (IB) analysis was performed at two time-points: 72 h and 
2 weeks (6-8 animals per group) after the last social defeat session, and was 
compared to the log2-transformed quantification of perisynaptic ECM protein levels 
8 weeks post-defeat187, presented vs. their respective control b-c) Decreased 
expression of chondroitin sulfate proteoglycans Brevican (Bcan), Neurocan 
(Ncan) and Phosphacan (Phcan), together with glycoproteins Tenascin (TnR) and 
Hyaluronan and proteoglycan link protein 1 (Hapln1) were present shortly after 
stress (72 h) in the SDPS group. At week 2 no difference in protein expression 
level was observed. d) Example blots of each protein at the 72 h and 8 week post-
defeat time-point for Control (C) and SDPS (S). Full blots, as well as corresponding 
gels for total protein (sample normalization) are available in Supplementary Figs. 
S4 and S5. Student’s t-test was used to test statistical significance between SDPS 
and control group at each time-point. *P<0.05; **P<0.01. Data are expressed as 
mean±SEM. 6
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P = 0.333; Fig. 2d), indicating a specific regulation of PNNs by SDPS both early after stress and at the phase when 
the de ressive-like state appears (cf. Fig. 1).
Apart from the perisomatic PNNs surrounding PV-interneurons, perisynaptic extracellular space is enriched 
with ECM proteins that are vital for synaptic  function17,31. Therefore, we also investigated the expression of 
individual ECM proteins in the synaptic fraction of the dorsal hippocampus at 72 h and 2 weeks following social 
defeat stress (Fig. 3a). We found the expression of the perisynaptic ECM to fo low an identical pattern with that of 
PNNs. Namely, early after stress we found decreased expression of ECM proteins, followed by a transient recovery 
period during which perisynaptic ECM regulation was absent, before increasing at the long-term (Fig. 3b,d). 
Specifically, at the early time point (72 h), synaptic expression of several chondroitin sulfate proteoglycans (CSPG) 
Figure 3.  SDPS induces a biphasic regulation of perisynaptic extracellular matrix. (a) Immunoblot (IB) 
analysis was performed at two time points: 72 h and 2 weeks (n = 6–8 animals per group) after the last social 
defeat session, and was compared to the  log2-transformed quantification of perisynaptic ECM protein levels 
8 weeks post-defeat13, presented vs. their respective control. (b,c) Decreased expression of chondroitin sulfate 
proteoglycans Brevican (Bcan), Neurocan (Ncan) and Phosphacan (Phcan), together with glycoproteins 
Tenascin (TnR) and Hyaluronan and proteoglycan link protein 1 (Hapln1) were present shortly after stress 
(72 h) in the SDPS group. At week 2 no difference in protein expression level was observed. (d) Example blots 
of each protein at the 72 h and week 2 post-d feat time p int for Control (C) and SDPS (S). Full blots, as well 
as corresponding gels for total protein (sample normalization) are available in Supplementary Figs. S4 and S5 
online. Student’s t-test was used to test statistical significance between SDPS and control group at each time 
point. *P < 0.05; **P < 0.01. Data are expressed as mean ± SEM.
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MMP-2 activity is decreased during 
the sustained depressive-like state 
Matrix metalloproteinase-mediated breakdown of ECM assemblies is 
an essential mechanism by which ECM remodeling is maintained72,193. 
To assess whether altered MMP activity potentially drives the SDPS-
associated ECM changes, we measured gelatinolytic activity of MMP-2 
and MMP-9 using in-gel zymography at the two time-points showing major 
ECM dysregulation (Fig. 4a). Early after social stress, we did not find a 
significant difference in the activity of either MMPs (vs. control: MMP-2, 
118%, P=0.619; MMP-9, 139%, P=0.301; Fig. 4b,d). Notably, at 8 weeks 
after social defeat, we found decreased MMP-2 activity in the SDPS animals 
compared with controls (vs. control: 76%, P=0.043), whereas no difference 
in MMP-9 activity was present (vs. control: 84%, P=0.239; (Fig. 4c,d). 
Together, our data suggest that increased build-up of the perisynaptic and 
pericellular ECM, as observed during the sustained depressive-like state, 
could result from decreased MMP-2-mediated breakdown of the ECM in 
the hippocampus, whereas the early ECM effects after social defeat are 
possibly regulated by an MMP-2/MMP-9 independent mechanism. 
DISCUSSION
Despite a strong link between stressful life events and depression, 
understanding the mechanisms that underlie the transition from initial 
stress to a pathological depressive state remains elusive. To date, the 
majority of preclinical studies have focused on the short-lasting effects of 
stress, although it is well-recognized that stress can elicit long-lasting and 
late-appearing effects32,33,194. In the present study, we characterized the 
development of affective and cognitive impairments during the days and 
weeks following social defeat stress to unravel how these core depressive-
like symptoms develop. Moreover, as our previous study demonstrated 
that changes in hippocampal ECM underlie hippocampus-dependent 
cognitive dysfunction during chronic depression187, we here characterized 
ECM remodeling over time to depict the progression of SDPS-induced 
hippocampal pathology. 
The core depressive symptoms include persistent low mood and anhedonia 
that reflect abnormal emotion regulation and reward processing195.  As an
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Figure 4. MMP-2 activity is reduced during the sustained depressive-like 
state a) In-gel zymography assays (Zy) were performed at 72 h and 8 weeks after 
social defeat. b) No difference in MMP-2 or MMP-9 activity was present shortly 
after social defeat; n = 6 animals per group c) At week 8 post-defeat, decreased 
MMP-2 activity was found in the SDPS group, without MMP-9 regulation; control n 
= 6 animals (control); n = 4 (SDPS). *P<0.05. Data are expressed as mean±SEM. 
d) Examples with equal loading showing the mature form of MMP-2 and MMP-9 
(white bands), and the position of the 75 kDa marker band for each time point. Full 
gels are available in Supplementary Fig. 6.
7
Vol.:(0123456789)
Scientific Reports |        (2020) 10:17308  | https://doi.org/10.1038/s41598-020-73173-2
www.nature.com/scientificreports/
from the lectican family, including brevican (Bcan), neurocan (Ncan) and phosphacan (Phcan) was reduced in 
the SDPS group (vs. control: Bcan, P = 0.039; Ncan, P = 0.029; Phcan, P = 0.022; Acan, P = 0.450). Similarly, the 
expression of the link-proteins Tenascin-R (TnR) and Hyaluronan and proteoglycan link protein 1 (Hapln1) was 
decreased shortly after social stress in the SDPS group (vs. control:  TnR160, P = 0.007;  TnR180, P = 0.047; Hapln1, 
P = 0.021) (Fig. 3c,d). At week 2 post-defeat, no difference in the expression of synaptic ECM proteins between 
the control and SDPS groups was present (vs. control: Bcan, P = 0.993; Ncan P = 0.760; Phcan, P = 0.671; Acan, 
P = 0.300;  TnR160, P = 0.327;  TnR180, P = 0.629; Hapln1, P = 0.491), illustrating a transient recovery of perisynaptic 
ECM protein levels, similar to what was observed for the number of PNNs.
Taken together, this temporal profile of hippocampal ECM organization shows that social defeat stress induces 
a persistent, yet dynamic ECM remodeling both at the perisynaptic, as well as at the pericellular level.
MMP‑2 activity is decreased during the sustained depressive‑like state. Matrix metalloproteinase-
mediated breakdown of ECM assemblies is an essential mechanism by which ECM remodeling is  maintained32,33. 
To assess whether altered MMP activity potentially drives the SDPS-associated ECM changes, we measured 
gelatinolytic activity of MMP-2 and MMP-9 using in-gel zymography at the two time points showing major 
ECM dysregulation (Fig. 4a), namely at 72 h and week 8 post-defeat. Early after social stress, we did not find 
a significant difference in the activity of either MMPs (vs. control: MMP-2, 118%, P = 0.619; MMP-9, 139%, 
P = 0.301; Fig. 4b,d). Notably, at 8 weeks after social defeat, we found decreased MMP-2 activity in the SDPS 
animals compared with controls (vs. control: 76%, P = 0.043), whereas no difference in MMP-9 activity was 
present (vs. control: 84%, P = 0.239; (Fig.  4c,d). Together, our data suggest that increased build-up of the 
perisynaptic and pericellular ECM, as observed during the sustained depressive-like state, could result from 
decreased MMP-2-mediated breakdown of the ECM in the hippocampus, whereas the early ECM effects after 
social defeat are possibly regulated by an MMP-2/MMP-9 independent mechanism.
Discussion
Despite a strong link between stressful life events and depression, understanding the mechanisms that underlie 
the transition from initial stress to a pathological depressive state remains elusive. To date, the majority of 
preclinical studies have focused on the short-lasting effects of stress, although it is well-recognized that stress 
can elicit long-lasting and late-appearing  effects15,16,34. In the present study, we characterized the development 
of affective and cognitive impairments during the days and weeks following social defeat stress to unravel how 
these core depressive-like symptoms develop. Moreover, as our previous study demonstrated that changes in 
hippocampal ECM underlie hippocampus-dependent cognitive dysfunction during chronic  depression13, we here 
characterized ECM remodeling over time to depict the progression of SDPS-induced hippocampal pathology.
Figure 4.  MMP-2 activity is reduced during the sustained depressive-like state. (a) In-gel zymography assays 
(Zy) were performed at 72 h and 8 weeks after social defeat. (b) No difference in MMP-2 or MMP-9 activity was 
present shortly after social defeat; n = 6 animals per group. (c) At week 8 post-defeat, decreased MMP-2 activity 
was found in the SDPS group, without MMP-9 regulation; n = 6 animals (control); n = 4 (SDPS). *P < 0.05. 
Data are expressed as mean ± SEM. (d) Examples with equal loading showing the mature form of MMP-2 and 
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from the lectican family, including brevican (Bcan), neurocan (Ncan) and phosphacan (Phcan) was reduced in 
the SDPS group (vs. control: Bcan, P = 0.039; Ncan, P = 0.029; Phcan, P = 0.022; Acan, P = 0.450). Similarly, the 
expression of the link-proteins Tenascin-R (TnR) and Hyaluronan and proteoglycan link protein 1 (Hapln1) was 
decreased shortly after social stress in the SDPS group (vs. control:  TnR160, P = 0.007;  TnR180, P = 0.047; Hapln1, 
P = 0.021) (Fig. 3c,d). At week 2 post-defeat, no difference in the expression of synaptic ECM proteins between 
the control and SDPS groups was present (vs. control: Bcan, P = 0.993; Ncan P = 0.760; Phcan, P = 0.671; Acan, 
P = 0.300;  TnR160, P = 0.327;  TnR180, P = 0.629; Hapln1, P = 0.491), illustrating a transient recovery of perisynaptic 
ECM protein levels, similar to what was observed for the number of PNNs.
Taken together, this temporal profile of hippocampal ECM organization shows that social defeat stress induces 
a persistent, yet dynamic ECM remodeling both at the perisynaptic, as well as at the pericellular level.
MMP‑2 activity is decreased during the sustained depressive‑like state. Matrix metalloproteinase-
mediated breakdown of ECM assemblies is an essential mechanism by which ECM remodel ng is  maintained32,33. 
To assess whether altered MMP activity potentially drives the SDPS-associated ECM nges, we measured 
gelatinolytic activity of MMP-2 and MMP-9 using in-gel zymography at the two time points showing major 
ECM dysregulation (Fig. 4a), namely at 72 h and week 8 post-defeat. Early after social stress, we did not find 
a significant difference in the activity of either MMPs (vs. control: MMP-2, 118%, P = 0.619; MMP-9, 139%, 
P = 0.301; Fig. 4b,d). Notably, at 8 weeks after social defeat, we found decreased MMP-2 activity in the SDPS 
animals compared with controls (vs. control: 76%, P = 0.043), whereas no difference in MMP-9 activity was 
present (vs. control: 84%, P = 0.239; (Fig.  4c,d). Together, our data suggest that increased build-up of the 
perisynaptic and pericellular ECM, as observed during the sustained depressive-like state, could result from 
decreased MMP-2-mediated breakdown of the ECM in the hippocampus, whereas the early ECM effects after 
social defeat are possibly regulated by an MMP-2/MMP-9 independent mechanism.
Discussion
Despite a strong link between stressful life events and depression, understanding the mechanisms that underlie 
the transition from initial stress to a pathological depressive state remains elusive. To date, the majority of 
preclinical studies have focused on the short-lasting effects of stress, although it is well-recognized that stress 
can elicit long-lasting and late-appearing  effects15,16,34. In the present study, we characterized the development 
of affective and cognitive impairments during the days and weeks following social defeat stress to unravel how 
these core depressive-like symptoms develop. Moreover, as our previous study demonstrated that changes in 
hippocampal ECM underlie hippocampus-dependent cognitive dysfunction during chronic  depression13, we here 
characterized ECM remodeling over time to depict the progression of SDPS-induced hippocampal pathology.
Figure 4.  MMP-2 activity is reduced during the sustained depressive-like state. (a) In-gel zymography assays 
(Zy) were performed at 72 h and 8 weeks after social defeat. (b) No difference in MMP-2 or MMP-9 ctivity was 
present shortly after social defeat; n = 6 animals per group. (c) At week 8 post-defeat, decreased MMP-2 activity 
was found in the SDPS group, without MMP-9 regulation; n = 6 animals (control); n = 4 (SDPS). *P < 0.05. 
Data are expressed as mean ± SEM. (d) Examples with equal loading showing the mature form of MMP-2 and 
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from the lectican family, including brevican (Bcan), neurocan (Ncan) and phosphacan (Phcan) was reduced in 
the SDPS group (v . control: Bcan, P = 0.039; Ncan, P = 0.029; Phcan, P = 0.022; Acan, P = 0.450). Similarly, the 
expr ssion of the link-pro eins Tenascin-R (TnR) and Hyaluronan and proteoglycan link protein 1 (Hapln1) was 
decreased shortly after social stress in the SDPS group (vs. control:  TnR160, P = 0.007;  TnR180, P = 0.047; Hapln1, 
P = 0.021) (Fig. 3c,d). At week 2 post-defeat, no difference in the expression of synaptic ECM proteins between 
the control and SDPS groups was present (vs. control: Bcan, P = 0.993; Ncan P = 0.760; Phcan, P = 0.671; Acan, 
P = 0.300;  TnR160, P = 0.327;  TnR180, P = 0.629; Hapln1, P = 0.491), illustrating a transient recovery of perisynaptic 
ECM protein levels, similar to what was observed for the number of PNNs.
Taken together, this temporal profile of hippocampal ECM organization shows that social defeat stress induces 
a persistent, yet dynamic ECM remodeling both at the perisynaptic, as well as at the pericellular level.
MMP‑2 activity is decreased during the sustained depressive‑like state. Matrix metalloproteinase-
mediated breakdown of ECM assemblies is an essential mechanism by which ECM remodeling is  maintained32,33. 
To assess whether altered MMP activity potentially drives the SDPS-associated ECM changes, we measured 
gelatinolytic activity of MMP-2 and MMP-9 using in-gel zymography at the two time points showing major 
ECM dysregulation (Fig. 4a), namely at 72 h and week 8 post-defeat. Early after social st , we did not find 
a significant difference in the activity of either MMPs (vs. control: MMP-2, 118%, P = 0.619; MMP-9, 139%, 
P = 0.301; Fig. 4b,d). Notably, at 8 weeks after social defeat, we found ecreased MMP-2 activity in the SDPS 
animals compared with controls (vs. control: 76%, P = 0.043), whereas no difference in MMP-9 activity was 
present (vs. control: 84%, P = 0.239; (Fig.  4c,d). Together, our data suggest that increased build-up of the 
perisynaptic and pericellular ECM, as observed during the sustained depressive-like state, could result from 
decreased MMP-2-mediated breakdown of the ECM in the hippocampus, whereas the early ECM effects after 
social defeat are possibly regulated by an MMP-2/MMP-9 independent mechanism.
Discussion
Despite a strong link between stressful life events and depression, understanding the mechanisms that underlie 
the transition from initial stress to a pathological depressive state remains elusive. To date, the majority of 
preclinical studies have focused on the short-lasting effects of stress, althoug  it is well-recognized that stress 
can elicit long-lasting and late-appearing  effects15,16,34. In the present study, we characterized the development 
of affective and cognitive impairments during the days and weeks following social defeat stress to unravel how 
these core depressive-like symptoms develop. Moreover, as our previous study demonstrated that changes in 
hippocampal ECM underlie hippocampus-dependent cognitive dysfunction during chronic  depression13, we here 
characterized ECM remodeling over time to depict the progression of SDPS-induced hippocampal pathology.
Figure 4.  MMP-2 activity is reduced during the sustaine  depressive-like state. (a) In-gel zymography assays 
(Zy) were performed at 72 h and 8 weeks after social defeat. (b) No difference in MMP-2 or MMP-9 activity was 
present shortly after social defeat; n = 6 animals per group. (c) At week 8 post-defeat, decreased MMP-2 activity 
was found in the SDPS group, without MMP-9 regulation; n = 6 animals (control); n = 4 (SDPS). *P < 0.05. 
Data are expressed as mean ± SEM. (d) Examples with equal loading showing the mature form of MMP-2 and 
MMP-9 (white bands), and the position of the 75 kDa marker b nd for each tim  point. Full gels are available in 
Supplementary Fig. 6 online.
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example, aberrant social interaction and avoidance of social contact are 
common in MDD patients196. Furthermore, the lack of social interaction can 
worsen the illness by augmenting stress responses, thereby perpetuating 
a vicious disease cycle197. In preclinical models, social interaction 
is often measured as the approach towards a social target, which is a 
naturally rewarding activity198. Here, we found that social deficits develop 
progressively during the weeks following social defeat stress. Social 
avoidance behavior early after social defeat stress is generally employed 
to identify stress-susceptible individuals in mice199,200. In discordance with 
this, we here show that rats display intact social behavior 24 h after social 
defeat, which is followed by gradually deteriorating social interaction. 
Short-term isolation increases the likelihood of social exploration in male 
rats201 and hence this species-specific behavior might have masked 
the initial deficits in social interaction. On the other hand, the delayed 
emergence of affective deficits could suggest a gradual progression of 
the (mal)adaptation underlying emotional regulation in depression. As 
such, stress-induced early changes might not be accurate in predicting 
the emergence of enduring affective vulnerability. In support of this, we 
recently showed that acute effects of defeat stress on social behavior are 
poor predictors of depression vulnerability26. In fact, and in accordance 
with the present study, our previous data suggest that diminished social 
interaction displayed 5 weeks post-social defeat most faithfully predicts 
SDPS susceptibility and depression proneness. These findings indicate 
that defeat-induced affective deficits develop gradually following social 
stress and are likely facilitated by prolonged social deprivation110 in rats. 
Although MDD is thought of as a primarily affective disorder, it is 
increasingly acknowledged that cognitive dysfunction is common among 
MDD patients and contributes profoundly to the disease burden202,203. While 
affective dysfunction and cognitive disturbance co-occur during depressive 
episodes, these symptoms can also be experienced independently of one 
another. Cognitive symptoms often persist even in remitted patients and 
can hinder functional recovery of patients204. Moreover, these residual 
symptoms can serve as a risk factor for relapse or potentially even increase 
susceptibility for a first depressive episode14. Additionally, recent studies 
suggest that cognitive performance of patients during premedication 
can predict antidepressant treatment response205. Thus, in addition to 
alleviating mood-affecting symptoms, it is critical to understand and relieve 
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the cognitive deficits in depression, which can propagate disability in 
patients.
In the current study, spatial memory deficits were present early after 
the last social defeat encounter. In accordance, several studies have 
described stress-induced deterioration of hippocampal function shortly 
after stress51,206. This early phase, i.e. days after stress, is accompanied 
with substantial structural remodeling of neurons and aberrant 
hippocampal plasticity, effects that are largely mediated via glucocorticoid 
signaling56,207,208. Similar to several other stress paradigms, we have 
shown that 24 h after social defeat glucocorticoid levels are increased but 
these levels become equal in the long-term187. It is then plausible that the 
early ECM changes we observed here act additionally, or synergistically, 
to glucocorticoid-mediated effects that are associated with hippocampal 
dysfunction and memory deficits209,210.
Strikingly, after these early stress effects subsided, we here showed a 
period of apparent intact hippocampal function that lasted several weeks 
before subsequent deterioration. The reversibility of the memory deficit 
that coincides with recent stress suggests that the late appearing effects 
evolve gradually and might be mediated by independent neurobiological 
substrates. In support, early stress effects, like increased glucocorticoid 
response, as well as those on heart rate, body temperature, activity211, and 
water- and food intake, dampen over time and are no longer present during 
the sustained depressive-like state187. Together, these findings highlight 
a dichotomy in the development of affective and cognitive depression-
related symptoms, and, importantly, dissociate more acute stress 
responses from the late-appearing pervasive deficits that characterize 
the enduring depressive-like state (Fig. 5). This divergent developmental 
course of affective and cognitive deficits in response to stress likely 
reflects dichotomous pathophysiological mechanisms underlying these 
endophenotypes of depression. Accordingly, these two behavioral domains 
affected in depression may require distinct therapeutic approaches in order 
to reach full recovery. 
We recently identified changes in hippocampal ECM to underlie 
hippocampus-dependent memory deficits at the sustained depressive-
like state187. In the present study, we profiled ECM changes in parallel 
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to the behavioral characterization, in order to understand how aberrant 
ECM evolves in response to stress. Moreover, many stress-related 
studies showed down- instead of up-regulation of ECM212–215, sparking our 
interest to study the temporal aspect of ECM regulation. Here, we found 
social defeat stress to induce an immediate decrease in the expression 
of synaptic ECM proteins and in the density of perineuronal nets (PNN+/
PV+-cells), similar as observed immediately after several other stressors 
applied214,216, without affecting the number of PV+-cells. Chondroitin sulfate 
proteoglycans (CSPGs) are among the most abundant ECM components 
in the brain, forming mesh-like structures around synapses, and they can 
condense into PNNs enwrapping predominantly PV+-interneurons69,217. 
Furthermore, the glycoprotein TnR links CSPGs together and Hapln1 
attaches CSPGs to the hyaluronan backbone, thereby providing stability 
to the molecular matrix66. Damage to the ECM can destabilize connectivity 
between neurons and glia, disrupt neural activity and affect neural 
plasticity218; all mechanisms that are critical for learning and memory. 
For example, genetic deletion of TnR results in changes in perisomatic 
inhibition and excitability of pyramidal cells that are linked to altered 
long-term potentiation, the cellular correlate of learning and memory143. 
In addition, TnR ablation impairs spatial and motor learning219. Similarly, 
loss of brevican disrupts long-term potentiation220, and results in memory 
deficits74. Together, the downregulation in the expression of several synaptic 
ECM proteins shortly after social defeat may result in ECM composition-
dependent aberrant synaptic transmission that could contribute to the 
observed memory deficits. 
Perineuronal nets are found to mainly enwrap PV+-interneurons in the 
hippocampal CA1 subregion77. Although the precise mechanisms by 
which PNNs regulate the activity of PV+-interneurons remains elusive, 
PNNs have been shown to modulate the excitability and high-frequency 
firing of PV+-interneurons131,221. Recently, it was shown that mainly 
Brevican, expressed by PV+-interneurons, controls PV-excitability via 
the modulation of excitatory inputs these neurons receive, and controls 
molecular components of synaptic and intrinsic plasticity74. Conversely, 
hippocampus-dependent learning, and intrinsic plasticity affect activity 
of PV+-interneurons and Brevican levels74,89. These reciprocal relations 
illustrate that an imbalance in PNNs can alter excitatory/inhibitory 
signaling as well as network plasticity crucial to cognitive processing83,99,222. 
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Thus, similar to the increased number of PNNs months after social 
defeat that coincides with reduced inhibitory network activity and cognitive 
deficits187, the decreased number of PNNs found shortly after defeat 
stress may alter inhibitory activity of PV+-interneurons and thereby impair 
hippocampus-dependent memory.
Figure 5. Schematic of the main conclusion: ECM imbalance coincides with 
cognitive deficits. Overview of the social-stress-induced behavioral impairments 
and changes in hippocampus ECM during the development from initial stress 
towards establishing a depressive-like state. Affective (grey) and cognitive (blue) 
deficits are not temporally associated. Yet, dysregulation of perisomatic (PNN) and 
perisynaptic ECM (green) coincides with moments of hippocampal dysfunction in 
terms of spatial memory in the rat SDPS model of depression.
The observed co-occurrence of ECM regulation in the synaptic fraction 
and at the level of PNNs suggests that stress induces a widespread 
ECM remodeling in the hippocampus that is presumably regulated by 
the enzymes that breakdown ECM, such as matrix metalloproteinases 
(MMPs)193. Although MMP-9 is mostly studied due to the much wider 
availability of tools, several MMPs and their regulators (e.g. tissue inhibitor 
of metalloproteinases, TIMPs) have been shown to be involved in memory 
deficits149,223–225. Here, we did not observe major changes in MMP-2 or 
MMP-9 activity during the early phase after social defeat stress, suggesting 
that a reduction in the pericellular and -synaptic ECM levels could possibly 
result from a reduced production or release of ECM proteins, rather than 
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The core depressiv  symptoms include persistent low moo  and anhedonia that reflect abnormal emotion 
regulation and reward  processing35. As an example, aberrant social interaction and avoidance of social contact 
are common in MDD  patients36. Furthermore, the lack of social interaction can worsen the illness by augmenting 
stress responses, thereby perpetuating a vicious disease  cycle37. In preclinical models, social interaction is often 
measured as the approach towards a social target, which is a naturally rewarding  activity38. Here, we found that 
social deficits develop progressively during the weeks following social defeat stress. Social avoidance early after 
social defeat stress is generally employed to identify stress-susceptible individuals in  mice39,40. In discordance 
with this, we here show that rats display intact social behavior 24 h after social defeat, which is followed by 
gra ually det riorating s cial interaction. Short- erm isolation increases the likelihood of social exploration in 
male  rats41 and hence this species-specific behavior might have masked the initial deficits in social interaction. 
On the other hand, the delayed emergence of affective deficits could suggest a gradual progression of the (mal)
adaptation underlying emotional regulation in depression. As such, stress-induced early cha ges might not be 
accurate in predicting the emergence of enduring affective vulnerability. In support of this, we recently showed 
that acute effects of defeat stress on social behavior are poor predictors of depression  vulnerability30. In fact, and 
in accordance with the present study, our previous data suggest that diminished social interaction displayed 
5 weeks post-social defeat most faithfully predicts SDPS susceptibility and depression proneness. These findings 
indicate that defeat-i duced affective deficits develop gradually foll wing social stress a d are likely facilitated 
by prolonged social  deprivation42 in rats.
Although MDD is thought of as a primarily affective disorder, it is increasingly acknowledged that cognitive 
dysfunction is common among MDD patients and contributes profoundly to the di ease  burde 43,44. While 
affective dysfunction and cognitive disturbance co-occur during depressive episodes, these symptoms can also be 
experienced independently of one another. Cognitive symptoms often persist even in remitted patients and can 
hinder function l recovery of  patients45. Moreover, these residual symptoms can serve as a risk factor for relapse 
or potentially even increase susceptibility for a first depressive  episode46. Additionally, recent studies suggest that 
cognitive performance of patients during premedication can predict antidepressant treatment  response47. Thus, 
in addition to alleviating mood-affecting symptoms, it is critical to understand and relieve the cognitive deficits 
in depression, which can propagate disability in patients.
In the current study, spatial memory deficits were present early after the last social defeat encounter. In 
accordance, several studies have described stress-induced deterioration of hippocampal function shortly after 
 stress9,48. This early phase, i.e. days after stress, is accompanied with substantial structural remodeling of neurons 
and aberrant hippocampal plasticity, effects that are largely mediated via glucocorticoid  signaling49–51. Similar 
to several other stress paradigms, we have shown that 24 h after social defeat glucocorticoid levels are increased, 
but these levels become equal in the long-term13. It is then plausible that the early ECM changes we observed 
here act additionally, or synergistically, to glucocorticoid-mediated effects that are associated with hippocampal 
dysfunction and memory  deficits52,53.
Strikingly, after these early stress effects subsided, we here showed a period of apparent intact hippocampal 
function that lasted several weeks before subsequent deterioration. The reversibility of the memory deficit that 
coincides with recent stress suggests that the late appearing effects evolve gradually and might be mediated by 
independent neurobiological substrates. In support, early stress effects, like increased glucocorticoid response, 
as well as those on heart rate, body temperature,  activity54, and water- and food intake, dampen over time and 
are no longer present during the sustained depressive-like  state13. Together, these findings highlight a dichotomy 
in the development of affective and cognitive depression-related symptoms, and, importantly, dissociate more 
acute stress responses from the late-appearing pervasive deficits that characterize the enduring depressive-
like state (Fig. 5). This divergent developmental course of affective and cognitive deficits in response to stress 
likely reflects dichotomous pathophysiological mechanisms underlying these endophenotypes of depression. 
Figure 5.  Schematic of the main conclusion: ECM imbalance coincides with cognitive deficits. Overview of the 
social-stress-induced behavioral impairments and changes in hippocampus ECM during the development from 
initial stress towards establishing a depressive-like state. Affective (grey) and cognitive (blue) deficits are not 
temporally associated. Yet, dysregulation of perisomatic (PNN) and perisynaptic ECM (green) coincides with 
hippocampal dysfunction in terms of spatial memory in the rat SDPS model of depression.
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increased breakdown of the ECM by MMP-2 or MMP-9. Although measuring 
enzyme activity is more informative than measuring MMP-protein levels, the 
assay might not report endogenous enzyme activity because of possible 
auto-activation within the gel and loss of MMP-bound TIMPs during 
preparation226. Moreover, as we analyzed the whole dorsal hippocampus, 
we cannot exclude the presence of a subregion-specific increase in MMP-
activity shortly after stress, as observed previously152. Alternatively, other 
ECM-cleaving enzymes, such as ADAMTS4/5227,228, could be regulated in 
response to stress and contribute to the ECM breakdown. It is plausible that 
proteolysis of ECM during and shortly after stress exposure may promote 
susceptibility to adverse environmental effects by making the extracellular 
milieu more permissive to synaptic reorganization. Eventually, this could 
result in the emergence of a pathological circuitry, which in turn could 
mediate the long-term changes manifested in late-appearing cognitive 
deficits. 
Interestingly, in the present study we found ECM levels, both at the 
perisynaptic and perisomatic level, to recover after the initial stress-induced 
downregulation. Thus, this ECM remodeling displayed a similar profile as 
hippocampus-dependent memory performance, namely, both showing a 
full recovery after the acute stress phase before deteriorating at a later 
phase. Previous studies have demonstrated reversibility of stress-induced 
hippocampal structural changes, such as an increase in the complexity 
of dendritic arborization of CA3 neurons and cognitive function after a 
recovery period following stress that is concurrent with improvement of 
cognitive deficits229. This reversal of the early stress effects has been 
suggested to represent a dynamic process rather than merely a return to 
the pre-stress state230. Indeed, we describe a transient rescue of stress-
induced structural and functional changes at the level of hippocampal 
ECM and memory performance, respectively. We hypothesize that the 
initial stress-induced ECM down-regulation possibly triggers a cascade 
of compensatory mechanisms, involving enzymes responsible for ECM 
breakdown, together with astrocytic and neuronal ECM production. 
Presumably these compensatory processes aim to counteract ECM-driven 
changes in PV activity, which is critical to experience-dependent plasticity 
and learning89. Because SDPS animals are deprived of environmental and 
social enrichment, it is possible that in these conditions compensatory 
systems fail, in turn contributing to the later emerging pathological state, 
observed months after social stress.
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Limitations
To shed light on the causal relationship of the early- and late-appearing 
ECM changes in the SDPS model, it would be critical to investigate 
whether ECM alterations and cognitive decline observed during the chronic 
phase of the depression-like state could be attenuated by preventing ECM 
remodeling during initial stress exposure or shortly thereafter. Although the 
interdependence of the early- and late-appearing ECM regulation remains 
under investigation, our findings suggest a critical involvement of ECM 
remodeling in the progression of stress-induced hippocampal dysfunction 
as both phases coincided with a corresponding memory deficit (Fig. 
5). In support, those time-points for which ECM regulation was absent 
coincided with intact hippocampal function. In this light, it is of interest that 
PNN numbers seemed to start their long-term upregulation most likely 
already 4–5 weeks after stress cessation, although not reaching statistical 
significance (cf. Fig. 2C). At this time point, we had a relatively low n-number 
and variation seemed larger than normal. This could indicate that PNN 
changes precede the behavioral deficits that become overt only 2 months 
after social stress, underscoring the causal nature of ECM changes as 
shown before187. Furthermore, as we found MMP-2 activity downregulated 
during the sustained depressive-like state, this suggests that attenuated 
MMP-2-mediated ECM breakdown facilitates the build-up of the ECM, 
thereby promoting the emergence of a state of limited plasticity. In relation 
to the cognitive phenotype we observe at the long-term, it is of interest that 
MMP-2 and MMP-9 activity are downregulated in serum of patients with 
recurrent depression, where higher MMP-levels were correlated with better 
cognitive performance231. On the other hand, we could not detect changes 
in activity of either enzyme shortly after stress cessation (cf. Fig. 4). This 
could indicate the involvement of other metalloproteinases, or an effect at 
the level of de novo ECM transcription and translation. Moreover, as we 
analyzed the whole dorsal hippocampus, we cannot exclude the presence 
of a subregion-specific increase in MMP-activity shortly after stress, as 
observed previously152. 
CONCLUSIONS
Collectively, our results show that while SDPS elicits enduring social 
avoidance and cognitive impairment, these phenotypes progress 
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differently, revealing a temporal dichotomy between affective behavior 
and cognitive function as often observed in MDD patients232. Moreover, 
our results reveal that SDPS induced a biphasic regulation of cognitive 
function, highlighting the dissociation of the sustained depressive-like state 
from the acute effects of stress. Furthermore, as we show that hippocampal 
ECM remodeling accompanies both early and long-lasting SDPS effects, 
targeting ECM levels may provide novel therapeutic opportunities against 
depression and other stress-related neuropsychiatric disorders. Together, 
from a translational point of view it is important to prioritize on the temporal 
aspects of affective and cognitive disturbances in animal models to 
elucidate the underlying causes of depression.
MATERIALS AND METHODS
Animals and the social defeat-induced 
persistent stress (SDPS) paradigm
All experiments were approved by the central ethics committee of the 
Netherlands and the Animal Users Committee of the Vrije Universiteit 
Amsterdam, in accordance with the relevant guidelines and regulations. 
The SDPS paradigm was carried out as previously described187, where 
male Wistar rats (≥ 9 weeks; Envigo, Netherlands) were used in a resident-
intruder paradigm with male Long-Evans rats (>4 months; Charles River, 
UK) as residents. The SDPS rats underwent 15-minute social defeat 
sessions daily with physical contact for 5 minutes. The defeat was repeated 
for five consecutive days and each day a new resident was used. From the 
first defeat session onwards, the SDPS rats were single-housed until the 
end of the experiment.
Time points taken for behavioral, and molecular analysis were named ‘2 
weeks post-defeat’ (behavior: day 17, 18; molecular: day 20 post-defeat), 
‘4 weeks post-defeat’ (behavior: day 31, 32; molecular: day 33 post-
defeat), and ‘8 weeks post-defeat’ (behavior: day 56, 58; molecular: day 
60 post-defeat).
Behavioral testing
All behavioral testing was performed during the dark phase of a 12 h 
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light-dark cycle (lights on at 7 PM), under a dim red light as described 
previously187. Affective function was tested with the Social Approach 
Avoidance (SAA) test, in which exploration and approach to a caged 
unfamiliar Long-Evans rat was measured during the first minute of the test 
as the time spent near the social target vs. time spent near the empty box; 
interaction ratio: social target zone / (social target zone + empty box zone). 
Cognitive function in terms of spatial memory was assessed with the 
Object Place Recognition (OPR test), in which exploration and approach 
of a relocated object was analyzed during the first minute of the test as 
time spent exploring the relocated object compared to the stable object; 
Discrimination index: relocated object / (relocated object + stable object). 
 
Immunohistochemistry 
Following transcardial perfusion with ice-cold 4% PFA in PBS and 
overnight post-fixation, brains were transferred to 30% sucrose in PBS at 
4 °C until sectioned and processed for immunohistochemistry as described 
previously187. Free-floating sections were incubated with primary antibodies 
(mouse anti-chondroitin sulfate proteoglycan 1:1,000, cat-301 MAB5284; 
rabbit anti-parvalbumin 1:1,000, Swant #235) overnight at 4 °C. After 
washing, sections were incubated with fluorescent-conjugated secondary 
antibodies (anti-mouse-Alexa-488 1:400, Invitrogen A11001; anti-rabbit-
Alexa-568 1:400, Invitrogen A11011) for 2 h at RT. Thereafter, the sections 
were washed 4 times 10 minutes with PBS at RT and mounted. Images 
were acquired on a fluorescent microscope (Leica DM5000), and analyzed 
by Fiji software178, using automated threshold and particle analysis to detect 
the number of PNN+ and PV+ cells and their double immunoreactivity. 
False-positive cells were excluded manually during the analysis. During 
image acquisition and cell quantification, the researcher was blind to the 
experimental groups. 
Tissue preparation, immunoblotting, 
MMP extraction & zymography
Dorsal hippocampus233 samples were homogenized to either isolate 
synaptosomes for immunoblotting using a sucrose gradient and processed 
for immunoblotting as described previously187 or to isolate ECM-bound 
MMPs for zymography as described234.
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Immunoblotting – Normalized immunoblotting data were subsequently 
log2-transformed and presented vs. those of control samples. In addition, 
data were compared to the log2-transformed quantification of perisynaptic 
ECM protein levels at 8 weeks post-defeat, as shown previously187.
MMP extraction & zymography – Tissue was homogenized (50 mM Tris 
pH 7.4, 10 mM CaCl2and 0.25% Triton X-100) and centrifuged (6,000x 
g, 30 minutes at 4 °C). The pellet was resuspended (50 mM Tris, pH 7.4, 
and 0.1 mM CaCl2), heated (60 °C, 15 minutes) and centrifuged (10,000x 
g, 30 minutes at 4 °C). After this, the supernatant was recovered and the 
protein concentration was determined using Bradford. Thereafter, proteins 
were precipitated (60% ethanol, 1 minute at 4 °C) and centrifuged (15,000x 
g, 5 minutes at 4 °C). Finally, the pellet was solubilized in non-reducing 
sample buffer (2% SDS) and heated (37 °C, 15 minutes) before loading on 
an SDS-PAGE gel containing gelatin (0.1% gelatin, 8% SDS); samples (10 
μg of protein) and recombinant mouse MMP-9 as positive control (5 ng, 
ab39309, Abcam). The gels were washed with 2.5% Triton X-100 (2x 20 
minutes) and then incubated for 7 days (50 mM Tris, pH 7.5, 10 mM CaCl2, 
1 μM ZnCl2, 1% Triton X-100, and 0.02% sodium azide; 37 °C, 80 rpm). 
Incubation was followed by Coomassie staining and destaining (5% HAc) 
until clear bands were visible. Gels were scanned and analyzed using Gel 
Doc EZ imager (Biorad, Herculus, CA, USA), and normalized based on 
Coomassie input.
Statistics
All data were analyzed using IBM SPSS Statistics 24. For group 
comparisons, two-tailed Student’s t-tests (with or without correction 
for unequal variation) were applied for normally distributed data and 
Mann-Whitney U-tests otherwise. Data were checked for normality 
using the Saphiro-Wilk test. All group data are depicted as mean±SEM, 
with individual data on top. Statistical significance level was set for 
P-values<0.05, trend for 0.05<P-value<0.10. Correlations were made for 
SAA and OPR behavior per batch of animals, using Spearman rank (n<15), 
or Pearson’s product moment (n≥15). Details of all statistical testing can be 
found in Supplementary Table S1, and individual data points are given in 
Supplementary Table S2.
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SUPPLEMENTARY FIGURES AND TABLES
 
Supplemental Figure 1: Prolonged social isolation in adult male Wistar rats 
does not influence affective and cognitive behavior or hippocampal PNN 
density. a) Adult rats were exposedto a 5-day sham social defeat paradigm, in 
which they explored an empty defeat box during 15 minutes. Pair-housed (PH) 
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Supplemental Figure 1: Prolonged social isolation in adult male Wistar rats does not 
influence affective and cognitive behavior or hippocampal PNN density. a) Adult rats 
were exposed to a 5-day sham social defeat paradigm, in which they explored an empty 
defeat box during 15 minut s. Pair-housed (PH) control rats r mained pair-housed 
throughout the experiment. Individually-housed (IH) control rats experienced a 9-week 
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controlrats remained pair-housed throughout the experiment. Individually-housed 
(IH) control rats experienced a 9-week period of individual housing starting from the 
moment of sham defeat onwards. Behavior was assessed with the social approach 
avoidance (SAA) and object place recognition (OPR) tests, 8 weeks after the last 
sham social defeat session.The day following the last behavioral test, animals 
were perfused and processed for PNN-counting. b,c) Social isolation had no effect 
on affective (b, Student’s t-test, P=0.655), or cognitive (c, Mann-Whitney U test, 
P=0.514) behavior, as shown previously187. d,e)The number of chondroitin sulfate 
proteoglycan (CSPG+)-richperineuronal nets (PNNs, green) onto parvalbumin-
expressing (PV+, red) interneurons were quantified with immunohistochemical 
(IHC) analysisin the dCA1 (d). No effect of prolonged social isolation was detected 
(Student’s t-test, P=0.476), whereas the SDPS paradigm increased PNNs on 
PV+interneurons at this time-point (cf. Fig. 2; Riga et al., 2017187). Example 
immunostainings are given; scale bar (75 μm) is indicated (e). Data are expressed 
as mean±SEM. 
 
Supplemental Figure 2: Stress-induced weight gain. Weight gain was measured 
as the difference in weight between social-defeat day 1, prior to defeat, and social-
defeat day 5, after defeat,and expressed as % from their corresponding controls 
in the same batch, to assess similar stress effects of social defeat187 between 
batches. A one-way ANOVA (timepoint/batch) did not reveal a significant effect 
(F(3,46)=1.55; P=0.216), indicating that equal stress was experienced across 
batches. P-values (one-tailed Student’s t-test) and individual data points are 
indicated. Data are expressed as mean±SE
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Supplemental Figure 3. Correlation of affective and cognitive phenotypes.SAA 
interaction ratio and OPR discrimination index were correlated per animal batch 
undergoing SAA and OPR behavior, either shortly after defeat (a), at week 2 (b), 
week 4 (c) and week 8 (d) post-defeat. Spearman correlations (r) and their P-values 
are indicated per group (Con, SDPS), as well as the trendline (dotted line). In 
addition, Pearson correlation over the entire group per time point indicated the 
absence of any significant correlations between affective and cognitive parameters 
(r24-48 h: -0.146 P=0.517; r2w:-0.212 P=0.319; r4w:-0.223 P=0.318; r8w:0.233 
P=0.165; see Supplemental Table 1).
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Supplemental Figure 3: Correlation of affective and cognitive phenotypes. SAA 
interaction ratio and OPR discrimination index were correlated per animal batch undergoing 
SAA nd OPR behavior, either shortly after def at (a), at week 2 (b), week 4 (c) and week 
8 (d) post-defeat. Spearman correlations (r) and their P-values are indicated per group (Con, 
SDPS), as well as the trendline (dotted line). In addition, Pea son correlation over the entire 
group per time point indicated the absence of any significant correlations between affective 
and cognitive parameters (r24-48 h: -0.146 P=0.517; r2 w:-0.212 P=0.319; r4 w: -0.223 P=0.318; 
r8 w:0.233 P=0.165; see Supplemental Table 1).  
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Supplemental Figure 4. Whole immunoblot compilation 72 h post defeat. Whole 
immunoblots (left) and trichloro-ethanol stained gels (right) are shown from which 
sections (orange dashed rectangle) are included in Figure 3 for the 72 h post-defeat 
time-point (C=control animal; SD=SDPS animal). Molecular weights are indicated. 
Supplementary information 
Koskinen et al. – From stress to depression: Development of extracellular matrix-dependent cognitive 
impairment following social stress 
 10 
 
Supplemental Figure 4. Whole immunoblot compilation 72 h post defeat. Whole immunoblots 
(left) and trichloro-ethanol stained gels (right) are shown from which sections (orange dashed 
rectangle) are included in Figure 3 for the 72 h post-defeat time-point (C=control animal; SD=SDPS 
animal). Molecular weights are indicated.  
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Supplemental Figure 5. Whole immunoblot compilation week 2 post defeat. 
Whole immunoblots (left) and trichloro-ethanol stained gels (right) are shown from 
which sections (orange dashed rectangle) are included in Figure 3 for the week 2 
post-defeat time-point (C=control animal; SD=SDPS animal). Molecular weights 
are indicated.
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Supplemental Figure 5. Whole immunoblot compilation week 2 post defeat. Whole 
immunoblots (left) and trichloro-ethanol stained gels (right) are shown from which sections (orange 
dashed rectangle) are included in Figure 3 for the week 2 post-defeat time-point (C=control animal; 
SD=SDPS animal). Molecular weights are indicated. 
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Supplemental Figure 6. Whole gel gelatinase assay 72 h and week 8 post-
defeat. Whole gels for in gel zymography (72 h, up; week 8, down) are shown from 
which sections (orange dashed rectangle) are included in Figure 4. The mature form 
of MMP-2 and MMP-9 (white bands), as well as molecular weights are indicated. 
Sample normalization for loading differences was performed on the Coomassie-
stained bands. M, marker; P, positive control of human MMP-9, C=control animal; 
SD=SDPS animal. Note that 1 SDPS sample (crossed, week 8) was considered an 
outlier at the protein level and for MMP activity.
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Supplemental Table 1. Overview statistics all figures. Shown are the results 
and details of the 2-tailed statistical analyses (type of test, n-number, t-value, Df, 
P-value) for the data shown in Figure 1 (behavior), Supplemental Figure 1 and 2 
(isolation on behavior), Supplemental Figure 3 (weight gain), Supplemental Figure 
4 (correlation of behavior), Figure 2 (PNN staining), Figure 3 (Immunoblot), and 
Figure 4 (MMP gelatinase activity) in SDPS vs. Control (CON) animals for the 
indicated time points. Significance (P<0.050) is indicated in bold, trend (P<0.100) 
in underlined; tests with unequal variance are in italics. 
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statistical analyses (type of test, n-number, t-value, Df, P-value) for the data shown in Figure 1 (behavior), 
Supplemental Figure 1 (isolation on behavior), Supplemental Figure 2 (weight gain), Supplemental Figure 3 
(correlation of behavior), Figure 2 (PNN staining), Figure 3 (Immunoblot), and Figure 4 (MMP gelatinase 
activity) in SDPS vs. control (CON) anim ls for the indicated time points. Significance (P<0.050) is indicated 
in bold, trend (P<0.100) in underlined; tests with unequal variance are in italics. 
 
Figure Statistical test (nCon, nSDPS) Statistics (t-value, Df) P-value 
1b Mann-Whitney U test  
CON vs. SDPS 24 h (11, 11) 
CON vs. SDPS week 8 (18, 19) 
 
Unpaired t-test  
CON vs. SDPS week 2 (12, 12) 
CON vs. SDPS week 4 (11, 11) 
 
CON vs. fictive 24 h 
CON vs. fictive week 2 
CON vs. fictive week 4 
CON vs. fictive week 8 
 
SDPS vs. fictive 24 h 
SDPS vs. fictive week 2 
SDPS vs. fictive week 4 






t(22) = 2.352 
t(20) = 2.456 
 
(t20) = 5.484 
t(22) = 8.888 
t(20) = 9.457 
t(34) = 11.104 
 
t(20) = 5.162 
t(22) = 2.575 
t(20) = 6.733 
t(36) = 6.382 
 
P = 0.935 
P = 0.026 
 
 
P = 0.028 
P = 0.023 
 
P < 10-4  
P < 10-4  
P = 10-4  
P < 10-4  
 
P < 10-4  
P = 0.017 
P < 10-4  
P < 10-4  
 
1c Unpaired t-test  
CON vs. SDPS 48 h (11, 11) 
CON vs. SDPS week 2 (12, 12) 
CON vs. SDPS week 4 (11, 11) 
CON vs. SDPS week 8 (18, 19) 
 
CON vs. fictive 48 h 
CON vs. fictive week 2 
CON vs. fictive week 4 
CON vs. fictive week 8 
 
SDPS vs. fictive 48 h 
SDPS vs. fictive week 2 
SDPS vs. fictive week 4 
SDPS vs. fictive week 8 
 
t(20) = 2.189 
t(22) = -1.067 
t(20) = -0.271 
t(35) = 3.366  
 
t(20) = 2.349 
t(22) = 2.944 
t(20) = 2.583 
t(34) = 5.094 
 
t(20) = -0.116 
t(22) = 3.356 
t(20) = 4.106 
t(36) = 1.890 
 
P = 0.041 
P = 0.298 
P = 0.789 
P = 0.002 
 
P = 0.029  
P = 0.008 
P = 0.018 
P < 0.001 
 
P = 0.908 
P = 0.003 
P = 0.001  
P = 0.067 
 
S1b Unpaired t-test (SAA) 
CONpair vs. CONiso week 8 (12, 12) 
 
Mann-Whitney U test (OPR) 
CONpair vs. CONiso week 8 (11, 11) 
CONiso vs. fictive week 8 
 
Unpaired t-test (OPR) 
CONpair vs. fictive week 8 
 
 







t(22) = 3.798 
 
 
P = 0.665 
 
 
P = 0.514 
P = 0.001  
 
 
P = 0.001  
 
S1c Unpaired t-test (PNN) 
CONpair vs. CONiso week 8 (3, 5) 
 
 
t(6) = 0.761 
 
 
P = 0.476 
 
S2 One way ANOVA  
Weight gain; control-normalized values (per 




F(3,46) = 1.55 
 
 
P = 0.216 
S3a–d Pearson correlation SAA & OPR per time 
point 
SAA24 h vs OPR48 h (22) 
SAA2 w vs OPR2w (24) 
SAA4 w vs OPR4 w (22) 
SAA8 w vs OPR8 w (37) 
 
Spearman correlation SAA & OPR per 
group per time point 
Control 
SAA24 h vs OPR48 h (11) 
SAA2 w vs OPR2w (12) 
SAA4 w vs OPR4 w (11) 




r24-48 h = -0.146  
r2 w = -0.212 
r4 w = -0.223 





r24-48 h = 0.318 
r2 w = 0.238 
r4 w = -0.227 




P = 0.517 
P = 0.319 
P = 0.318 





P = 0.340 
P = 0.457 
P = 0.502 




* Note, the week 8 immunoblot data (non-log2-transformed) have been published before187, 
and are not repeated to adhere to the 3R-principle of animal research.
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SDPS 
SAA24 h vs OPR48 h (11) 
SAA2 w vs OPR2w (12) 
SAA4 w vs OPR4 w (11) 
SAA8 w vs OPR8 w (19) 
 
r24-48 h = -0.518 
r2 w = -0.175 
r4 w = -0.364 
r8 w = 0.004 
 
P = 0.102 
P = 0.587 
P = 0.272 
P = 0.989 
2b Unpaired t-test  
CON vs. SDPS 72 h (5, 4) 
CON vs. SDPS week 2 (4, 3) 
CON vs. SDPS week 4 (3, 4) 
CON vs. SDPS week 8 (4, 4) 
 
t(7) = 2.489 
t(5) = -1.730 
t(5) = -1.833 
t(6) = -4.966 
 
P = 0.042 
P = 0.144 
P = 0.126 
P = 0.001 
 
2d Unpaired t-test  
CON vs. SDPS 72h 
CON vs. SDPS week 2 
CON vs. SDPS week 4 
CON vs. SDPS week 8 
 
t(5) = -0.030 
t(5) = -1.673 
t(5) = -1.940 
t(3.850) = -1.105 
 
P = 0.977  
P = 0.155  
P = 0.110  
P = 0.333  
 
3b,c Log2 transformed data 
72 h  
Unpaired t-test  
CON vs. SDPS Acan (8, 7) 
CON vs. SDPS Bcan (8, 7) 
CON vs. SDPS Ncan (8, 7) 
CON vs. SDPS Pcan (8, 7) 
CON vs. SDPS TenR160 (8, 6) 
CON vs. SDPS TenR180 (8, 7) 
 
Mann-Whitney U test  
CON vs. SDPS Hapln1 (8, 7) 
 
Week 2  
Unpaired t-test  
CON vs. SDPS Acan (6, 8) 
CON vs. SDPS Bcan (6, 8) 
CON vs. SDPS Ncan (6, 8) 
CON vs. SDPS Pcan (6, 8) 
CON vs. SDPS TenR160 (6, 8) 
CON vs. SDPS TenR180 (6, 8) 
CON vs. SDPS Hapln1 
 
Week 8* 
Unpaired t-test  
CON vs. SDPS Acan (4, 5) 
CON vs. SDPS Bcan (4, 5) 
CON vs. SDPS Pcan (4, 5) 
CON vs. SDPS TenR160 (4, 4) 
CON vs. SDPS TenR180 (4, 4) 
CON vs. SDPS Hapln1 
 
Mann-Whitney U test 




t(13) = 0.779 
t(13) = 2.300 
t(13) = 2.453 
t(13) = 2.610 
t(13) = 3.213 







t(12) = 1.083 
t(12) = 0.009 
t(12) = -0.312 
t(12) = 0.435 
t(12) = -1.021 
t(12) = -0.495 




t(7) = -1.107 
t(7) = -3.582 
t(7) = -3.563 
t(7) = -1.999 
t(7) = -1.505 





P = 0.450 
P = 0.039  
P = 0.029  
P = 0.022  
P = 0.007  
P = 0.047  
 
 




P = 0.300 
P = 0.993 
P = 0.760 
P = 0.671 
P = 0.327 
P = 0.629 




P = 0.305 
P = 0.009 
P = 0.009 
P = 0.093 
P = 0.183 
P = 0.015 
 
 
P = 0.016 
 
4b,c 72 h  
Unpaired t-test  
CON vs. SDPS MMP-2 (6, 6) 
CON vs. SDPS MMP-9 (6, 6) 
 
Week 8 
Unpaired t-test  
CON vs. SDPS MMP-2 (6, 4) 




t(10) = -0.513 




t(8) = 2.398 




P = 0.619 




P = 0.043 
P = 0.239 
 
* Note, the week 8 immunoblot data (non-log2-transformed) have been published before2, and are not repeated to adhere to the 3R-
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1b Mann-Whitney U test  
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CON vs. SDPS week 8 (18, 19) 
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t(22) = 2.352 
t(20) = 2.456 
 
(t20) = 5.484 
t(22) = 8.888 
t(20) = 9.457 
t(34) = 11.104 
 
t(20) = 5.162 
t(22) = 2.575 
t(20) = 6.733 
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P = 0.026 
 
 
P = 0.028 
P = 0.023 
 
P < 10-4  
P < 10-4  
P = 10-4  
P < 10-4  
 
P < 10-4  
P = 0.017 
P < 10-4  
P < 10-4  
 
1c Unpaired t-test  
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CON vs. SDPS week 2 (12, 12) 
CON vs. SDPS week 4 (11, 11) 
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t(20) = 2.189 
t(22) = -1.067 
t(20) = -0.271 
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t(20) = 2.349 
t(22) = 2.944 
t(20) = 2.583 
t(34) = 5.094 
 
t(20) = -0.116 
t(22) = 3.356 
t(20) = 4.106 
t(36) = 1.890 
 
P = 0.041 
P = 0.298 
P = 0.789 
P = 0.002 
 
P = 0.029  
P = 0.008 
P = 0.018 
P < 0.001 
 
P = 0.908 
P = 0.003 
P = 0.001  
P = 0.067 
 
S1b Unpaired t-test (SAA) 
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Mann-Whitney U test (OPR) 
CONpair vs. CONiso week 8 (11, 11) 
CONiso vs. fictive week 8 
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t(22) = 3.798 
 
 
P = 0.665 
 
 
P = 0.514 
P = 0.001  
 
 
P = 0.001  
 
S1c Unpaired t-test (PNN) 
CONpair vs. CONiso week 8 (3, 5) 
 
 
t(6) = 0.761 
 
 
P = 0.476 
 
S2 One way ANOVA  
Weight gain; control-normalized values (per 




F(3,46) = 1.55 
 
 
P = 0.216 
S3a–d Pearson correlation SAA & OPR per time 
point 
SAA24 h vs OPR48 h (22) 
SAA2 w vs OPR2w (24) 
SAA4 w vs OPR4 w (22) 
SAA8 w vs OPR8 w (37) 
 
Spearman correlation SAA & OPR per 
group per time point 
Control 
SAA24 h vs OPR48 h (11) 
SAA2 w vs OPR2w (12) 
SAA4 w vs OPR4 w (11) 




r24-48 h = -0.146  
r2 w = -0.212 
r4 w = -0.223 





r24-48 h = 0.318 
r2 w = 0.238 
r4 w = -0.227 




P = 0.517 
P = 0.319 
P = 0.318 





P = 0.340 
P = 0.457 
P = 0.502 
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ABSTRACT
Increasing evidence highlights the important role of the extracellular matrix 
(ECM) in regulating experience-dependent plasticity in the adult brain. 
Our previous studies provided compelling evidence for the involvement 
of aberrant hippocampal ECM assembly in stress-induced cognitive 
dysfunction, both shortly and long-term after stress exposure. However, 
the underlying molecular mechanisms driving these ECM changes remain 
unknown. Here, we explored the hypothesis that metalloproteinase 9 (MMP-
9)-mediated breakdown of ECM in response to social defeat stress underlies 
the hippocampal impairment observed in the days after stress exposure. 
We show that systemic administration of the gelatinase inhibitor IPR-179 
during social defeat, prevents spatial working memory deficits, emerging 
early after stress. This suggests that MMP-mediated proteolytic activity is 
involved in stress-induced hippocampal dysfunction. Systemic IPR-179 
administration did not protect against stress-induced downregulation of 
perisynaptic ECM proteins in the hippocampus. Nevertheless, IPR-179 
attenuated the degradation of perineuronal nets (PNNs) in the CA1 area, 
as seen after social defeat. Although IPR-179 shows promise to protect 
from stress-driven cognitive dysfunction, additional research is needed to 
parse the mechanisms through which it exerts its effects. 
INTRODUCTION
Matrix metalloproteinases (MMPs) are calcium-dependent endopeptidases, 
synthesized and secreted both by neurons and glial cells, important in 
orchestrating structural and functional plasticity both in the developing and 
the adult brain72,235. MMPs are secreted into the extracellular space where 
they regulate neuroplasticity by cleaving extracellular matrix (ECM) proteins, 
cell adhesion molecules (CAM) and neurotrophins235. MMPs are secreted 
as inactive pro-forms that undergo activation upon proteolytic cleavage 
of their pro-domain. To avoid excessive MMP-mediated breakdown, their 
activity is tightly regulated by tissue inhibitor of metalloproteinases (TIMPs), 
which bind to MMPs’ catalytic site and are often co-released together with 
the MMPs236.
MMPs regulate structural and functional plasticity, for example by modulating 
neuronal arborization, spine morphology and long-term potentiation 
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(LTP)71,237–239. In particular, MMP-9 is crucial for the maintenance of LTP 
in the hippocampus240, mPFC241 and amygdala242. Although MMP-9 levels 
are low in the adult brain, MMP-9 activity rapidly increases in response to 
synaptic activity at excitatory synapses243,244. Accordingly, the spatially and 
temporally controlled MMP-9 activation is essential for learning and memory 
processes, as demonstrated by studies showing impaired cognition when 
MMP-9 activity is inhibited during behavioral tasks148,149,245,246. 
Aberrant  MMP regulation is increasingly associated with the pathophysiology 
of psychiatric disorders, including major depressive disorder (MDD)247. As 
an example, increased plasma levels of MMP-9 were found in patients 
diagnosed with MDD248. Importantly, peripheral MMP-9 levels in MDD 
patients correlate with poor performance in cognitive tasks, suggesting 
a link between MMP-9 regulation and cognitive performance in MDD231. 
Furthermore, doxycycline-induced inhibition of MMP activity prior to fear 
conditioning was shown to mitigate fear responses in humans249, hinting to 
the involvement of MMPs in the formation of fear memories. Likewise, fear 
conditioning in mice increases MMP-9 expression in the hippocampus245. 
A recent preclinical study demonstrated that chronic restraint stress in rats 
specifically increased MMP-9 activity in the hippocampal CA1-subregion152. 
Importantly, the adverse effects of chronic stress on hippocampal-
dependent memory were prevented by chronic inactivation of MMP-9 
during stress exposure. Taken together, these findings demonstrate the 
involvement of MMP-9 in mediating stress responses, and in particular, 
stress effects on cognition. Furthermore, these studies highlight MMP-9 as 
a potent therapeutic target against stress-related pathology. 
Extracellular matrix proteins are major substrates for MMP-9 and MMP-2, 
the most abundantly expressed MMPs in the brain72. As such, MMPs are an 
integral part of the machinery mediating ECM remodeling, critically involved 
in experience-dependent plasticity65,250. Previously, we demonstrated a 
biphasic regulation of pericellular and perisynaptic ECM components in 
response to social defeat stress, in which an early ECM downregulation 
is followed by an increased expression of ECM components later on187,251. 
While our studies highlight the ECM as a crucial substrate of stress effects 
in the CA1, the exact role of MMPs in stress-induced ECM remodeling in 
the CA1 remains to be studied. 
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Here, we set out to address this question by systematically administrating a 
gelatinase inhibitor prior to defeat on each day of stress exposure. For this, 
we used a novel blood brain barrier (BBB)-permeable gelatinase inhibitor, 
IPR-179, which binds both to MMP-9 and MMP-2 at a nanomolar range, 
albeit with a higher affinity to the former252,253. We hypothesized that, similar 
to restraint stress152, social defeat might lead to increased MMP-9 activity 
in the CA1, where we observe the specific stress-induced downregulation 
of PNNs. We predicted that IPR-179 presence at the time of stress might 
prevent MMP-9 over-activation, thereby halting the subsequent decrease 
in pericellular and perisynaptic ECM, and the accompanying memory 
deficits present acutely after stress. 
Our results demonstrate that IPR-179 effectively prevented the emergence 
of early social defeat-induced memory impairment observed 48 hours 
after the last defeat session. The beneficial effect of IPR-179 on cognitive 
function was accompanied by amelioration of the effects of social defeat 
stress on hippocampal PNNs. On the contrary, IPR-179 did not prevent 
defeat-induced reduction in the expression of perisynaptic ECM proteins. 
Although the exact molecular mechanisms mediating the behavioral 
effects of IPR-179 remain unclear, these data could hint to a divergent role 
of perisomatic vs. perisynaptic ECM in stress-induced cognitive deficits. 
RESULTS
Expression of synaptic extracellular matrix 
proteins is altered during social defeat stress
We previously showed that early after 5 social defeat sessions the 
expression of perisynaptic ECM in the hippocampus is reduced251. Here, 
to address the temporal dynamics of stress-induced ECM remodelling, 
we investigated expression of perisynaptic ECM proteins after 3 defeat 
sessions (Fig. 1a). Three sessions of daily defeat reduced the expression 
of the chondroitin sulfate proteoglycan (CSPG) neurocan (Ncan) (Ncan: 
U=4, P=0.024), while the expression of aggrecan (Acan) was increased 
(Acan: t(9)=2.733, P=0.034). A trend for reduced phosphacan (Phcan) 
expression was present (Phcan: U=7, P=0.087), while changes in brevican 
(Bcan) expression levels were not observed (Bcan: t(9)=1.377, P=0.202). 
Likewise, no change in the expression of the link-like ECM proteins 
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Hyaluronan and proteoglycan link protein 1 (Hapln1) and tenascin-R 
was present at this timepoint (Hapln1: t(10)=1.156, P=0.274; TnR160: 
t(10)=1.656, P=0.129; TnR180: U=10, P=0.240) (Fig. 1b). Taken together, 
our results demonstrate that partial ECM remodeling occurs already early 
on during social defeat stress. 
Inhibition of MMP-9 during stress exposure rescues social 
defeat-induced cognitive impairment 
The ECM remodeling we previously observed 72 h after the 5th social 
defeat session was associated with a non-significant increase in MMP-
9 activity251. here, we aimed to assess whether altered MMP activity 
during social defeat stress, when ECM reorganization is already 
initiated (cf. Fig. 1), underlies the cognitive deficit present after defeat 
stress. For this we systemically administered IPR-179, a gelatinase 
inhibitor with a high affinity to MMP-9252, prior to each social defeat session 
as well as 24 hours after the last defeat episode. Two independent 
batches of defeat-exposed animals were used for these experiments (Fig. 
2a). Cognitive function was assessed using the object place recognition 
(OPR) test with a 15-minute retention interval, at 48 h after social defeat, 
which is the earliest time point we have observed an OPR deficit in SDPS 
animals251. At 48 h following the last defeat episode, and 24 h after the 
last of 6 treatments with IPR-179 we observed normal, control-level 
OPR performance in SDPS rats. In particular, vehicle-treated SDPS rats 
performed worse than both control and IPR-179-treated SDPS animals, 
however, a group comparison did not reach statistical significance (Kruskal-
Wallis, P=0.118; Fig. 2b). 
We further analyzed the discrimination ratio of each individual group by 
comparing it against a fictive group with a mean of 0.5 and equal variation 
as the group tested123. Control and SDPS+IPR-179 groups showed a 
clear preference for the relocated object (vs. fictive: control+vehicle, 
t(22)=2.827, P=0.010; SDPS+IPR-179, t(22)= 2.339, P=0.029), indicating 
intact spatial memory. Conversely, vehicle-treated SDPS rats did not 
discriminate between the familiar and the relocated object (SDPS+vehicle 
vs. fictive, MWU, P=0.755), confirming impaired spatial memory. The two 
independent batches each showed the same trend as the group average 
(Table 1). Collectively, these results suggest that inhibition of MMP-9 
activity during stress exposure is effective in preventing stress-induced 
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cognitive dysfunction emerging early after a stressful experience. However, 
in absence of a significant between-group effect, these data need to be 
interpreted with caution. 
Figure 1. ECM remodeling starts during social defeat. a) Using a short social 
defeat protocol, immunoblot analysis of ECM proteins was performed 24 h after 
the last of 3 social defeat sessions. b) Although expression of chondroitin sulfate 
proteoglycans Aggrecan (Acan) increased significantly after 3 social defeat 
sessions, that of Neurocan (Ncan) and Phosphacan (Phcan) decreased. Brevican 
(Bcan), the Tenascin-R (TenR) isoforms and Hyaluronan and proteoglycan link 
protein 1 (Hapln1) did not change significantly in expression. c) Example blots are 
indicated, the full blots are depicted in Supplementary Figure S1. Unpaired t-tests 
are indicated (#P<0.100, *P<0.050). Data are expressed as mean±SEM.
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MMP-9 inhibition during defeat does 
not prevent stress-induced reduction of 
perisynaptic ECM levels or nectin-3 cleavage 
Based on our behavioral results showing normalization of the stress-
induced OPR deficit by IPR-179, we hypothesized that inhibition of MMP-9 
activity could prevent the downregulation of hippocampal perisynaptic ECM 
proteins, as seen early after defeat251. For this, we analyzed expression 
levels of several ECM proteins via immunoblot, 72-h after the last defeat 
episode (cf. Fig. 1a)251. 
Replicating our previous findings251, five daily sessions of social defeat 
reduced expression of the majority of CSPGs tested (control+veh vs. 
SDPS+veh, Acan: t(10)=2.042, P=0.034; Bcan: t(10)=2.040, P=0.035; 
Ncan: t(10)=1.976, P=0.038; Phcan: t(10)=1.970, P=0.039). No defeat 
effect was observed for any of the ECM-tethering proteins (Hapln1: t(10)=-
0.429, P=0.339); TnR160: t(10)=-0.110, P=0.458; TnR180: t(10)=1,422, 
P=0.093) (Fig. 3a). Against our expectations, pretreatment with IPR-179 
did not prevent defeat-induced downregulation of perisynaptic ECM, and 
in fact, in some cases it even promoted SDPS-induced reduction in protein 
expression (control vs. SDPS+IPR; Acan: t(10)=5.010, P=0.001; Bcan: 
t(10)=2.289, P=0.045; Ncan: t(10)=2.650, P=0.024; Phcan: t(10)=2.643, 
P=0.025; TnR160: t(10)=0.995, P=0.343; TnR180: t(10)=1.737, P=0.113; 
Hapln1: t(10)=2.611, P=0.026) (Fig. 3a). 
In addition to ECM proteins, MMPs cleave cell adhesion molecules, 
including nectin-3152, which is implicated in immediate stress effects. To 
examine whether a non-ECM MMP substrate could mediate the beneficial 
effects of IPR-179 in cognitive function after defeat, we here quantified 
full-length nectin-3 expression in the dorsal hippocampus (CA1-3 and 
DG) (Fig. 3b). No effect of defeat was observed for nectin-3 expression 
(control+veh vs. SDPS+veh, t(10)=0.273, P=0.790). Furthermore, IPR-
179 treatment did not alter nectin-3 expression levels (control+veh vs. 
SDPS+IPR, t(10)=1.290, P=0.226). Altogether, these results indicate 
that nectin-3 levels are not altered by social defeat stress nor by IPR-179 
administration in vivo.
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Figure 2. Gelatinase inhibitor IPR-179 prevents the emergence of stress-
induced spatial memory impairment. a) Adult rats were subjected to the SDPS 
(social defeat-induced persistent stress) paradigm in which they received 5 days of 
social defeat and individual housing. Control rats remained pair-housed throughout 
the experiment. The MMP-9 inhibitor (IPR-179) or vehicle were administered daily 
(arrows) via i.p. injections 30 min prior to the start of each defeat session (day 
1–5). A last injection was given 24 hours after the last defeat episode (day 6). 
Performance in the object place recognition (OPR) test was assessed the next day 
(day 7). Brains we collected for immunoblot (IB) and immunohistochemical (IHC) 
analysis 24 hours after the OPR test (day 8). b) Two independent batches (n=6 
animals /group /batch) were ran and are indicated separately. IPR-179 prevented 
the development of the social defeat-induced hippocampal deficit. Vehicle-injected 
control rats showed preference for the relocated object, while SDPS vehicle-
treated rats failed to perform at the OPR task, showing preference ratio close to 
chance levels. Notably, in IPR-179-treated SDPS rats normal memory retention 
was observed, with the group showing preference for the relocated object. Kruskal-
Wallis (KW) was used to assess overall group differences; unpaired t-tests/MWU 
against a fictive group with a mean of 0.5 and equal variation123 are indicated 
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Taken together, our immunoblot analysis demonstrated that synaptic 
expression of several lecticans and other ECM components was not 
normalized by systemic administration of IPR-179 during social defeat, as 
measured in the dorsal hippocampus. Hence this compound seemed not 
effective in preventing SDPS-induced synaptic ECM degradation, despite 
the positive effect at the behavioral level.
Metalloproteinase inhibition during defeat 
attenuates stress-induced reduction of PNNs
Many of the ECM proteins are present both at the perisynaptic fraction, 
as well as in the PNNs, and MMP-mediated degradation can affect 
both types of ECM. Since IPR-179 behavioral effects apparently were 
not mediated via modifications in perisynaptic ECM, we next assessed 
its effect on PNNs, 72 hours after the last stress exposure (cf. Fig. 
1a)251. We quantified the number of PNNs in the CA1 subregion of the 
dorsal hippocampus, as these were shown to be downregulated shortly 
after social defeat stress251. One-way ANOVA demonstrated a non-
significant group effect F(2,10)=3.086, P=0.102. Replicating our previous 
findings, at 72 h after the last of 5 defeat episodes CA1 PNNs density 
was reduced (con+veh: 5.26±0.45, SDPS+veh:3.97±0.31) (Fig. 4a). 
Notably. stress-induced reduction in PNN numbers was alleviated in 
IPR-179-treated rats (SDPS+IPR-179: 4.47±0.27). Furthermore, defeat 
stress reduced overall CSPG intensity, while this effect was absent in 
the IPR-treated animals which resembled controls (Kolmogorov-Smirnov 
pairwise tests: con+veh vs. SDPS+veh, P<0.001; con+veh vs. SDPS+IPR, 
P=0.028; SDPS+veh vs. SDPS+IPR, P=0.092; Bonferroni corrected 
α=0.017),  Together, these data suggest that IPR-179 administration could, 
at least partially, counteract stress-induced PNN breakdown. 
DISCUSSION
By employing the SDPS paradigm, in which a 5-day social defeat is 
combined with social isolation, we have previously identified hippocampal 
ECM remodeling to be affected both early after stress, as well as months 
after the initial stress exposure187,251. While a downregulation of ECM 
components is present early after stress, an increase in ECM levels is 
present months after the initial stress exposure251. Notably, we previously
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Figure 3. Gelatinase inhibitor IPR-179 does not prevent degradation of 
perisynaptic ECM proteins, nor affects nectin-3 levels. Immunoblot analysis 
of ECM proteins was performed 72 h after the last social defeat session on 
batch 1 animals. a) Decreased expression of chondroitin sulfate proteoglycans 
Aggrecan (Acan), Brevican (Bcan), Neurocan (Ncan) and Phosphacan (Phcan) 
was present in the SDPS-vehicle vs. the control group, as shown previously251. 
IPR-treatment did not prevent SDPS-induced downregulation of ECM proteins. 
Decreased expression of Hyaluronan and proteoglycan link protein 1 (Hapln1) 
was observed in the inhibitor-treated SDPS group vs. the control vehicle-treated 
group. No difference in the expression of Tenascin-R isoforms was observed. The 
expression of full length nectin-3 was not significantly affected by stress, nor stress 
in combination with IPR-179. b) Example blots are indicated, the full blots are 














































































*P<0.050, ***P≤0.001). Data are expressed as mean±SEM.
Figure 4. Gelatinase inhibitor IPR-179 partially rescues stress-induced 
reduction in PNN density. a) The number of chondroitin sulfate proteoglycan 
(CSPG+)-rich perineuronal net (PNN)-enwrapped interneurons were quantified 
using immunohistochemistry. Vehicle-treated SDPS rats showed a reduction in the 
number of CSPG+PV+ cells in the CA1 region compared to the control group, while 
no difference in the number of PNNs was observed between the control group and 
SDPS group treated with the gelatinase inhibitor IPR-179. b) Cumulative frequency 
distribution of CSPG+ cells demonstrated increased CSPG intensity in vehicle-
treated SDPS group, while IPR-treated SDPS rats showed intensity values similar 
to the control group. c) Representative images of CSPG (green) and PV (red) 
staining in the CA1 region of dorsal hippocampus are shown. Scale bar (75 µm) is 
indicated. *P<0.050, ***P<0.001. Data are expressed as mean±SEM.
demonstrated that the late increase in hippocampal ECM mediates 
cognitive dysfunction187. Together, this has prompted us to investigate the 
upstream mechanisms that drive these dynamic and long-lasting ECM 
changes in response to chronic defeat stress. 
Our previous study hinted to the involvement of increased MMP-9 activity 
in response to defeat stress. Specifically, 72 hours after the last defeat 
bout, ~ 40% increase in MMP-9 activity levels was observed, although this 
did not reach statistical significance251. We here showed that expression 
levels of several of the CSPGs are decreased already after 3 defeat bouts, 
suggesting that ECM degradation occurs early on. Therefore, in this pilot 
study, we investigated the possibility that inhibition of metalloproteinase 
activity, in particular MMP-9 activity, during stress would prevent stress-
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that inhibition of MMP-9 activity was effective in restoring stress-induced 
memory deficits present early after stress, although the exact role of the 
ECM remodeling in this process remains less clear. 
Metalloproteinase-mediated degradation of ECM is an important 
mechanism by which a balance in ECM levels is maintained193. Therefore, 
the prime candidates for stress-driven ECM remodeling are MMPs and 
other proteinases, such as a disintegrin and metalloproteinase with 
thrombospondin motifs (ADAMTS)254,255. In particular, a prior study has 
demonstrated that a chronic (21 days) restrain stress paradigm results 
in increased MMP-9 activity specifically in the CA1 subregion152. Notably, 
the authors provided first evidence of causality between increased 
metalloproteinase activity and stress-induced cognitive impairment by 
showing that MMP-9 inhibition during stress exposure prevented the 
emergence of stress-induced deficits in an object temporal order task and 
in sociability. In agreement, we here demonstrated that by inhibiting MMP-
9 activity during social defeat stress, the early defeat-induced memory 
deficit in the object place recognition task is averted. Importantly, recent 
study in rodents showed that chronic IPR-179 treatment did not alter motor 
activity or anxiety-like behavior252, that could confound the interpretation 
of the results in this cognitive task. Together, these findings demonstrate 
that attenuated MMP-9 activity during stress exerts protective effects on 
hippocampal function.
Given the important role of metalloproteinases in ECM breakdown, 
we hypothesized that stabilization of the ECM via an MMP-targeted 
intervention could prevent stress-induced ECM downregulation. However, 
our quantitative immunoblotting analysis of synaptosomes from the dorsal 
hippocampus showed that the inhibitor did not prevent ECM breakdown 
at the perisynaptic space, suggesting that MMP-9 is not a predominant 
protease cleaving perisynaptic ECM proteins after stress, albeit that this 
effect could be local and specific to the CA1 only152. Instead, other ECM 
degrading enzymes could contribute to stress-induced perisynaptic ECM 
breakdown. As an example, ADAMTS4 has been shown to be a major 
protease degrading aggrecan, brevican, neurocan and versican254,256,257. 
Experiments assessing the activity of different MMPs and ADAMTSs in 
response to social defeat are needed to test this. Alternatively, stress-
induced remodeling of the perisynaptic ECM could result from protease-
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independent mechanisms, such as reduced glial or neuronal production 
and/or release of these ECM components70,258. 
Cleavage of the cell adhesion molecule nectin-3 has been shown to 
depend on MMP-9 activity152. Notably, the pioneering study of Kooij et al. 
demonstrated that chronic stress reduced nectin-3 in perisynaptic CA1, 
and that, by stabilizing nectin-3 levels through repeated MMP-9 inhibition 
(MMP-9 PEX inhibitor) during the 21-day exposure to stress, hippocampal 
dysfunction was prevented. However, we did not find differences in the 
expression of nectin-3 after stress. The discrepancy could result from 
several methodological differences, such as tissue studied and type and 
duration of the stressors. 
It is worth noting that MMP-9 plays a crucial role in regulating blood-brain-
barrier (BBB) permeability252,263,264. Interestingly, loss of BBB integrity has 
been shown to promote depressive-like behavior in stress-susceptible 
mice265,266. Hence, systemic administration of IPR-179 could prevent stress-
induced disruption of the BBB, thereby exerting protective effects on the 
hippocampus. Alternatively, our systemic injections could have caused 
ECM remodeling in other brain areas that in turn affect hippocampus PNN 
remodeling (see below). Taken together, potential mechanisms through 
which IPR-179 exerts its protective effects on the hippocampus could 
involve a plethora of ECM-independent mechanisms, including preventing 
activation of microglia, cytokine production, entry of toxic compounds and 
ionic imbalance267.
Intriguingly, as opposed to perisynaptic ECM levels, IPR-treated SDPS 
animals showed attenuation of defeat-induced reduction in CA1 PNN 
density, suggesting that the inhibitor is effective in preventing stress-
induced PNN cleavage. These PNN-specific effects of the inhibitor could 
be due to differences in the sulfation pattern of the glycosaminoglycan 
(GAG) chains of the CSPGs between PNNs and more diffuse perisynaptic 
ECM67. The sulfation patterns of GAGs give rise to charged structures that 
in turn determine the binding properties and interaction of the CSPGs and 
affect their proteolysis259. Hence, the specific microenvironment formed by 
condensed CSPGs in PNNs could hypothetically be more prone to MMP-
9-mediated cleavage and, consequently, the inhibitor could exert more 
potent effect on the PNNs. However, our data on the effects of IPR-179 on 
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PNNs need to be interpreted with caution due to the low sample size and 
unknown biological significance of changes in PNN intensity.
A recent study showed that MMP-9 inhibition was effective in protecting 
PNNs and PV+-interneurons from oxidative stress260, which has been 
increasingly linked with the pathophysiology of psychiatric disorders261. 
The authors showed that a transgenic mouse of redox dysregulation 
carrying deficit of glutathione synthesis displayed reduced number of PV+-
enveloping PNNs260. Notably, this reduction in PNNs was associated with 
increased MMP-9 activity due to oxidative stress that, in turn, increased 
and sustained cytokine secretion. Importantly, treatment with an MMP-
9 inhibitor prevented the reduction in PNN+/PV+ cell density, as well as 
cytokine secretion, in the redox dysregulated mice. Together these data 
revealed redox-sensitivity of MMP-9 and highlighted the important role 
of the PNNs as protective shields of PV-interneurons. Based on this, it 
is plausible, that the PNN-preserving effects of IPR in our model could 
protect PV interneurons from oxidative stress, previously shown to be 
increased by social defeat stress262. By extension, IPR effects could 
maintain intact PV activity, promoting E/I balance in the hippocampal 
network and eventually normalizing cognitive deficits. In support of this, 
a recent study demonstrated that chronic IPR-179 treatment in mice was 
effective in controlling neuronal excitability associated with kainic acid-
induced epileptic activity252. Furthermore, the authors showed that IPR 
treatment rescued object place memory deficit following epileptic seizures, 
suggesting that IPR-mediated stabilization of network activity is crucial to 
support healthy memory. 
It is tempting to speculate that specifically aberrant PNN coverage of PV+ 
GABAergic interneurons, rather than dysregulation of perisynaptic ECM at 
excitatory synapses, contributes to the spatial memory deficit evident early 
after defeat stress, possible by modulating PV-interneuron activity74,221. 
Indeed, several studies have demonstrated the crucial role of PV+-cells in 
hippocampal-mediated cognitive functions268–270. Most importantly, recent 
studies have provided evidence that by counteracting stress-induced activity 
changes in PV+-cells, the emergence of stress-induced behavioral deficits 
can be prevented across different brain systems. As an example, chronic 
stress was shown to decrease intrinsic excitability of PV+-cells in the barrel 
cortex, while pharmacogenetic activation of barrel cortex PV+-cells during 
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stress exposure prevented development of stress-driven sensory deficit271. 
Moreover, reduced excitatory synaptic input onto prefrontal PV+-cells has 
been shown to promote stress-induced helplessness272. Taken together, 
this implies that PNN-specific effects of IPR could preserve PV-mediated 
plasticity in the hippocampus, promoting intact learning and memory. 
Limitations and future studies
Further studies are needed to probe the effects of defeat stress as well 
as MMP-9 inhibition on PV+-cells, to investigate the hypothesis that IPR 
exerts PNN-specific effects on PV-mediated plasticity in the hippocampus. 
Furthermore, it would be of interest to characterize whether IPR-179 
treatment administered during stress prevents late-appearing ECM 
upregulation, inhibitory neurotransmission dysfunction and accompanied 
memory deficit. This experiment would be critical in addressing the 
interdependence of the early- and late-appearing ECM changes, and 
revealing whether the early remodeling is a major driving force for 
ECM dysregulation and cognitive deficits later on, during the sustained 
depressive-like state. 
Of note, because IPR-179 was administered systematically in this pilot 
study, we cannot pinpoint whether its effects were due to a direct effect of 
the inhibitor on the hippocampal CA1 subregion. To answer this question, 
future studies with CA1-targeted application of the inhibitor should be 
conducted. If CA1-targeted intervention is similarly effective in preventing 
stress-induced cognitive dysfunction, it would suggest that the CA1 is 
central in mediating the cognitive-protecting effects rather than serving 
as a downstream target region. Moreover, although previous studies 
have shown that IPR-179 specifically inhibit MMP-9 and MMP-2252,253, we 
cannot exclude that off-target effects play a role in mediating the outcome. 
Likewise, in our study we did not assess whether systemic application of 
IPR-179 was effective in reducing MMP-9/MMP-2 activity, therefore, the 
MMP-dependence of the treatment needs to be corroborated by further 
studies. 
Lastly, the molecular and cellular mechanisms underlying the apparent 
PNN-specific need follow up studies, i.e., in relation to the different sulfation 
pattern of PNNs67. Despite the necessity of follow-up studies, this pilot 
116
study showed that attenuation of metalloproteinase activity during stress 
has potential in protecting against stress-induced cognitive dysfunction 
and highlight a promise of MMP-targeted interventions against stress 
pathology, including early effects of stress on cognition. 
MATERIALS AND METHODS
Animals and the social 
defeat-induced persistent stress paradigm
All experiments were approved by the Vrije University Amsterdam Animal 
Users Committee and in accordance with the relevant guidelines and 
regulations. Wistar male rats, 7 weeks old and weighing <200 g upon arrival 
(Envigo, The Netherlands) were pair-housed and allowed to habituate 
to the facility for at least 2 weeks before the start of the experiments 
to adapt to the reverse day-night cycle (lights on at 19:00, lights off at 
7:00) animals were kept in. Long-Evans male rats (Charles River, UK) 
were used as residents for the resident-intruder paradigm. The residents 
were pair-housed with tube-ligated females >1 week before the start of 
the experiment. Females were removed from the resident’s cage prior to 
the defeat sessions. The SDPS rats underwent 15-minute social defeat 
sessions daily. During the defeat, the rats were first placed inside the 
defeat apparatus, while a transparent perforated plexiglass partition wall 
separated the intruder from the resident, permitting sensory exchange but 
preventing all physical contact for 5 minutes. The partition wall was then 
removed, and a 5-minute fight phase started. Following the defeat, the 
rats were again separated, and sensory exchange was allowed for another 
5-minutes, after which the intruders were placed back to their home cage. 
Social defeat was repeated for five consecutive days and each day a new 
resident was used. From the first defeat session onwards, SDPS rats were 
single-housed and kept in social isolation until the end of the experiments. 
Controls were pair-housed for the entire duration of the experiment. During 
defeat days, control animals were transported to the defeat room and left 
to explore an empty defeat box for 10 minutes, before returning back to 
their housing room. 
Two batches of rats, (batch 1, n=6 per group; batch 2, n=6 per group) 
were used for these experiments, where all animals underwent behavioral 
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analysis 48 h after the last defeat bout. Animals from batch 1 were used 
to determine ECM protein levels, and animals from batch 2 were used for 
PNN analysis (see below). 
Drug administration
Animals were treated on days 1-5 during the social defeat paradigm and 
24 h after the last defeat bout (day 6). The inhibitor (IPR-179, iProteos) 
was injected i.p. (6 mg/kg)252 30 minutes before the onset of each defeat 
session. Control rats were injected i.p. (5 mL/kg) with saline daily 30 
minutes before they explored an empty cage for 10 minutes. 
Object Place Recognition
The Object Place Recognition (OPR) test measures short-term spatial 
memory and is mediated by hippocampal CA1 region273. All animals were 
habituated to the testing arenas (79 x 57 x 42 cm, PVC) before they 
underwent any behavioral testing. During the habituation phase, rats were 
transported to the video-recording room and let to freely explore an empty 
testing arena for 10 minutes. Habituation was conducted for 3 times. All 
behavioral testing was performed during the dark phase under a dim red 
light. The OPR test consisted of 3 phases: habituation, sampling and testing. 
During habituation, animals were allowed to explore an empty arena for 5 
minutes. This was followed by a sampling phase upon which two identical 
objects (8 x 8 x 35 cm, metal, cylinders or cubes) were introduced to the 
testing arena, in opposite corners. After the sampling phase, the rats were 
placed back to their cage. The two objects were replaced with a set of 
two clean identical objects, and one was relocated to a different corner 
within the arena. After a 15-minute interval, the rats were introduced back 
to the arena and exploration of the objects was recorded for an additional 
3 minutes (testing phase). Because rats quickly habituate to novelty and 
their initial response is most representative of their interest, data from the 
first 1 minute of the testing phase were analyzed. The discrimination index 
was calculated by measuring the time spent exploring the relocated object 




Rats were anesthetized with a lethal dose of pentobarbital and perfused 
transcardially (ice-cold 4% PFA). Following overnight post-fixation in 4% 
PFA in PBS, brains were transferred to 30% sucrose in PBS at 4 °C until 
sectioned (n=3–4 per group). Free-floating cryostat sections (35 µm) were 
collected from the dorsal hippocampus (AP -2.40 to -4.56) and stored in 
PBS+0.02% NaN3 until further use. Sections were washed 3 times for 10 
minutes in PBS, followed by incubation for 1 h at RT in blocking solution 
(2.5% BSA, 0.1% Triton, 5% goat serum in PBS). After blocking, the sections 
were incubated with primary antibodies (mouse anti-chondroitin sulfate 
proteoglycan 1:1,000, cat-301 MAB5284; rabbit anti-parvalbumin 1:1,000, 
Swant #235) overnight at 4 °C. This was followed by washing in PBS 4 times 
10 minutes at RT, and incubation with fluorescent-conjugated secondary 
antibodies (anti-mouse-Alexa-488 1:400, Invitrogen A11001; anti-rabbit-
Alexa-568 1:400, Invitrogen A11011) for 2 h at RT. Thereafter, sections 
were washed 4 times 10 minutes with PBS at RT. Sections were mounted 
onto microscope slides using PBS+0.02% gelatin and cover-slipped 
with DAPI-containing mounting medium (H-1500 Vector Laboratories). 
Images were acquired on a fluorescent microscope (Leica DM5000). The 
Fiji software, using automated threshold and particle analysis, was used 
to detect the number of CSPG+ cells and accompanied intensity values. 
False-positive cells were excluded manually during the analysis. During 
image acquisition and for cell quantification, the researcher was blind to 
the experimental groups. 
Tissue preparation – synaptosomes
Following decapitation, the brain was removed, and the dorsal hippocampus 
was immediately dissected on ice274, and frozen on dry ice. Samples were 
homogenized in ice-cold 0.32 M sucrose (5% of homogenate was collected 
as total cell lysate) and then centrifuged at 1000x g for 10 minutes. The 
supernatant was loaded on top of a sucrose gradient consisting of 0.85 and 
1.2 M sucrose. After centrifugation at 100,000x g for 2 h, the synaptosome 
fraction at the interface of 0.85 ⁄ 1.2 M sucrose was collected and then 
lysed in hypotonic solution.
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Immunoblot
The protein concentration of synaptosome fractions was determined 
(Bradford protein assay) and 10 µg of protein was loaded per sample for 
electrophoresis. Prior to SDS-gel separation, samples were treated with 
chondroitinase ABC, in order to digest GAG-chains. For this, samples 
were incubated for 90 minutes in 37 °C in buffer containing chABC (0.002 
U/ µL) and sodium acetate (NaAc), pH 8.0, after which samples were 
lysed in Laemmli lysis buffer. The following primary antibodies were used: 
rabbit anti-aggrecan (1:700, AB1013, Abcam); guinea-pig anti-brevican 
(1:2,000; generously provided by C.I. Seidenbecher, Magdeburg), mouse 
anti-neurocan (1:1,000, N0913 Sigma); mouse anti-phosphacan (1:1,000; 
3F8, Developmental Studies Hybridoma Bank); mouse anti-Tenascin-R 
(1:2,000, mTNR-2 Acris Antibodies); rabbit anti-Hapln1 (1:1,000, ab98038 
Abcam); rabbit anti-Nectin-3 (1:2,000; Abcam, ab63931). After incubation 
with horseradish peroxidase-conjugated secondary antibody (1:10,000; 
Dako, Glostrup, Denmark) and visualization with Femto Chemiluminescent 
Substrate (Thermo Scientific, Rockford, IL, USA), blots were scanned 
using the Li-Cor Odyssey Fc (Westburg, Leusden, The Netherlands) and 
analyzed with Image Studio (Li-Cor, Lincoln, NE, USA). Total protein was 
visualized using trichloro-ethanol staining and scanned using a Gel Doc 
EZ imager (BioRad, Herculus, CA, USA) and analyzed with Image Lab 
(BioRad) to correct for differences in sample loading.
Statistics
Shaphiro-Wilk test was used to check normality of data. When normality 
of data was confirmed, analysis of variance (one-way) followed by one- 
or two-tailed unpaired Student’s t-tests, depending on prior significant 
observations. Alternatively, a Kruskal-Wallis test was applied. A two-tailed 
Student’s t-test (unpaired) was used to test significance against chance 
level for the OPR test (fictive group with equal variance)123, or a Mann-
Whitney U-test in case normality was violated. Pairwise Kolmogorov-
Smirnov test was used to test significance of PNN intensity frequency 
distribution between groups, with manual Bonferroni correction (α=0.017). 
Significance was set at P<0.050, trend at P<0.100.
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SUPPLEMENTARY FIGURES AND TABLES
Supplemental Figure 1. Whole immunoblot compilation. Whole immunoblots 
are shown from which sections (orange dashed rectangle) are included in Figure 
2 (C=control+vehicle animal; SD-=SDPS+vehicle animal; SD+= SDPS+IPR-179 
animal). Molecular weights are indicated. 
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Supplemental Table 1. Overview statistics all figures. Shown are the results and 
details of the statistical analyses (type of test, n-number, t-value, Df, P-value) for the 
data shown in Figure 1 (immunoblot), Figure 2 (behavior), Figure 3 (immunoblot) 
and Figure 4 (PNN staining) in SDPS+vehicle, SDPS+IPR-179 and control+vehicle 
animals. Significance (P<0.050) is indicated in bold, trend (P<0.100) in underlined; 




Figure Statistical test (nCon, nSDPS, 
nSDPS+IPR)) 
Statistics (t-value, Df) P-value 
1b Unpaired t-test 
CON vs. 3x SDPS 
   Acan (6, 5) 
   Bcan (6, 5) 
   TnR160 (6, 6) 
   Hapln (6, 6) 
 
Mann-Whitney U-test 
CON vs. 3x SDPS 
   Ncan (6, 6) 
   Phcan (6, 6) 
   TnR180 (6, 6) 
 
 
t(5.936) = 2.733 
t(9) = 1.377 
t(10) = 1.656 




U = 4 
U = 7 




P = 0.034 
P = 0.202 
P = 0.129 




P = 0.024 
P = 0.087 
P = 0.240 
 
2b Kruskal-Wallis 
OPR 48 h (12, 12, 12) 
 
Unpaired t-test 
Con+veh vs. fictive  
SDPS+veh vs. fictive 
SDPS+IPR vs. fictive 
 
 
H = 3.996 
 
 
t(22) = 2.827 
U = 66.50 
t(22) = 2.339 
 
 
P = 0.137 
 
 
P = 0.010 
P = 0.766 















Con+veh vs. SDPS+veh 
   Acan (6, 6) 
   Bcan (6, 6) 
   Ncan (6, 6) 
   Phcan (6, 6) 
   TnR160 (6, 6) 
   TnR180 (6, 6) 
   Hapln (6, 6) 
    
   Nectin-3 (6, 6) 
 
Con+veh vs. SDPS+IPR 
   Acan (6, 6) 
   Bcan (6, 6) 
   Ncan (6, 6) 
   Phcan (6, 6) 
   TnR160 (6, 6) 
   TnR180 (6, 6) 
   Hapln (6, 6) 




t(10) = 2.042 
t(10) = 2.040 
t(10) = 1.976 
t(10) = 1.970 
t(10) = -0.110 
t(10) = 1.422 
t(10) = -0.429 
 
t(10) = 0.273 
 
 
t(10) = 5.010 
t(10) = 2.289 
t(10) = 2.650 
t(10) = 2.643 
t(10) = 0.995 
t(10) = 1.737 
t(10) = 2.611 
t(10) = 1.290 
 
one-tailed 
P = 0.034  
P = 0.035 
P = 0.038 
P = 0.039 
P = 0.458 
P = 0.093 
P = 0.339 
two-tailed 
P = 0.790 
 
two-tailed 
P = 0.001 
P = 0.045 
P = 0.024 
P = 0.025 
P = 0.343 
P = 0.113 
P = 0.026 







PNNs (4, 3, 4) 
 
Kolmogorov-Smirnov test 
        Con+veh vs. SDPS+veh 
Con+veh vs. SDPS+IPR 






F(2, 10) = 3.086 
 
 
        D = 0.199 
        D = 0.115 






P = 0.102 
 
 
P < 0.001 
P = 0.028 




Supplemental Table 1. Overview statistics all figures. Shown are the results and details of the 
statistical analyses (type of test, n-number, t-value, Df, P-value) for the data shown in Figure 1 
(immunoblot), Figure 2 (behavior), Figure 3 (immunoblot) and Figure 4 (PNN staining) in 
SDPS+vehicle, SDPS+IPR-179 and control+vehicle animals. Significance (P<0.050) is indicated 








Combination of vicarious and physical 
social defeat in mice results in late cognitive 
impairment and hippocampal extracellular 
matrix remodeling
Maija-Kreetta Koskinen, Ioannis Kramvis, August Benjamin Smit, 




Social stress increases the risk of major depressive disorder (MDD), 
which is currently the most prevalent psychiatric disorder. Aiming to study 
chronicity of depression in mice, we set up a novel model of psychosocial 
stress. In this model, physical social defeat is coupled with vicarious 
defeat, during which the defeat of conspecifics is witnessed (physical and 
vicarious defeat-induced persistent stress (PVDPS)). We then profiled 
the temporal development of affective deficits and cognitive impairment, 
core symptoms of depression, in the weeks after stress. We found social 
withdrawal to persist up to 5 weeks post-defeat, after which it dissipated. 
In contrast, spatial memory deficits developed between week 3 and 5 
post-defeat, demonstrating the importance of an incubation period during 
which the effects of stress fully emerge. We recently identified changes 
in hippocampal ECM assembly to mediate cognitive deficits during the 
sustained depressive-like state in rats. Therefore, we here explored 
whether molecular and cellular changes in hippocampus ECM and synaptic 
communication was paralleled by reduced cognitive capacity in mice after 
the induction of social stress. Similar to the rat model, late-appearing 
cognitive deficits in defeated mice coincided with increased perisynaptic 
and pericellular (perineuronal nets; PNNs) ECM, together with aberrant 
inhibitory, but not excitatory, neurotransmission in the hippocampal CA1 
subregion. Finally, we showed that while late chronic antidepressant 
treatment did not prevent the development of defeat-induced cognitive 
deficits, a late chronic enrichment therapy was sufficient in reversing 
these effects. Altogether, our data 1) demonstrate a temporally disparate 
regulation of affective and cognitive function in response to physical and 
vicarious defeat stress, 2) underscore the importance of incubation of stress 
on the late-appearing and chronic cognitive deficits, and 3) corroborate a 
role for ECM in mediating persistent stress effects on memory. 
INTRODUCTION
Major depressive disorder (MDD) is among the most prevalent psychiatric 
disorders, with growing incidence worldwide1. Key symptoms of MDD are 
low mood, inability to experience pleasure (anhedonia), social withdrawal 
and mild cognitive impairment1. As stressful life events significantly 
increase the risk for MDD21, preclinical depression studies largely rely on 
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the application of chronic stress to mimic the depressive state. Chronic 
stress results in the expression of many key depressive-like symptoms, 
such as anhedonia, social disturbances and cognitive decline105,275. 
Although MDD is chronic in nature and typically requires months or even 
years to fully emerge32,33, most preclinical studies focus on characterizing 
the early effects of stress. However, persistent stress-induced adaptations 
are likely crucial in determining whether an individual develops an enduring 
pathological state in the long-term. 
In order to model the lasting nature of stress, we previously employed 
the social defeat-induced persistent (SDPS) paradigm in rats26,187,276. In 
this model, a 5-day social defeat, during which an intruder rat is forced 
to subordination by a larger territorial male, is combined with a prolonged 
period of social isolation. The defeated rats show depressive-like symptoms, 
such as anhedonia111,120, social withdrawal187,276, impaired social recognition 
and spatial memory deficits187. Notably, these depressive-like behavioral 
manifestations are present months after the cessation of defeat stress, 
highlighting the suitability of the model to study chronicity of depression. 
Furthermore, late antidepressant treatment rescues these sustained 
depressive-like behavioral, and cellular symptoms120,187, demonstrating the 
predictive validity of the model. 
Besides probing mood-related symptoms, we have used the rat SDPS 
paradigm to study persistent cognitive deficits associated with the 
depressive-like state187, since cognitive dysfunction is a major contributor to 
functional impairment and recurrence of depressive episodes13. Importantly, 
cognitive symptoms are often present in remitted patients14,185,203, 
indicating a dichotomy between mood and cognition and exemplifying 
the inadequacy of current treatment strategies to tackle cognitive deficits 
in MDD. We recently identified hippocampal extracellular matrix (ECM) 
as a crucial substrate for cognitive dysfunction in SDPS187,276, furthering 
our understanding of the molecular mechanisms underlying cognitive 
symptoms in MDD. 
The brain ECM is a complex protein network that occupies the extracellular 
space64,277. Key components of the brain ECM are chondroitin sulfate 
proteoglycans (CSPGs), that together with other ECM proteins, form 
protein scaffolds around cells and synapses. These protein structures 
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provide structural support and are important in the regulation of experience-
dependent plasticity both in the developing and in the adult brain75,131,278. 
For example, perineuronal nets (PNNs), condensed ECM structures 
enwrapping mainly parvalbumin (PV)-expressing interneurons, are 
crucial in regulating critical period-like plasticity92,93,95, and are increasingly 
associated with brain disorders. As an example, aberrant PNN composition 
have been observed in patients diagnosed with schizophrenia102,190 and 
bipolar disorder104. 
Given the sparsity of data on long-lasting cognitive deficits in mouse 
models employing social defeat as stressor, we here aimed to develop a 
model of chronic depression in mice akin to our rat SDPS model187, yet with 
the available mouse genetic toolbox that allows for circuit- and cell-specific 
studies in mind. To reach this aim, we combined physical social defeat 
sessions with vicarious defeat. Previously, it was shown that vicarious defeat, 
by witnessing the defeat of others, results in a depressive-like phenotype, 
including social avoidance and anhedonia279. We therefore reasoned that 
by coupling witnessing defeat to physical defeat, we could exacerbate the 
impact of psychosocial stress, possibly leading to a sustained depressive-
like state similar as in rats. After a 10-day social stress paradigm, consisted 
of a daily physical and daily vicarious defeat session, we characterized 
social interaction, anxiety-like behavior and cognitive function during 
a period of ~2 months following exposure to stress. Furthermore, we 
assessed the effects of this novel stress model on hippocampal ECM and 
inhibitory and excitatory neurotransmission, to assess whether the model 
recapitulates molecular and cellular hippocampal dysfunction associated 
with depressive-like symptoms at the cognitive level. Lastly, we studied 
the effectiveness of pharmacotherapy and enrichment therapy in reversing 
defeat-induced behavioral deficits. 
RESULTS
Physical and vicarious defeat stress 
results in reduced social approach 
Social withdrawal is a common symptom in many psychiatric disorders, 
including depression and anxiety disorders280,281. The social approach 
avoidance test (SAA), in which interaction with an unfamiliar social target 
is measured, is commonly employed in mice to measure their social 
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behavior199,200. To assess the development of a social interaction deficit 
in response to social defeat and witnessing stress, we first subjected all 
PVDPS mice (Suppl Fig 1) to the SAA test at 24 h after the last defeat day. 
Thereafter, we split up the group to re-test them either with an interval of 
at least 4 weeks (group A) or 6 weeks (group B) after the last defeat day 
(Fig. 1A, B). The PVDPS paradigm resulted in a significant decrease in 
social interaction at 24 h after the last defeat encounter (MWU: control 
vs. PVDPS, U=183.5; P=0.014; Fig. 1C). Analysis of SAA performance 
at 4 weeks showed decreased social interaction of PVDPS mice vs. 
controls (group A; t-test: control vs. PVDPS, P=0.012; Fig. 1D). Correlation 
of test-retest (24 h vs. 4 weeks) for both controls and PVDPS mice of 
group A did not show significant correlations (Kendall tau control: 0.473, 
P=0.105; Kendall tau PVDPS: 0.419, P=0.062; Suppl. Fig 1). Surprisingly, 
at the 6-week interval (group B), PVDPS mice showed normalized social 
interaction (MWU: control vs. PVDPS, U=112, P=0.944; Wilcoxon ranked, 
P=0.005; Fig. 1E). Correlation of test-retest (24 h vs. 6 weeks), was not 
present in any of the groups (Kendall tau control: 0.217; P=0.355; Kendall 
tau PVDPS: 0.307, P=0.072; Suppl. Fig. 1). 
The SAA test performed 24 h after the last social defeat encounter is 
frequently used to identify stress-susceptible and -resistant individuals199,282. 
In our own dataset, a considerable variation in 24 h SAA individual 
performance argued in favor of the presence of such subpopulations after 
PVDPS (cf Fig. 1C). To check whether stress-susceptibility weighs in the 
apparent time point-dependent results, we classified PVDPS mice based 
on their 24 h test social interaction ratios283,284 (Fig. 1C). For the group tested 
at an interval of 4 weeks, 6 mice were classified as PVDPS-susceptible 
(PVDPS-SUS: social interaction ratio group mean 0.27±0.8), and 6 mice 
were identified as PVDPS-resilient (PVDPS-RES: social interaction ratio 
group mean 0.79±0.18) (Suppl Fig. 1). Similarly, of the group tested at an 
interval of 6 weeks (group B), 9 mice (47.4%) showed social avoidance 
and were classified as PVDPS-SUS (social interaction ratio group mean 
0.15 ± 0.16), while 10 mice (52.6%) were identified as control-like, PVDPS-
RES mice (social interaction ratio group mean 0.87±0.11) (Suppl Fig. 
1). Notably, pair-wise comparisons between SAA 24 h and week 4 tests 
demonstrated that PVDPS-RES mice of group A displayed significantly 
decreased social interaction ratio (t(5)=4.781, P=0.005; Suppl Fig. 1), 
highlighting a difference between early and late stress effects, with the 
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latter not maintained in this group. Furthermore, group B PVDPS-SUS 
mice showed a full reversal of social avoidance by week 6, compared to 
their performance 24 h after the last defeat (W=45, P=0.004). This confirms 
the general observation in the field that the affective phenotype is not a 
stable induced trait and gradually dissipates after social defeat. Moreover, 
this transient nature of affective dysfunction is independent of the witnessing 
component in the paradigm used here. 
Cognitive impairment develops 
gradually in response to PVDPS 
Cognitive dysfunction is a pertinent symptom in several stress-related 
psychiatric disorders, including MDD117. Here, we employed object place 
recognition (OPR) task with a 15-minute retention interval to assess 
hippocampal-dependent short-term spatial memory285. To characterize the 
development of cognitive deficits over time, we assessed OPR performance 
in group A mice (see above), at 5 days and 5 weeks after the last defeat 
session. Furthermore, we tested late OPR performance in the Group B 
mice by subjecting them only to the OPR test at week 6 post-defeat (Fig. 
1A). 
For group A mice, a mixed ANOVA on the early (day 5) and late (week 5) 
OPR performance demonstrated a significant effect of defeat (F1,18=6.709, 
P=0.019), while no defeat x time interaction (F1,18=0.609, P=0.445), or 
effect of time (F1,18=2.249, P=0.151) were present. The effect of defeat 
on OPR performance seemed to be specific for the 5-week interval (Fig. 
1F). Indeed, while at day 5 both control and PVDPS animals showed a 
(trend for) preference for the relocated object (vs. fictive: control, U=9, 
P=0.015; PVDPS, t(22)=1.941, P=0.065), indicative of relatively intact 
short-term spatial memory early after stress, analysis of performance at 
the 5-week interval indicated intact memory only for controls (vs. fictive: 
control, t(14)=2.265, P=0.040; PVDPS, t(22)=0.258, P=0.799; Fig. 1F). 
Similarly, group B mice showed impaired memory performance at week 
6 (control vs. PVDPS, U=28, P<0.001; Fig. 1G). At this time point, control 
mice demonstrated intact memory function (control vs. fictive, U=14, 
P<0.001), while PVDPS mice did not show preference for the relocated 
object (PVDPS vs. a fictive control, U=233.5, P=0.503). 
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Figure 1. Affective deficit and cognitive impairment show distinct 
developmental trajectory in response to physical and vicarious social defeat 
stress. A, B) Experimental schedule (A); mice were subjected to a 10-day social 
defeat paradigm consisted of daily physical and vicarious defeat sessions (PVDPS 
mice, B), while control mice were individually housed but did not undergo defeat 
sessions. Behavior was assessed with the social approach avoidance (SAA) and 
object place recognition (OPR) tests, both early and late after social defeat. Groups 
A and B mice were tested in the SAA test 24 h after the last social defeat bout. Group 
A mice were tested in the OPR test 5 days after defeat, followed by re-testing in the 
SAA and OPR tests at week 4 and week 5, respectively. Following the SAA 24 h test, 
group B mice underwent the OPR and SAA tests at week 6 after defeat. C) Acutely 
(24 h) after the last social defeat the PVDPS mice (group A, B) showed reduced 
approach towards a social target compared to the control group. D) Affective deficit 
persisted up to 4 weeks after stress. PVDPS mice tested at week 4 post-stress 
(group A) show a reduced social interaction ratio compared to control mice. E) The 
affective deficit dissipated by week 6 post-defeat. PVDPS mice tested at week 6 
post-stress (group B) showed no difference in social approach compared to control 
mice. F) Cognitive impairment gradually develops over time. Early after last social 
defeat encounter, PVDPS mice showed intact spatial memory. Re-testing at week 
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mice were subjected to a 10-day social defeat paradigm consisted of daily physical and vicarious 
defeat sessions (PVDPS mice, B), while control mice were individually housed but did not undergo 
defeat s ssions. Behavi r was assessed with t e ocial approach avoidanc  (SAA) and object 
place recognition (OPR) tests, both early and late after social defeat. Groups A and B mice were 
tested in the SAA test 24 h after the last social defeat bout. Group A mice were tested in the OPR 
test 5 days after def at, followed by re-testing in th  SAA and OPR t ts at week 4 and week 5, 
respectively. Following the SAA 24 h test, group B mice underwent the OPR and SAA tests at 
week 6 after defeat. C) Acutely (24 h) after the last social defeat the PVDPS mice (group A, B) 
showed educed pproach towards a social target compared to the ontrol group. D) Affective 
deficit persisted up to 4 weeks after stress. PVDPS mice tested at week 4 post-stress (group A) 
show a reduced social interaction ratio compared to control mice. E) The affective deficit dissipated 
by week 6 po t-defeat. PVDPS mice tested at week 6 ost-stress (group B) sh wed no difference 
in social approach compared to control mice. F) Cognitive impairment gradually develops over 
time. Early after last social defeat encounter, PVDPS mice showed intact spatial memory. Re-
testing at week 5 post-defeat revealed reduced object spatial discrimination in PVDPS mice. G) 
PVDPS-induced cognitive impairment persisted at week 6, despite the loss of the affective deficit. 
PVDPS mice tested at week 6 post-defeat failed to discriminate between a stable and relocated 
object. Student’s t-test, Mann-Whitney U test or Two-way ANOVA were used to test statistical 
significance between PVDPS and control group. #P< 0.05 compared to a fictive group with a mean 
of 0.5 and equal variation; *P< 0.05; **P< 0.01; ***P< 0.0001. Data are expressed as mean±SEM. 
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5 post-defeat revealed reduced object spatial discrimination in PVDPS mice. G) 
PVDPS-induced cognitive impairment persisted at week 6, despite the loss of the 
affective deficit. PVDPS mice tested at week 6 post-defeat failed to discriminate 
between a stable and relocated object. Student’s t-test, Mann-Whitney U test or 
Two-way ANOVA were used to test statistical significance between PVDPS and 
control group. #P< 0.05 compared to a fictive group with a mean of 0.5 and equal 
variation; *P< 0.05; **P< 0.01; ***P< 0.0001. Data are expressed as mean±SEM.
Hence, taken together, these results demonstrate that stress-induced 
spatial memory impairments are not present early after stress, but gradually 
emerge and persist for weeks after defeat stress. 
To identify more accurately the timepoint when the OPR deficit emerges, 
we assessed OPR memory after a 1-, 3- and 5-week interval of the last 
defeat session in an independent batch of mice (Group C; Suppl. Fig. 2). 
A mixed ANOVA of OPR performance over the three time-points (week 1, 
3 and 5) demonstrated a significant main effect of time (F1.951,70.23=4.635, 
P=0.014), but no effect of defeat (F1,36=1.211, P=0.278) or defeat x time 
interaction (F2,72=1.548, P=0.220). Analysis of test performance against 
chance showed that the control group showed memory for the relocated 
object at all time points (vs. fictive: wk1, P=0.073; wk3, P=0.001, wk5, 
P=0.0457), but that PVDPS mice were unable to perform the OPR test 
at week 5 only (vs. fictive: wk1, P=0.009; wk3, P<0.001, wk5, P=0.351). 
Thus, this spatial memory deficit appears to emerge in the PVDPS mice 
between week 3 and 5 post-defeat. 
Dissonance between deficits of 
the affective and cognitive domain 
In order to judge in what respect the affective and cognitive domains 
overlap in the PVDPS mouse model, we first correlated the acute as well 
as late SAA behavior to the late OPR behavior measured in groups A-C 
(Suppl. Fig. 2). None of the correlations were significant, hinting to the fact 
that these domains are distinct in nature and that initial stress experience 
might not be predictive for the development of cognitive deficits.
Although we found lack of correlations in SAA-OPR performance in 
the total groups, we wanted to explore whether early SAA performance 
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predicts vulnerability to hippocampal dysfunction that emerges later on. 
For this, we explored late (week 6) OPR performance within the PVDPS-
SUS and PVDPS-RES subpopulations of group B (Fig. 2A). A significant 
difference in spatial memory retention was present for the PVDPS 
subgroups compared to control mice at week 6 OPR test (KW: H=15.53, 
P=0.001; Fig. 2B). Post-hoc analysis confirmed a significant reduction in 
discrimination ratios of both the PVDPS subgroups (vs. control: PVDPS-
RES, Z=2.976, P<0.001; PVDPS-SUS, Z=3.709, P=0.001), whereas no 
difference between the two PVDPS subgroups was present (Z=0.952, 
P=0.166; Fig. 2B). Furthermore, control mice showed a preference for 
the relocated object (control vs. fictive, U=14, P<0.001), while both of the 
PVDPS subgroups failed to discriminate between the objects (vs. fictive: 
PVDPS-RES, t(24)=0.043, P=0.966; PVDPS-SUS, U=0.37.5, P=0.353). 
Altogether, these data indicate distinct effects of PVDPS on affective and 
cognitive domains, and shows that although PVDPS-RES displayed intact 
social behavior early on, they did not escape the effects of PVDPS on 
cognitive function in the long run. 
PVDPS-induced increase in 
anxiety-like behavior is transient
Depression and anxiety disorders are highly comorbid286. Social defeat 
increases anxiety-like behavior in mice and therefore serves as a model 
to study anxiety-related pathology31,282,287. Based on this, we temporally 
profiled anxiety-like behavior using the elevated plus-maze (EPM) at 
two time-points after social defeat, namely at day 5 and week 5 post-
defeat. To circumvent a habituation effect often seen after repeated EPM 
testing288,289, we used independent groups of mice (Group D and B) for 
these two timepoints. In accordance with previous studies282,287, early after 
social defeat stress (day 5), the PVDPS group spent significantly less 
time in the open arms of the maze compared to the control group (control 
vs. PVDPS, t(16)=3.438, P=0.003), whereas the closed arm time was 
increased in the PVDPS group (control vs. PVDPS, t(16)=2.491, P=0.024), 
indicating overall increased anxiety-like behavior (Suppl. Fig. 3A). Next, we 
assessed whether the anxiety-like phenotype is long-lasting by testing an 
independent group of mice for EPM behavior at week 5 post-stress (Group 
A). In contrast to the early time-point, PVDPS mice spent similar time at 
both the open (control vs. PVDPS, t(18)=0.264, P=0.795) and closed arm 
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(control vs. PVDPS, t(18)=0.216, P=0.831) compared to the control group, 
demonstrating that the anxiety-like phenotype does not persist over time, 
as previously reported by others282.  
Figure 2. Resilience to stress does not protect from the late emerging cognitive 
impairment. A) PVDPS mice (group B) were classified as susceptible (social 
avoidance PVDPS-SUS) and resilient (no social approach; PVDPS-RES) based on 
their performance at the SAA 24 h test. B) Resilience to early social avoidance did 
not protect from late cognitive deficit as both the PVDPS -SUS and PVDPS -RES 
mice showed impaired cognitive function in the late OPR test. Kruskal-Wallis test 
was used to test statistical significance between PVDPS subgroups and control 
group, followed by Dunn’s post-hoc testing. Mann-Whitney U or unpaired t-test was 
used to test significance compared to chance level. #P<0.05 compared to a fictive 
group with a mean of 0.5 and equal variation; *P<0.05; **P<0.01; ***P<0.0001. 
Data are expressed as mean±SEM.
Cognitive deficit coincides with 
changes in hippocampal ECM assembly
In our earlier studies we showed that altered expression of hippocampal 
ECM underlies hippocampal dysfunction during sustained depressive-
like state in rats187. Specifically, the chronic depressive-like state, marked 
by spatial memory deficit and social avoidance (> 8 weeks after social 
defeat), coincides with an increased number of PV-enwrapping PNNs 
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changes occur in mice in response to social defeat stress. For this, we first 
quantified the number of PNNs in the CA1 region of dorsal hippocampus 
from brains that were collected 48 h after the week 5 OPR test (Group A) 
(Fig. 3A,B). Similar to the rat hippocampus, the majority of PNN-coated 
neurons (WFA+-cells; >90%) in the CA1 subregion were identified to be 
PV-expressing (PV+) (Fig. 3B,C). Related to the long-term effects of social 
stress, we found an increase in the number of WFA+ cells in the CA1 
region in the PVDPS mice (control vs. PVDPS; all WFA+ cells, t(8)=2.406, 
P=0.043), as well as in the number of PNN-coated PV+ neurons (WFA+/
PV+-cells, t(8)=3.147, P=0.014) (Fig. 3D,E). The increase in PNN number 
was specific for PNNs surrounding PV-cells as no change in the number of 
PV- PNNs was found between the control and PVDPS group (WFA-/PV+-
cells; control vs. PVDPS, U=12, P>0.999) (Fig. 3D). Moreover, we did not 
observe any difference in the total number of PV+-cells (control vs. PVDPS, 
t(8)=0.673, P=0.520), indicating that the increase in the number of PNNs 
results from specific effects of defeat stress on PNNs (Fig. 3E,F). 
Besides the pericellular PNNs, ECM surrounds synapses and is an integral 
part of the synaptic machinery75. In the rat SDPS model, the increase in 
PNN density was accompanied by an increased expression of several 
ECM proteins, including CSPGs from the lectican family187. Therefore, 
we here assessed the expression levels of several ECM proteins in the 
synaptic fraction of the dorsal hippocampus. Similar as above, brains were 
collected 48 h after the week 5 OPR test (Group A) (Fig. 4A). Analysis of 
peri-synaptic ECM expression levels demonstrated increased expression 
of the lecticans aggrecan (Acan) and brevican (Bcan) in the PVDPS group 
compared to controls (control vs. PVDPS; Acan: t(8)=4.757, P=0.002; 
Bcan: t(8)=2.811, P=0.023) (Fig. 4B, C). In addition, expression of 
phosphacan (Phcan) and versican (Vcan) was increased in the PVDPS 
group, although this did not reach statistical significance (control vs. 
PVDPS; Phcan: t(8)=2.003, P=0.080; Vcan: t(8)=2.035, P=0.076). We did 
not find any differences in the expression of neurocan (Ncan) or tenascin 
(TnR) between the groups (control vs. PVDPS; Ncan: t(8)=0.975, P=0.358; 
TnR180: U=4.5, P=0.133; TnR160: t(8)=1.792, P=0.111). 
Taken together, our analysis of the pericellular and perisynaptic ECM 
showed that social defeat stress induced a late-appearing build-up of the 
ECM at dorsal hippocampus that coincides with hippocampal-dependent 
memory deficit weeks after stress cessation.   
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Figure 3. CA1 perineuronal net density is increased long after exposure to 
social stress.  A) The number of wisteria floribunda agglutinin positive (WFA+) 
perineuronal nets (PNN) and parvalbumin-expressing (PV+) interneurons were 
quantified using immunohistochemistry (IHC) . Mice were perfused and brains for 
IHC analysis were collected 24 h following the week 5 OPR test (group A). B) 
Representative IHC images of WFA (green) and PV (red) in the hippocampal CA1 
pyramidal layer. C) The majority of WFA+ cells (>90%) in the CA1 pyramidal layer 















































































































associated WFA+ cells were increased in the hippocampal CA1 region of PVDPS 
mice. E) PVDPS did not change the total number of PV+ cells in the hippocampal 
CA1. F) The majority of PV+ cells (>80%) were WFA+, indiscriminative of group. 
Student’s t-test was used to test statistical significance between PVDPS and 
control group; *P<0.05; ns=non-significant. Data are expressed as mean±SEM. 
Scale bar (B) indicates 75 μm.
Figure 4. Increased expression of perisynaptic extracellular matrix proteins 
in the dorsal hippocampus long after exposure to social stress. A) Brains were 
collected for Immunoblot (IB) analysis 48 h after the week 5 OPR test (group A). 
B) PVDPS significantly increased expression of chondroitin sulfate proteoglycans 
Aggrecan (Acan) and Brevican (Bcan);a trend for increased expression of 
Phosphacan (Phcan) and Versican (Vcan) was observed. Student’s t-test was 
used to test statistical significance between PVDPS and control group; *P< 0.05; 
**P< 0.01. Data are expressed as mean±SEM. 
Increase in the number PNNs coincides with 
altered inhibitory neurotransmission in the CA1 region
Parvalbumin-expressing interneurons provide strong perisomatic inhibitory 
input onto pyramidal cells83. As perineuronal nets can modulate intrinsic 
properties and output of the cells they surround74,221, we tested whether 
the increased density of PV-associated PNNs in the PVDPS group is 
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Figure 4. Increased expression of perisynaptic extracellular matrix proteins in the dorsal 
hippocampus long after exposure to social stress. A) Brains were collected for Immunoblot 
(IB) analysis 48 h after the week 5 OPR test (group A). B) PVDPS significantly increased 
expression of chondroitin sulfate proteoglycans Aggrecan (Acan) and Brevican (Bcan);a trend for 
increased expression of Phosphacan (Phcan) and Versican (Vcan) was observed. Student’s t-test 
was used to test statistical significance between PVDPS and control group; *P< 0.05; **P< 0.01. 
Data are expressed as mean±SEM.  
 
of the lecticans aggrecan (Acan) and brevican (Bcan) in the PVDPS group compared 
to controls (control vs. PVDPS; Acan: t(8)=4.757, P=0.002; Bcan: t(8)=2.811, 
P=0.023) (Fig. 4B, C). In addition, expression of phosphacan (Phcan) and versican 
(Vcan) was increased in the PVDPS group, although this did not reach statistical 
significance (control vs. PVDPS; Phcan: t(8)=2.003, P=0.080; Vcan: t(8)=2.035, 
P=0.076). We did not find any differences in the expression of neurocan (Ncan) or 
tenascin (TnR) between the groups (control vs. PVDPS; Ncan: t(8)=0.975, P=0.358; 
TnR180: U=4.5, P=0.133; TnR160: t(8)=1.792, P=0.111).  
 
Taken togeth r, our analysis of the pericellular and perisynaptic ECM showed that 
social defeat stress induced a late-appearing build-up of the ECM at dorsal 
hippocampus that coincides with hippocampal-dependent memory deficit weeks after 




accompanied by aberrant inhibitory neurotransmission, as previously 
shown187. For this, we recorded spontaneous inhibitory postsynaptic 
currents (sIPSC) in hippocampal CA1 pyramidal neurons long after 
the initial stress exposure (week 7–12 post-stress; group C) (Fig. 5A). 
We found a reduction in the frequency of sIPSC in the PVDPS group 
compared to controls (control 4.8±0.57 Hz; PVDPS 3.2±0.45 Hz; control 
vs. PVDPS, t(27)=2.187, P=0.038) (Fig. 5B, C), that was accompanied 
with a modest, but significant, increase in sIPSC amplitude (control 
20.3±0.39 pA; PVDPS 22.8±0.75 pA; control vs. PVDPS, t(19.27)=3.016, 
P=0.007) (Fig. 5B, D). No between-group differences were found in the 
frequency (t(28)=0.019, P=0.985) or amplitude (t(18.03)=0.440, P=0.589) 
of spontaneous excitatory postsynaptic currents (sEPSC) (Fig. 5E-G), 
indicating a specific effect of PVDPS on GABAergic neurotransmission. 
Altogether, these results demonstrate that inhibitory neurotransmission is 
reduced in the CA1 region months after exposure to social defeat stress, 
possibly mediating hippocampal dysfunction and the observed memory 
impairment after PVDPS. 
PVDPS-induced cognitive impairment 
is resistant to antidepressant treatment
Chronic antidepressant treatment that is given either during or directly 
after social defeat stress prevents the emergence of social avoidance 
and anhedonia282,290. In the present study, we assessed the potential of 
fluoxetine, a selective serotonin reuptake inhibitor (SSRI), in preventing 
the development of social defeat-induced late-emerging cognitive deficit, 
as we did previously in rat120. For this, control and PVDPS mice (group E) 
received 3 weeks of fluoxetine (Flx) treatment or water as control (H2O). 
This took place at week 3 post-defeat, after which group performance in 
the OPR task was assessed at week 6 post-defeat (Fig. 6A). Of note, 
mice were assigned to their treatment groups based on the SAA 24 h test, 
at which PVDPS mice showed reduced social interaction ratio compared 
to the control mice (control vs. PVDPS, U=104.5, P<0.001) (Suppl. Fig. 
4A-B).
Two-way ANOVA demonstrated a significant main effect of stress and 
chronic antidepressant treatment on OPR performance at week 6 (defeat 
F1,42=5.01, P=0.031; treatment F1,42=5.068, P=0.030; Fig. 6B), where either 
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Figure 5. PVDPS reduced inhibitory neurotransmission in the hippocampal 
CA1 region. A) Electrophysiological recordings were performed after behavioral 
testing at week 7–12 post-defeat (group C). B) Example traces of sIPSC recordings 
in control and PVDPS mice. C) Frequency of sIPSC was reduced in the PVDPS 
mice compared to control mice. D) Amplitude of sIPSC was increased in the 
PVDPS group compared to controls. E) Example traces of sEPSC recordings in 
control and PVDPS mice. F,G) No change in the frequency or amplitude of sEPSC 
was observed. Student’s t-test was used to test statistical significance between 
PVDPS and control group; *P<0.05. Data are expressed as mean±SEM.
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Figure 5. PVDPS reduced inhibitory neurotransmission in the hippocampal CA1 region. A) 
Electrophysiological recordings were performed after behavioral testing at week 7–12 post-defeat 
(group C). B) Example traces of sIPSC recordings in control and PVDPS mice. C) Frequency of 
sIPSC was reduced in the PVDPS mice compared to control m ce. D) Amplitude of sIPSC was 
incre sed in the PVDPS group compared to controls. E) Example traces of sEPSC recordings in 
control and PVDPS mice. F,G) No change in the frequency or amplitude of sEPSC was observed. 
Student’s t-test was used to test statistical significance between PVDPS and control group; 
*P<0.05. Data are expressed as mean±SEM. 
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stress or FLX treatment decreased OPR performance. No interaction effect 
was present (defeat x treatment F1,42=0.103, P=0.750; Fig. 6B). 
Comparison of OPR scores against chance levels confirmed this 
observation; water-treated control mice showed a significant preference 
for the relocated object (controlH2O vs. a fictive control, t(18)=2.816, 
P=0.011). None of the other three groups were significantly different from 
chance levels (vs. fictive: controlFLX, t(22)=0.273, P=0.788; PVDPSH2O, 
t(20)=0.446, P=0.660; PVDPSFLX, t(24)=1.005, P=0.325), indicating 
disturbed memory in these groups. Altogether, these findings suggest that 
fluoxetine did not prevent the persistent defeat-induced memory deficit, and 
in addition, it deteriorated cognitive function in naïve control mice. Notably, 
we did not observe any differences in distance travelled during the OPR 
test, (F3,44=0.416, P=0.743) (Suppl. Fig. 4), suggesting that the observed 
differences are due to a true discrimination deficit rather than resulting 
from changes in general locomotor activity. 
Behavioral therapy restores 
stress-induced cognitive deficit 
As pharmacotherapy was ineffective in preventing PVDPS-induced 
cognitive impairment, we next studied whether a 3-week enrichment 
therapy (ET), started at week 6 after the last defeat session, is effective in 
rescuing memory performance in PVDPS mice (Fig. 7A). For this, group 
B mice underwent ET, that started after behavioral testing at week 6. After 
three weeks of daily transfer to an enriched cage for 2–3 h, mice were re-
tested in the OPR task at week 9. PVDPS mice were allocated to treatment 
groups based on their week 6 OPR performance, at which they showed 
reduced discrimination index compared to the control mice (cf. Fig. 1G). 
Untreated control and PVDPS mice showed similar OPR performance at 9 
weeks post-defeat as compared to 6 weeks post-defeat (Wilcoxon; control: 
P=0.099; PVDPS: P=0.477) (Fig. 7B). Control mice showed a preference 
for the relocated object at week 6 and 9, as demonstrated by comparison of 
the discrimination ratios against chance levels (control vs. a fictive control 
week 6, U=14, P<0.001; week 9, U=37, P=0.045). Non-treated PVDPS 
mice were not significantly different from chance levels at either of the time 
points (PVDPS vs. a fictive control week 6, t(20)=0.199, P=0.844; week 
9, U=51, P=0.562), indicating disturbed object place memory. Conversely, 
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ET-exposed PVDPS mice showed an increase in performance at 9 weeks 
post-defeat as compared to 6 weeks post-defeat (Wilcoxon; PVDPSET: 
P=0.015 (Fig. 7B). In particular, before ET they showed no preference 
for the relocated object (week 6), whereas a significant preference was 
present after ET at week 9 (PVDPS vs. a fictive control week 6, U=55 
P=0.340; week 9, t(22)=2.429, P=0.024), confirming improved memory. 
Altogether, these findings imply that short bouts of daily enrichment is 
effective in rescuing the late-appearing cognitive deficit in defeated mice, 
similar as has been observed for rats291.
Figure 6. Late antidepressant treatment did not prevent development of 
PVDPS-induced cognitive impairment. A) Chronic fluoxetine treatment started 3 
weeks after the last social defeat, and lasted for 3 weeks, after which mice (group 
E) were tested in the OPR task. B) Antidepressant treatment was not effective in 
preventing late emerging cognitive dysfunction. Both PVDPS-treated and PVDPS-
untreated mice failed to discriminate between stable and relocated object. Similar 
to the PVDPS mice, control mice that were treated with the antidepressant showed 
impaired spatial memory. Two-way ANOVA was used to test statistical significance 
between control and PVDPS groups, followed by post-hoc testing. #P<0.05 
compared to a fictive group with a mean of 0.5 and equal variation; *P<0.05. Data 
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Figure 7. Behavioral therapy restored PVDPS-induced cognitive impairment. 
A) Mice (group B) were tested in the OPR test at week 6, followed by daily 
enrichment therapy (ET) for a period of 3 weeks, and OPR re-testing at week 9. B) 
PVDPS mice that underwent ET showed intact spatial memory similar to controls 
while non-treated PVDPS mice failed to discriminate between stable and relocated 
object. ET-exposed PVDPS mice showed an increase in performance at 9 weeks 
post-defeat as compared to 6 weeks post-defeat (Wilcoxon; PVDPSET: P=0.015. 
#P< 0.05 compared to a fictive group with a mean of 0.5 and equal variation. Data 








































In this study, we characterized both the early and lasting effects of combined 
psychosocial and physical stress in mice, with a focus on social behavior, 
anxiety and cognitive function. Investigation of enduring stress effects 
is crucial as depression and other stress-related psychiatric disorders 
typically take time to fully develop32. In addition to behavioral profiling, 
we studied hippocampal ECM changes long after stress, as our previous 
studies using social defeat stress in rats identified ECM remodeling as 
a crucial substrate in mediating persistent cognitive decline187. Last, we 
explored the potential of pharmacotherapy and a form of behavioral 
therapy to reverse the stress-induced behavioral symptoms. 
To establish a mouse model to study chronicity of depression91 similar to 
the rat SDPS model, we here combined daily physical defeat sessions with 
vicarious defeat. Accumulating evidence indicates that mice show affective 
sensitivity to the emotional state of conspecifics similar to humans. These 
empathy-associated behaviors include for example contagion of pain292 
and observational fear293. Observational fear, in which mice are vicariously 
fear-conditioned by observing another conspecific receiving foot shocks, 
results in freezing responses in the observer mouse293. Furthermore, 
previous studies have shown that vicariously defeated mice show social 
avoidance behavior and anhedonia279, similar to physically defeated 
mice282 one month after stress. These behavioral manifestations in 
vicariously defeated mice likely reflect empathy-related behavior that are 
the result of socially transmitted signals294. Moreover, it is well known that 
witnessing a traumatic event can trigger psychopathology in humans, such 
as post-traumatic stress disorder (PTSD)295. Importantly, affective deficits 
were not immediately present but rather evolved in our model, similarly 
like we have observed for the rat SDPS paradigm187. This underscores 
the importance of time as a crucial factor in long-term effects of stress. 
We therefore reasoned that the combination of different stressors, physical 
and vicarious in nature, could have a strong impact on the mice, as it likely 
activates additional emotional and empathy-related mechanisms. 
Affective deficits
Aberrant social behavior is common in stress-related disorders, including 
MDD and anxiety disorders. Social approach-avoidance in mice is 
142
commonly used to study neural mechanisms underlying aberrant social 
behavior, such as social withdrawal and social anxiety. In accordance with 
earlier studies employing a 10-day physical social defeat paradigm199,200,282 
or vicarious defeat279, PVDPS mice showed diminished interest to interact 
with a social target when tested early after stress. Reduced social interest 
in response to defeat stress, both physical and vicarious, has been reported 
to last up to 4 weeks post-defeat279,282,296. In accordance with these reports, 
we confirmed reduced social interaction to last up to 4 weeks post-defeat 
stress. Yet, this phenotype was no longer present when mice were tested 
6 weeks after stress exposure, demonstrating a gradual normalization of 
social behavior. Based on these findings, physical and vicarious defeat do 
not appear to result in a synergistic effect that would extensively sustain 
an affective deficit as observed in rats187,276. Interestingly, a previous study 
comparing the long-lasting effects of vicarious and physical defeat stress 
noted that the emotionally stressed mice showed gradual strengthening of 
social avoidance, while this was not the case for the physically defeated 
mice279. These findings suggest that the underlying neurobiological 
mechanisms driving the effects of vicarious defeat on social avoidance 
differ from that of physical defeat. Indeed, dissecting the neurobiological 
circuitries underlying empathy-related vicarious defeat and physical defeat 
offers an interesting avenue for future research. 
The impact of stress on individuals differs strikingly. Only a subset of 
humans develop pathological conditions, such as MDD, in response to 
stressful life events297,298. Vulnerability to psychopathologies depends on 
the individual’s stress response, which dictates whether an appropriate 
reaction and an effective return to homeostasis is achieved23. However, 
the mechanisms mediating differences in human stress responses are 
poorly understood. The social defeat model in mice is commonly used 
to probe neurobiological mechanisms that underlie both vulnerability and 
resilience to stress200. Typically, based on the interaction scores of the SAA 
test carried out 24 h after the last defeat episode, mice are grouped into 
stress-resilient and -susceptible individuals, showing social approach and 
avoidance, respectively199,200,282. Our analysis indicates that mice classified 
as resilient based on this early SAA test could develop avoidance behavior 
later on. Likewise, mice appointed as susceptible showed normalized 
approach behavior by week 6 after stress, pinpointing to a dissociation 




MDD not only impacts on the affective domain, rather, it commonly 
expresses as cognitive symptoms1,35,185. It is increasingly acknowledged 
that cognitive symptoms can impede a patients’ daily functioning and 
increase the risk of recurrent depressive episodes14,185,203. Notably, 
cognitive symptoms associated with MDD are often present in remitted 
patients12, indicating a dichotomy between remission rates of the mood-
related and cognitive symptoms. Furthermore, these findings exemplify 
that current treatment strategies, which target mood-related symptoms, 
are inadequate to tackle the cognitive deficits associated with MDD and 
hence the full-blown depressive phenotype. Despite the frequency and 
perpetuating nature of cognitive disturbances, the cognitive domain in MDD 
has remained less studied and the underlying molecular mechanisms are 
not well-understood. 
Hippocampal dysfunction appears to play a crucial role in mediating 
cognitive impairment in patients diagnosed with MDD39,45. To capture 
this, we temporally characterized the effects of PVDPS on hippocampal-
dependent short-term spatial memory. In our previous studies in rats, 
we revealed a biphasic regulation of cognitive function in response to 
SDPS276. Notably, SDPS rats showed impaired memory early after stress, 
which was followed by a recovery period that lasted over several weeks, 
before later cognitive decline. In the present study, defeated mice were 
not impaired in the OPR task when tested early after stress, yet cognitive 
impairment developed over the weeks following stress and fully emerged 
by week 5. Although the temporal dynamics of the cognitive impairment 
differ between species, these findings underscore the importance of stress 
recency, namely, the time elapsed after stress, in dictating the end result91. 
Indeed, in mice, the spatial memory deficit would remain unnoticed if the 
behavioral profiling did not extend over several weeks after the last stress 
episode. 
Furthermore, our results highlight the dissociation between social avoidance 
vulnerability and cognitive impairment, as both susceptible and resilient 
mice were prone to late-appearing stress-induced cognitive decline. 
In the long-run, non-avoidant, stress-resilient mice are still prone to the 
maladaptive changes induced by stress in terms of developing cognitive 
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deficits (cf. Suppl Fig 2). Moreover, performance in social interaction did 
not correlate to performance in the OPR task in control mice, suggesting 
that there is no cross-talk between the affective and cognitive domains (cf. 
Suppl Fig 2). Thus, our findings indicate that the early SAA test has limited 
power to assess overall stress vulnerability, and the development of long-
term cognitive deficits. In rats, the SAA test only has predictive power when 
used during week 5 post-defeat26. 
A previous study has reported intact hippocampal- and perirhinal cortex-
dependent function, assessed by the OPR and novel object recognition 
(NOR) tests, respectively, in response to social defeat in mice299. In this 
study, memory performance was tested within the first week after stress 
and as such, their observations are in accordance with our findings. 
Another study, employing a 6-day repeated social defeat model in which 
the aggressor is placed into the home cage of a C57BL/6 mouse, reported 
transient impairment in spatial memory assessed with the Barnes maze300. 
The authors demonstrated that the defeated mice showed impaired spatial 
memory recall in the Barnes maze early after stress but not when tested 
5 weeks later300. Despite the apparent discrepancies, which are possibly 
explained by the differences in the stress paradigm and type of memory 
tested, these findings further exemplify that stress exerts time-dependent 
changes on cognition. Furthermore, the combination of physical and 
vicarious defeat may have a synergistic effect, resulting in lasting cognitive 
impairments. In the current study, we characterized the effects of defeat 
stress on short-term spatial memory that is heavily dependent on the 
dorsal hippocampus285. Yet, future studies should characterize whether 
other type of memory processes are affected in response to social defeat 
stress, how these deficits develop, and how they relate to other measures 
of depressive-like behavior. 
The present findings, supported by our previous studies26,276, indicate 
that defeated animals progressively become more vulnerable to cognitive 
impairment. Studies have shown that rats become gradually more sensitive 
to mild stressors following social defeat. As an example, rats show 
increased physiological and behavioral responses to mild stressor, such as 
cage cleaning, over the weeks following defeat stress301. Although weeks 
of solitary housing alone did not result in impaired memory in mice, as 
exemplified by intact memory in the controls, defeated mice could become 
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more sensitive to social deprivation over time302. Thereby, time-dependent 
sensitization to mild stressors could contribute to the late-appearing 
cognitive deficit in these mice.
Lingering cognitive symptoms are regarded as major risk factors for 
subsequent depressive episodes303, however the underlying molecular 
mechanisms mediating this remains unknown. As defeated mice 
demonstrate persistent cognitive impairment in the absence of affective 
deficits and anxiety-like behavior, our model offers a preclinical tool to 
study these phenomena separately. For example, it would be of interest to 
explore whether mice that show cognitive decline late after stress are more 
prone to subsequent subthreshold stressors and whether re-exposure to 
stress would result in the re-appearance of other depressive-like symptoms, 
such as affective deficits. 
Taken together, our findings underscore the importance of stress recency, 
as cognitive impairment only emerged after several weeks post-stress, 
while social avoidance dissipated at this time point. Furthermore, the 
observed temporal profile highlights a dichotomy between affective and 
cognitive domains in response to stress. This is in accordance with clinical 
observations frequently reporting cognitive symptoms as independent of 
the affective component along the course of depression232. As we did not 
assess the effects of physical defeat or vicarious defeat alone, we cannot 
conclude whether the late-emerging and long-lasting cognitive deficits is 




As up to 30-40% of patients diagnosed with MDD are resistant to any type of 
treatment, including SSRIs, tricyclic antidepressants and electroconvulsive 
treatment304, there is a huge demand for more effective treatment options 
and better understanding of the mechanisms of actions of the current 
treatments. Furthermore, cognitive impairment is emerging as an essential 
therapeutic target in patients with MDD35. In preclinical studies, the effects 
of antidepressants against stress-induced phenotypes is often assessed 
by starting a treatment during stress or shortly thereafter296,302. However, 
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from a translational perspective, it is more relevant to start the treatment 
later on, when a full depressive-like phenotype has been established. In 
patients diagnosed with MDD, pharmacotherapy is typically implemented 
several weeks or even months after the symptoms have emerged. In 
order to recapitulate the effects of a late antidepressant treatment, here, 
we started treatment with pharmacological antidepressants 3 weeks after 
stress cessation.  
We demonstrate that chronic (i.e. 3 week) fluoxetine treatment did not 
prevent the emergence of the late-appearing cognitive deficit. Although 
methodological factors, such as dose and duration of the treatment, cannot 
be ruled out entirely, we can speculate on other reasons for the observed 
ineffectiveness of fluoxetine against memory impairment. Fluoxetine is 
known to reinstate juvenile-like plasticity in the adult brain62,63. Indeed, the 
mechanism of action of antidepressants is increasingly attributed to their 
plasticity-promoting effects61. Hence, it is crucial to consider the critical 
role of the environment in mediating their antidepressant properties. In 
support of this, a recent study used a stress-based approach in mice to 
demonstrated that fluoxetine has a permissive, rather than an instructive 
role on depressive-like phenotype305. In particular, the authors showed that 
when fluoxetine treatment was combined with stressful housing conditions, 
stressed mice continued to display depressive-like behavior. Conversely, 
mice that were housed in enriched conditions after the stress, showed 
reversal of depressive-like symptoms, indicating that environmental 
contributions weigh on the efficiency of antidepressants305. Furthermore, 
a study in humans demonstrated that citalopram, another type of SSRI, 
augments the influence of living conditions in patients diagnosed with 
MDD306, supporting the translational value of these preclinical findings. 
The environment-driven modulation of the effects of antidepressants could 
explain both the lack of impact of fluoxetine in defeated mice and the 
fluoxetine-induced memory-impairing effects in control mice seen here. 
Defeated mice are housed without social or cage enrichment. Therefore, 
these mice lack the stimulating environmental cues that could steer the 
effects of fluoxetine, resulting in beneficial rewiring of the maladapted 
neural circuits. Likewise, fluoxetine-treated control mice could become 
more prone to mild stressors, such as prolonged social isolation, with 
detrimental effects on cognition. In our non-treated control mice, sustained 
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isolation stress could remain a subthreshold stressor, which alone does 
not exert debilitating effects. However, it is possible that when coupled 
with the plasticity-promoting antidepressant treatment, mice become more 
prone to the effects of impoverished environments, leading, for example, 
to hippocampal dysfunction. 
Opposed to antidepressant pharmacotherapy, we showed that behavioral 
therapy, in the form of a daily transfer to an enriched housing situation for a 
period of 3 weeks, was effective in restoring social defeat-induced cognitive 
decline. Notably, we show that this treatment strategy was successful 
in reversing the phenotype after it had fully emerged. Environmental 
enrichment has been shown to improve hippocampal-dependent cognition 
both in healthy animals and in disease models with cognitive decline307–309, 
albeit that it is always applied in a continuous fashion rather than an 
intermittent daily exposure. Notably, various studies have demonstrated 
that environmental enrichment prior to or during stress could be effective 
in preventing stress-induced affective and/or cognitive deficits310–312, in 
addition to daily enrichment directly after stress313,314. Only a few studies in 
rat have successfully used daily enrichment late after stress, namely when 
the stress-induced behavioral manifestations were unfolded completely 
(Kamal et al 2010291; own unpublished observations). In humans, 
behavioral and cognitive therapies –regarded as the human counterpart of 
the enrichment therapy applied here–often when co-applied with physical 
exercise, are effective in reducing depressive symptoms, including 
cognitive deficits315–317. Interestingly, patients treated with behavioral and 
cognitive therapies show reduced relapse rates317. Future studies should 
explore whether these lasting therapeutic responses are mediated through 
alleviated cognitive function. 
ECM changes and inhibitory signaling 
impairments in the trajectory towards depression
Our molecular and cellular analysis showed that the effects of social defeat 
stress on extracellular matrix and inhibitory neurotransmission were similar 
to what previously observed during the chronic depressive-like state in 
rats276. In particular, we showed that the late-appearing cognitive deficit 
in PVDPS mice is accompanied by an increased number of PNNs in the 
CA1 subregion, similar to what is observed in SDPS-exposed rats187. 
148
Furthermore, we observed increased expression of several ECM proteins 
in the synaptic fraction of the dorsal hippocampus, in accordance with 
our rat study187. Although in the current study we did not assess causality 
between ECM build-up and memory deficit, it is tempting to speculate that 
these ECM changes underlie the hippocampal memory deficit similar to 
the rat SDPS model. 
In accordance with our previous findings187, we show here that PNN 
accumulation coincides with altered hippocampal inhibitory input onto 
principal cells. PV-expressing interneurons, which provide strong inhibitory 
control onto hippocampal pyramidal neurons83, are enwrapped by PNNs 
in increasing numbers in defeated mice long after defeat. Therefore, an 
attractive hypothesis is that the observed reduction in inhibitory tone 
reflects decreased output from these interneurons. In support of this view, 
we have previously shown that an ECM-targeting intervention, that rescues 
SDPS-induced cognitive impairment and balances PNN density, restores 
sIPSC frequency at hippocampus CA1187. This demonstrates an interplay 
between hippocampal ECM, inhibitory circuit and cognitive function. 
However, experimental evidence demonstrating the involvement of PV-
interneurons deficits in social defeat-induced cognitive impairment remain 
to be established. Given the robust effect of the current defeat paradigm 
on the cognitive domain, it serves as an ideal model to study the role of 
PV-interneurons in persistent effects of social stress. 
Although the molecular mechanisms mediating the plasticity promoting 
effects of our behavioral intervention291 are not fully understood, 
environmental enrichment has been shown to induce ECM remodeling318–320, 
possibly via increased metalloproteinase activity321. Therefore, in defeated 
mice reversal of cognitive impairment could occur through ECM remodeling, 
which in turn could allow reshaping of maladapted neural circuits. Our own 
unpublished observations of restoration of perisynaptic ECM levels after ET 
in SDPS rats, which coincided with normalization of hippocampal plasticity 
(LTP), support this notion. Future research should be aimed to unravel the 
molecular mechanisms underlying the beneficial effects of environmental 
enrichment therapy on memory after PVDPS. 
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CONCLUSIONS
Here, we described a novel model of psychosocial stress, in which 
physical social defeat stress is combined with vicarious stress, in the form 
of witnessing the defeat of others. By employing this model, we showed 
that defeat stress results in a late-emerging, yet sustained decline in the 
cognitive domain in the absence of acute stress. Conversely, impairments 
in the affective domain gradually dissipate. Furthermore, we demonstrated 
that psychosocial stress results in ECM remodeling and aberrant inhibitory 
neurotransmission in the hippocampus, which might underlie the observed 
deficits in hippocampus-mediated memory. Lastly, we show that while 
late-emerging cognitive impairment is not responsive to pharmacotherapy, 
enrichment therapy reverses the cognitive deficit emerged long after social 
defeat stress, indicating the predictive value of our model.   
MATERIALS AND METHODS
Animals and the physical and vicarious 
defeat-induced persistent stress (PVDPS) paradigm
Animals were single housed in temperature-controlled rooms (21±1 °C) 
with water and food ad libitum, on a 12/12 h rhythm with lights off at 19:00. 
All experiments were approved by the Vrije University Amsterdam Animal 
Users Committee and in accordance with the relevant guidelines and 
regulations. 
pvdps residents and aggression screening
CD1 mice (male, retired breeders > 20 weeks old, Harlan, Netherlands) 
were used as aggressors. Mice were individually housed upon arrival and 
habituated in the facility > 1 week before the start of the experiments. 
At least 5 days before social defeat encounters, the CD-1 mice were 
transferred to a new home cage, which served as defeat cage (plastic, 
55 x 20 x 16 cm, Fig. 1B , Suppl. Fig. 1). Prior to the defeat paradigm 
(5–10 days), CD1 mice were screened for aggressiveness, by putting a 
C57BL/6 (6-7 weeks old, Charles River, France) mouse into their home 
cage and subsequent manual scoring of aggressiveness during a 3-minute 
period. The following inclusion criteria were used: > 3 attacks during each 
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of the three screening sessions, with the initial attack occurring within 
first minute. CD1 aggressors that attacked too vigorously (biting) were 
excluded. The same CD-1 mice were used for several defeats but were 
re-screened before the start of each defeat experiment (typically 3–5 days 
of screening).  
social and vicarious defeat
Male mice bred in house on a C57Bl/6 background (Charles River, 
France) were individually housed and habituated > 1 week. At day 1 of the 
PVDPS paradigm (aged ~7 weeks old), PVDPS mice were placed into the 
home cage of the CD-1 aggressor, and underwent 10 minutes of either 
experiencing or witnessing a social defeat. Mice were subjected to 2x 
PVDPS episodes per day (one physical and one vicarious) for a total of 10 
consecutive days. The following housing/defeating experimental setup was 
used: the defeat box was divided into three compartments by removable 
transparent perforated plexiglass partition walls (Fig. 1B , Suppl. Fig. 1). 
After the defeat session, the intruder C57BL/6 mice were housed on either 
side of the resident (CD-1) mouse that was housed in the larger middle 
compartment of the cage. At the start of the defeat session (morning), the 
intruder C57BL/6 mice was transferred to the side compartment of a new, 
unfamiliar CD1 mouse. The partition walls separated the intruder mice from 
the resident, permitting sensory interaction but preventing physical contact. 
After 5 minutes, one partition wall was removed to initiate a 10-minute 
fight phase. During this time, the second PVDPS mouse witnessed the 
defeat but was otherwise safe, still separated by its own partition wall. 
Physical contact between the intruder and resident mice was stopped by 
re-inserting the Plexiglas divider, and placing the mice back to the original 
compartments of the defeat apparatus. Later during the same day (interval 
typically > 3 h), the second mouse participated in physical defeat, while the 
first intruder was exposed to a witnessing session. This was repeated for 
10-days and each day a new CD1 resident was used, with alternating the 
order of daily physical and vicarious defeat sessions. After the last defeat 
session at day 10, the intruder mice were individually housed in cages that 
lacked enrichment (only tissue paper as nesting material). Control mice 
were individually housed and during the defeat let to explore an empty 
defeat apparatus for 10 minutes daily. Normal cage enrichment (wooden 
block, tube, nesting material) was provided for the control mice. 
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Behavioral testing
Habituation - All animals were habituated to the testing arenas (50 x 50 x 
35 cm, white plastic) before they underwent any behavioral testing, which 
typically took place the week before the PVDPS paradigm started. During 
the habituation phase, mice were transported to the video-recording room 
and let to freely explore an empty testing arena for 10 minutes. Habituation 
was conducted for 3 times. All behavioral testing was performed during 
the light phase. Each behavioral session was recorded by a video camera 
and tracked and analyzed using the Viewer software (BIOBSERVE, Gmbh, 
Bonn, Germany). 
Social Approach Avoidance (SAA) test - The SAA test consisted of 3 
phases: habituation, sampling and testing. During habituation, the animals 
were allowed to explore the empty arena for 5 minutes. This was followed 
by a sampling phase when two empty interaction cups (10 x 12 cm, metal 
cylinder with bars) were introduced to the arena on opposing sides of 
the box, and the animals were allowed to explore the empty cups for 5 
minutes. After the sampling phase, the mice were placed back to their 
home cage, and an unfamiliar CD-1 mouse was placed in one of the cups. 
Immediately thereafter, the animals were introduced back to the arena and 
were allowed to explore the arena again for 5 minutes. For each mouse, 
the interaction ratio was calculated as time spent near the social target 
vs. time spent near the empty cup: social target zone / (social target zone 
+ empty cup zone) during the first minute of the test. SAA test days per 
experimental batch are indicated in Table 1.
Object Place Recognition (OPR) test - The OPR test consisted of 3 phases: 
habituation, sampling and testing. During habituation, the animals were 
allowed to explore an empty arena for 5 minutes. This was followed by a 
5-minute sampling phase upon which two identical objects (4 x 4 x 10 cm, 
metal, cylinders or cubes) were introduced to the testing arena. After the 
sampling phase, mice were placed back to their home-cage. Two objects 
were replaced with a set of two identical objects, but now one object was 
relocated to a different corner within the arena. After a 15-minute interval, 
mice were introduced back to the arena and let explore the objects for 
3 minutes. For each mouse, the discrimination index was calculated by 
measuring the time spent exploring the relocated object compared to 
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the stable object: relocated object / (relocated object + stable object). 
The first minute of the testing session was analyzed. OPR test days per 
experimental batch are indicated in Table 1.  
Elevated Plus Maze (EPM) - Two independent batches of mice were used 
for the EPM test; Group A was tested at week 1 (day 5 post-defeat) and 
group B at week 5 (day 35 post-defeat; Table 1). All animals were brought to 
the holding room 30 min prior the start of the testing. Mice were introduced 
into one of the closed arms (arms 30 x 6 cm, walls 35 cm high, elevated 
50 cm above the ground), and allowed to freely explore the maze for 5 min 
while being video-tracked (Bio-observer). The EPM was illuminated with a 
single white fluorescent light bulb from above (open arms 70 lx, closed arm 
30 lx). The border between center and arm entries was defined at 2 cm 
into each arm, producing the number of entries into the open arms, into the 
closed arms, onto the center platform, and time spent on the open arms. In 
addition, latency to explore was defined by the time between introduction 
onto the maze and the first appearance in the maze center.
Tissue preparation
synaptosome isolation
The tissue for immunoblot analysis was collected 48 hours after the OPR 
week 5 test (Table 1). Following decapitation, the brain was removed, and 
the dorsal hippocampus was immediately dissected on ice, and flash-frozen 
using dry ice. Samples were homogenized in ice-cold 0.32 M sucrose (5% 
of homogenate was collected as total cell lysate) and then centrifuged at 
1000x g for 10 minutes. The supernatant was loaded on top of a sucrose 
gradient consisting of 0.85 and 1.2 M sucrose. After centrifugation at 
100,000x g for 2 h, the synaptosome fraction at the interface of 0.85 ⁄ 1.2 
M sucrose was collected and then lysed in hypotonic solution.
immunoblotting
Hippocampal synaptosomes, excluding samples used for Nectin-3 
immunoblotting, were treated with chondroitinase ABC before separation 
on SDS-gel. Samples (10 µg) were lysed in Laemmli lysis buffer, separated 
by electrophoresis on gradient precast gels (Criterion TGX stain-free, 
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Bio-Rad) and blotted on polyvinylidene difluoride membrane (Bio-Rad). 
The following primary antibodies were used: rabbit anti-aggrecan (1:700; 
AB1031, Millipore), guinea pig anti-brevican (1:2,000; provided by C.I. 
Seidenbecher, Magdeburg), mouse anti-neurocan 1:1,000; N0913, Alpha 
Diagnostics), mouse anti-phosphacan (1:1,000; 3F8, Developmental 
Studies Hybridoma Bank), mouse anti-versican (1:1,000; 75-324, 
NeuroMab), mouse anti-tenascin-R (1:2,000; mTN-R2, Acris Antibodies) 
and mouse anti nectin-3 (1:3,000; ab63931, Abcam). The primary 
antibodies were incubated o/n in 4 C. After washing 4 times 10 minutes in 
TBST, the blots were incubated with horseradish peroxidase-conjugated 
secondary antibody (1:10,000, Dako, Glostrup, Denmark). The blots were 
then scanned using the Li-Cor Odyssey Fc (Westburg, Leusden, The 
Netherlands) and analyzed with Image studio (Li.Cor, Lincoln, NE, USA). 
Total protein was visualized using trichloro ethanol staining, scanned using 
Gel Doc EZ imager (BioRad) and analyzed with Image Lab (BioRad) to 
correct for loading differences. 
immunoHistocHemistry
The brains were collected for immunnohistochemical analysis 48 h after 
the week 5 OPR test (group A; Table 1). Following transcardial perfusion, 
dissection and overnight post-fixation in ice-cold 4% PFA in PBS, 
brains were transferred to 30% sucrose in PBS in 4 °C until sectioned. 
Free-floating cryostat sections (35 µm) were collected from the dorsal 
hippocampus and stored in PBS+0.02% NaN3 until further use. Sections 
were washed 3 times for 10 minutes in PBS, followed by a blocking for 1 h 
at RT in blocking solution (2.5% BSA, 0.1% Triton, 5% normal goat serum 
in PBS). After blocking, the sections were incubated with primary antibody 
(rabbit anti-parvalbumin 1:1000, Swant #235) overnight at 4 °C. This was 
followed by washing in PBS 4 times for 10 minutes at RT, and incubation 
with Wisteria Floribunda Agglutin (WFA, 1:400, Vector Laboratories) and 
fluorescent-conjugated secondary antibody (anti-rabbit-Alexa-568 1:400, 
Invitrogen A11011) for 2 h at RT. Thereafter, the sections were washed 
4 times 10 min with PBS at RT. Sections were mounted onto microscope 
slides using PBS+0.02% gelatin and coverslipped with DAPI-containing 
mounting medium (H-1500 Vector Laboratories). Images were acquired on 
a fluorescent microscope (Leica DM5000) 20x objective, and analyzed by 
Fiji software26, using automated threshold and particle analysis to detect 
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the number of PNN+ and PV+ cells and their double immunoreactivity. 
False-positive detected cells were excluded manually during the analysis. 
During image acquisition and cell quantification, the researcher was blind 
to the experimental groups. 
Electrophysiology
The electrophysiological analysis was performed at week 7–12 post-defeat 
(mice aged between 16–21 weeks during the recordings). Mice were 
swiftly decapitated, brains were extracted and placed for up to 10 minutes 
in ice-cold oxygenated ‘slicing solution’ containing (in mM): 93 N-methyl-
d-glucamine, 2.5 KCl, 1.2 NaH2PO4.H2O, 30 NaHCO3, 20 HEPES, 25 
Glucose, 5 Na-Ascorbate, 2 Thiourea, 3 Na-Pyruvate, 12 N-acetyl-L-
cysteine, 10 MgSO4.7H2O, 0.5 CaCl2.2H2O; pH 7.4, 305 mOsm, perfused 
with carbogen (95% O2, 5% CO2). Horizontal hippocampal slices (300 
μm) were acquired, using a vibrating-blade microtome (HM-650V, Thermo 
Scientific), in ice-cold carbogen-perfused ‘slicing solution’. Upon slicing, 
each slice was left to recover for 2 minutes at 32 °C in carbogen-perfused 
‘slicing solution’. Subsequently, slices were placed in room temperature 
‘holding solution’ containing (in mM): 92 NaCl, 2.5 KCl, 1.2 NaH2PO4.H2O, 
30 NaHCO3, 20 HEPES, 25 Glucose, 5 Na-Ascorbate, 2 Thiourea, 3 Na-
Pyruvate, 12 N-acetyl-L-cysteine, 2 MgSO4.7H2O, 2 CaCl2.2H2O; pH 7.4, 
305 mOsm, perfused with carbogen. Individual slices were transferred to a 
submerged recording chamber, and left to equilibrate for 10 minutes, under 
continuous perfusion, at a rate of 2 mL/minute, with room temperature 
‘recording solution’ containing (in mM); 124 NaCl, 3 KCl, 1 NaH2PO4.H2O, 26 
NaHCO3, 10 Glucose, 1 MgSO4.7H2O, 2 CaCl2.2H2O; pH 7.4, 305 mOsm, 
perfused with carbogen. Subsequently, hippocampal CA1 pyramidal 
neurons were visualized under differential interference contrast microscopy 
and selected based on their morphology and basic cell firing properties. 
Whole-cell patch-clamp configuration was achieved using standard 
borosilicate glass pipettes (~3.0 MΩ resistance) filled with intracellular 
solution containing (in mM): 70 K-Gluconate, 70 KCl, 10 HEPES, 4 ATP-
Mg, 4 K2-Phosphocreatine, 0.4 GTP; 0.5% Biocytin, pH 7.35, 290 mOsm. 
Upon achieving a stable whole-cell patch-clamp configuration, ‘recording 
solution’ was supplemented with 10 μM 6-cyano-7nitroquinoxaline-2,3-
dione (CNQX), 50 μM DL-2-Amino-5-Phosphonopentanoic acid (DL-APV), 
and 4 μM (2S)-3-[[(1S)-1-(3,4-Dichlorophenyl)ethyl]amino-2hydroxypropyl]
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(phenylmethyl) phosphinic acid hydrochloride (CGP55845) in order to 
block AMPA, NMDA, and GABAB receptor-mediated currents, respectively. 
Subsequently, 3x5-minute voltage-clamp gap-free recordings were 
acquired with pClamp software (Molecular Devices), using a Multiclamp 
700B amplifier (Molecular Devices), sampled at 10 kHz, low-pass filtered 
at 3 kHz, and digitized with an Axon Digidata 1440A (Molecular Devices). 
Series resistance was monitored online in between each gap-free 




Fluoxetine hydrochloridium (Sigma-Aldrich) was dissolved in tap water 
(0.08 mg/mL) and delivered via drinking water for 3 weeks, starting at 
week 3 post-defeat (Table 1). The bottles were protected from light using 
aluminum foil and changed weekly. 
enricHment tHerapy
PVDPS mice underwent enrichment therapy for 3 weeks starting week 
6 post-defeat (Table 1). The mice were let explore their own enrichment 
cage for 2–3 hours daily for 3 weeks. The enrichment cage (type 2 cage) 
contained toys, such as long PVC tubes, wooden blocks, cardboard, 
hidden food pellets and ping pong balls. The cages were changed every 
week and new toys were introduced. 
Statistics
Two-tailed Student’s t-tests (with or without correction for unequal variation) 
were applied for normally distributed data and Mann–Whitney U-tests 
or Wilcoxon tests otherwise. Normality was assessed with Kolmogorov-
Smirnov and Saphiro-Wilk tests. In the case of normally distributed data but 
with unequal variances, Welch’s unequal variance t-test was used. Mixed 
ANOVA test was performed for defeat as between-subject factor and time 
as repeated measures (ET OPR performance), or using Kruskal-Wallis 
when normality was not met. PVDPS mice were divided into stress-resilient 
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and susceptible subgroups based on the following criteria284: mice with 
SAA interaction ratios within 1 SD above of control mean were classified 
as stress resilient, whereas mice with SAA interaction ratios below 1 SD 
from the control mean as susceptible. Four PVDPS mice (Group B) were 
removed from SAA analysis (both SAA24h and week 6) as their week 6 
SAA test behavioral videos were lost due to a technical issue. 
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SUPPLEMENTARY FIGURES AND TABLES
Table 1. Individual groups of mice used in the experiments. Different behavioral 
tests with their time points are indicated for each of the batches, together with 
details of treatment or tissue collection. Reference to the figure in which the data is
shown is indicated in brackets. w=week.  
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Batch Behavioral tests, days post-defeat 
(figure panel) 
Treatment / Tissue 
Group A SAA 24 h, 1 (Fig. 1B; Supp. Fig. 1D) 
SAA w4, 31 (Fig. 1C) 
OPR day 5, 5; OPR w5, 37 (Fig. 1E) 
EPM w5; 35 (Supp. Fig. 3) 
IHC (Fig. 3) 
WB (Fig. 4) 
(tissue collected 48 h 
after w5 OPR test) 
Group B SAA 24 h, 1 (Fig. 1B; Supp. Fig. 1E) 
SAA w6, 41 (Fig. 1D) 
OPR w6, 40 (Fig. 1F) 
OPR w9, 69 (Fig. 7B) 
Behavioral therapy from 
w6 to w9 (47–69) days post-
defeat) 
Group C SAA 24 h, 1 (Supp. Fig. 2G)  
OPR w1, 5; w3, 22; w6, 37 (Supp. Fig. 2H) 
Ephys (Fig. 5) 
(recordings w7 to w12 
(51-84 days post-defeat) 
Group D SAA 24 h, 1 (data not shown) 




SAA 24 h, 1 (Supp. Fig. 4A) 
OPR w6; 46 (Fig. 6) 
Fluoxetine from w3 to 
w6 (21–46 days post-defeat) 
Table 1. Individual groups of mice used in the experiments. Different behavioral tests with 
their time points are indicated for each of the batches, together with details of treatment or tissue 





Supplementary figure 1. Social interaction in the mouse PVDPS paradigm 
does not predict the late OPR deficit. A) Custom-made defeat cage. The CD-1 
resident is housed in the larger middle compartment and experimental PVDPS mice 
are housed on both sides of the resident in the smaller compartments, separated 
by transparent perforated partition walls. B-C) Correlations between the SAA 24 h 
vs. SAA week 4 test (A; group A) and week 6 test (B; group B). D-E) Clustering of 
PVDPS mice into PVDPS-resilient and PVDPS-susceptible subgroups, based on 
the SAA 24h test, revealed a significant decrease in social interaction in PVDPS-
resilient mice at week 4 (D). Avoidance behavior was transient, as PVDPS-
susceptible mice showed normalized SAA performance by week 6 SAA test (E).
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Supplementary figure 2. Development of cognitive impairment following 
PVDPS. A-F) Correlations between the acute or late SAA test vs. late OPR behavior 
for mice of groups A, B and C. In none of the comparisons, SAA behavior correlated 
to OPR behavior, as we have observed previously in the rat SDPS model187. G-H) 
Following a 24 h SAA test (G), mice were tested in the OPR task at week 1, 3 and 
5 post-social defeat (group C). PVDPS mice demonstrated intact memory function 
both at week 1 and 3 post-defeat. At week 5 post-defeat PVDPS mice showed 
a reduced ability to discriminate between the stable and displaced objects (H). 
#P<0.05 compared to a fictive group with a mean of 0.5 and equal variation. Data 
are expressed as mean±SEM.
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Supplementary figure 3. PVDPS-induced increase in anxiety-like behavior is 
transient. Mice were tested in elevated plus maze test either at week 1 or at week 
5 post-defeat. A) PVDPS mice showed a reduction in time spent in the open arm 
and an increase in time spent in the closed arm, and hence an overall increased 
anxiety-like behavior early after stress. B) No difference in time spent in the open 
arms or closed arms were observed. Hence, anxiety-like behavior was normalized 
at week 5 post-defeat. 
Supplementary figure 4. Behavioral assessment of fluoxetine treatment 
groups. A) PVDPS mice (group E) showed reduced social approach compared to 
control mice at SAA 24 h test. B) Mice were allocated to treatment groups (see Fig. 
6) based on the SAA 24 h test; each group showing equal interaction ration with a 
similar variance at this time point. C-D) There was no between-group difference in 
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CHAPTER 6.  
General discussion
In part taken from: Incubation of depression: ECM assembly and 
parvalbumin interneurons after stress
S Spijker, MK Koskinen, D Riga 
Neurosci Biobehav Rev, 118, 65-79 (2020)
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In my studies, I aimed to increase understanding of the neural mechanisms 
that underlie MDD, which is amongst the leading causes of disability 
worldwide and carry an immense socioeconomic burden1. While persistent 
low mood and anhedonia are the core characteristics of depression2, 
mild cognitive dysfunction is increasingly acknowledged as an integral 
trait of the disorder. Yet, the neural mechanisms that mediate impaired 
cognition, such as memory deficits associated with depression, are not 
well-understood. By employing the SDPS model, a well-validated model 
of psychosocial stress31,111,120, I explored molecular mechanisms which 
contribute to cognitive dysfunction associated with a depressive-like state. 
Notably, in chapter 2, altered ECM assembly in the rat hippocampus was 
shown to mediate cognitive impairment during a sustained depressive-like 
state, months (> 8 weeks) after the initial stress experience. Furthermore, 
in chapter 3, I characterized how the depressive-like state and the 
accompanied molecular and behavioral phenotypes develop over time, in 
order to uncover the mechanisms contributing to the transition from stress 
to chronic depression in the rat. In chapter 4, I explored the therapeutic 
potential of a metalloproteinase inhibitor against social defeat-induced 
hippocampal dysfunction. Lastly, in chapter 5, by developing a novel 
preclinical paradigm with increased translational value, I characterized the 
long-lasting behavioral effects of social defeat stress in mice and explored 
ECM changes in the hippocampus long after stress cessation. 
Below, I will discuss these findings by first focusing on the SDPS as a 
model for depression. I will highlight differences and similarities found 
between the rat and mouse models in regard to their affective and 
cognitive behavior in the SDPS/PVDPS paradigms. This is followed by a 
more in-depth discussion on the role of the ECM as a molecular substrate 
for stress-driven hippocampal pathology, as well as its role in mediating 
antidepressant responses. 
Modeling major depressive disorder – 
SDPS/PVDPS as preclinical models for depression
Preclinical models with high translational value are fundamental for 
the dissection of underlying disease mechanisms. When human 
psychopathologies are modelled in preclinical settings, the question is 
which criteria are fulfilled, and hence to what extent the model has a specific 
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translational value. Among these criteria etiological (cause), constructive 
(underlying mechanisms), face (symptomatology) and predictive validity 
(responsiveness to treatment) are crucial322. In case of MDD, where the 
cause(s) are largely unknown, preclinical models rely on stress, as stress 
is a major predisposing factor for depression21 and stress responses are 
largely evolutionary conserved323. It is apparent that the complexity of the 
human depressive phenotype cannot be fully captured with animal models. 
However, both the SDPS and PVDPS models fulfill many aspects of the 
criteria discussed above. Importantly, the models utilize an etiologically 
valid stressor, social stress, which is one of the most powerful stressors 
in humans as well as in rodents324. While favorable social interaction can 
exert stress-buffering effects198, adverse social experiences, such as 
bullying325 and social isolation197, can promote psychopathology. Likewise, 
social conflict, which is utilized in social defeat paradigms, is among the 
most intense stressor in mice and rats that live in hierarchical groups324. 
Furthermore, in our rat SDPS paradigm, social defeat bouts are coupled 
with a prolonged social isolation, emulating lack of social support, which 
is known to increase risk for depressive episodes and to exacerbate 
depressive symptoms in humans326. As an attempt to increase the 
emotional impact of the defeat in mice, physical defeat sessions in PVDPS 
were coupled with witnessing the defeat of others. Similar to humans, in 
which vicarious experiences can cause pathophysiology295, rodents show 
emotional contagion of pain and fear294. 
Although it is evident that some depressive symptoms, such as feelings 
of guilt and worthlessness, together with suicidal thoughts cannot be 
recapitulated in animal models, both SDPS and PVDPS induced core 
depressive-like symptoms. As an example, in rats SDPS results in lasting 
anhedonia112, disturbed social behavior and cognitive dysfunction111, 
thereby capturing the key symptoms of MDD. Furthermore, as shown 
by others120 as well, we demonstrated that the depressive-like state after 
SDPS in rats responds to chronic antidepressant treatment. Moreover, 
in mice daily exposure to enriched environment291, mimicking cognitive 
therapy in humans, was effective in restoring PVDPS-induced cognitive 
decline. Altogether, these findings exemplify the usefulness of the SDPS 
model in studying depression-related pathology. Notably, utilizing these 
two different defeat stress-based paradigms in my studies, I discovered 
many important species-specific effects in rats versus mice, which should 
inform future study designs.  
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Affective disturbances in SDPS and PVDPS
Affective deficits represent core traits of MDD and are the main focus 
in animal models. In particular, deficits in social interaction are common 
in patients with MDD196. While lack of social support can predispose to 
affective disturbances, social support can enhance resilience to stress and 
protect against stress-induced pathology327, highlighting the importance 
of affirmative social contact. Furthermore, impaired social functioning can 
lead to social withdrawal, which can further exacerbate social isolation and 
promote disease psychopathology328. 
In our studies, we characterized the development of disturbed social 
behavior in response to SDPS by assessing approach towards an 
unfamiliar social target (of the same strain as the residents) in the social 
approach-avoidance (SAA) test329. Although SDPS/PVDPS resulted in 
increased social withdrawal both in rats and in mice, the developmental 
course of these affective disturbance differs greatly between the species. 
While mice showed avoidance acutely after the last defeat exposure, 
in rats social avoidance developed gradually over time. Furthermore, in 
mice the reduced approach lasted around four weeks after stress, while 
decreased social interaction persisted –for up to 6 months– after it was 
established in rats. Notably, the development of the affective deficit in 
rats was prevented by pair-housing192, while social isolation alone did not 
result in social avoidance187. Together, these findings showcase the need 
of a prior defeat experience as an accelerator that increases vulnerability 
to the subthreshold isolation stress, while social support buffers against 
stress effects. This highlights the pertinence of a social component in the 
rat SDPS model and the important role of social interaction in disease 
progression similar to the human condition196. 
On the contrary, social isolation in mice did not induce long-lasting 
affective disturbances persistently, and in this species, neural adaptations 
that underlie social avoidance behavior receded over time. In mice, we 
combined physical defeat with vicarious defeat, with the aim to intensify 
the emotional load of the stressor and hence its perpetuation. Vicarious 
defeat likely involves empathy-related mechanisms, which activate similar 
neural mechanisms in the observer mouse as in the mouse experiencing 
the physical defeat330. The combination of these stressors resulted in an 
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enduring affective disturbance lasting 4 weeks, however this did not extend 
beyond 5–6 weeks (chapter 5). It is important to note that we did not study 
the effects of each of the stressors alone, thus specific contributions of 
physical and/or emotional stress on the phenotype cannot be assessed. 
Altogether, these findings highlight species-specific differences in defeat-
induced affective disturbances and showcase that the affective deficit in 
mice cannot be maintained by social isolation as opposed to rats. 
These species differences could stem from their innate differences in 
social behavior. Although both rats and mice are gregarious animals, 
many differences in their sociability exists. For example, rats and mice 
differ regarding their social organization and aggressiveness (reviewed 
in Kondrakiewicz et. al 2018331). Male mice establish social dominance 
hierarchies in a group but continuously compete for dominance, which 
results in aggressive confrontations, whereas in rat groups the dominance 
is more likely to remain stable once established. Innate differences in 
social structures imply that coping with social stress can differ between 
these species. As an example, frequent aggressive confrontations in mice 
may have resulted in adaptations that render mice less susceptible to the 
effects of defeat bouts. Consequently, this could be reflected in a transient 
affective disturbance, which cannot be maintained by social isolation. 
Furthermore, mice and rats show different sensitivity to social reward. 
As an example, rats prefer social interaction over cocaine in conditioned 
place preference test, while mice tend to show preference towards the 
drug332. Consequently, reduced social interaction may emulate social 
anhedonia in rats, while this might not be the case in mice. The neural 
mechanisms mediating susceptibility or resilience to social defeat-induced 
social avoidance in mice are closely associated with adaptive changes 
in the midbrain mesolimbic system200,282,333. In susceptible mice the firing 
of ventral tegmental area (VTA) dopaminergic cells projecting to the 
nucleus accumbens (NAc) is increased. This results in activity-dependent 
release of brain-derived neurotrophic factor (BDNF) and increases BDNF-
mediated signaling in the NAc. Whether similar changes mediate reduced 
social approach in rats remains to be established. Indeed, it would be of 
interest to study the similarities and differences between the species in 
relation to defeat-induced approach/avoidance behavior at the molecular 
level. Studying the molecular mechanisms underlying chronic affective 
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deficits in rats could perhaps be more pertinent to human depression in 
which persistent social dysfunction is observed281.  
Cognitive disturbances in SDPS and PVDPS 
Mild cognitive dysfunction is increasingly acknowledged as an innate 
feature of MDD136. Strikingly, cognitive dysfunction often persists in patients 
remitted from depression13, demonstrating the occurrence of cognitive 
impairment independently of episodes of negative affect. Treatment of 
MDD has mainly focused on alleviating mood symptoms, although cognitive 
symptoms can prolong duration and increase risk of depression episodes, 
and hinder remission. Moreover, cognitive deficits are major contributors 
to occupational deficiency, which burdens the socioeconomic impact of the 
disorder. 
Converging clinical and preclinical data pinpoint to hippocampal 
dysfunction as a major source of cognitive symptoms39. Deficits in retrieval 
of declarative memory has been associated with hippocampal volume 
reduction in MDD patients. Furthermore, difficulties in spatial navigation 
task, which are associated with aberrant hippocampal function, have 
been observed in patients diagnosed with MDD44. As highlighted earlier, 
the majority of preclinical research is focused on assessing early stress 
effects and associate these changes with a depressive-like state. In our 
studies, much more akin to models like early life stress334, we characterized 
hippocampal (mal)adaptations that persist after dissipation of the early 
stress effects, to better model dysfunction that contributes to the chronicity 
of depression. Notably, we found cognitive deficits to be present early after 
stress in rats, while in mice the deficit apparently emerged only later on. 
Apart from species-specific effects, differences in stress duration could 
contribute to the observed phenotypes. While the defeat paradigm lasts 
for 5 consecutive days in rats, mice undergo social defeat and witnessing 
for 10 days. Hence, chronicity of stress in mice could lead to divergent 
neurophysiological adaptations, and different trajectory of cognitive deficits. 
It has been shown that 5 defeat sessions in mice fail to induce social 
avoidance phenotype335, suggesting that in mice more chronic exposure 
is required to develop a depression-related phenotype. Altogether, both 
in rats and mice time-dependent effects of stress are observed, indicating 
that stress-triggered adaptations continue to occur in absence of stress. 
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We found that cognitive impairment was present weeks after the initial stress 
both in rats and mice, emulating the chronicity of cognitive dysfunction in 
MDD. Importantly, although affective deficits dissipated over time in mice, 
spatial memory impairment persisted at least up to 9 weeks post-stress, 
underscoring the suitability of the PVDPS model to assess lasting stress-
induced cognitive impairment similar to rats. In mice this could be done in 
absence of an affective component, thereby studying cognitive impairment 
alone at, for example, the molecular level. Furthermore, we showed that 
in both species, affective disturbances and cognitive impairment occurred 
independently of each other, recapitulating clinical observations232. 
Altogether, these findings unraveled drastic differences between early 
and late appearing behavioral effects, highlighting the importance of an 
incubation effect of stress.
Importantly, we found species differences in the effects of antidepressants 
in reversing defeat-induced cognitive impairment. Whereas late imipramine 
treatment reversed hippocampal deficits in rats, chronic fluoxetine 
treatment, initiated weeks after stress, was not effective in preventing the 
development of cognitive deficit in mice. Yet, daily enrichment therapy 
rescued the defeat-induced memory deficit in mice, similar as in rats 
(chapter 5 and own unpublished observations). These disparities may 
reflect diversity in the underlying neural circuits affected by defeat stress. For 
example, the serotonergic system, known to play a crucial role in mediating 
antidepressant responses336, may be differently affected by defeat stress 
in these two species. Furthermore, timing of the antidepressant treatment 
may be crucial in determining the end result. In rats, the treatment was 
initiated only after the depressive state was established, while in mice 
the treatment started before the cognitive impairment had fully emerged. 
Future work should decipher the underlying mechanisms of these species-
specific differences in antidepressant response, as this could be of great 
value for studies screening the effects of antidepressant agents. 
Extracellular matrix remodeling 
during the depressive-like state
In our studies, we identified hippocampal ECM remodeling as a novel 
mechanism contributing to hippocampal impairment during a chronic 
depressive-like state. Notably, we showed that the long-term effects of 
SDPS involve increased expression of perisynaptic ECM components and 
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increased number of PNNs enwrapping PV+ cells in the dorsal hippocampus. 
These alterations in ECM assembly were accompanied by impaired LTP 
and aberrant inhibitory neurotransmission in the CA1 subregion. We also 
demonstrated that by disrupting the ECM with ChABC, which results in 
reorganization of the ECM assembly, we could restore SDPS-induced 
LTP deficit, altered inhibitory neurotransmission and memory impairment. 
Altogether, these findings demonstrate a causal relationship between ECM 
changes and memory impairment. 
However, the mechanisms mediating the therapeutic effects of ChABC 
remain poorly understood, as ChABC induces a widespread effect on 
ECM, degrading both the perisynaptic and pericellular ECM. Hence, 
several mechanisms might contribute to the effects of ChABC. Potentiation 
of structural reorganization may be a critical step in allowing rewiring of 
hippocampal circuits337,338. As an example, projections from the medial 
PFC to dorsal CA1 region, together with CA3 Schaffer collaterals and 
input from the entorhinal cortex, are crucial in processing episodic-like 
memory273,339,340. By degrading abundant persisynaptic ECM, ChABC may 
assist in refining connectivity between these brain regions, as well as within 
local hippocampal circuits, thereby improving spatial memory processing in 
SDPS animals. This connectivity remodeling may include ChABC-assisted 
increase in spine motility337,338, which could allow structural and functional 
plasticity. Furthermore, ChABC could promote lateral diffusion of AMPA 
receptors, thereby augmenting synaptic transmission73. 
Given the close relationship between glial cells and the ECM70, where 
glial cells serve as a source of both ECM proteins and their degrading 
enzymes, future studies are needed to understand glial contribution in 
ECM modifications in the SDPS animals. A recent study provided evidence 
for the involvement of astrocyte-derived ECM changes in response to 
stress, supporting an important role for glial cells in stress effects. In this 
study, the cortical astroglial translatome was profiled early after a CMS 
paradigm, which led to despair- and anxiety-like phenotypes341. In CMS-
exposed mice, stress triggered an increase in astrocyte-derived ECM 
components, particularly proteoglycans. These translational changes were 
accompanied by increased PNN density in the cortex. Importantly, intra-
PFC ChABC-mediated degradation of PNNs reversed the depressive-like 
effects of CMS, confirming the antidepressant potential of ECM remodeling 
after chronic stress, in support of our own observations.
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It is important to note that complete loss of PNNs, as seen acutely and in 
the first weeks after ChABC administration, might not be beneficial, as a 
fine balance in ECM level is needed for optimal memory processing. This 
is supported by our finding showing ChABC-induced reduction in social 
recognition and spatial memory in control animals. Thus, interventions that 
involve subtle ECM changes could appear more effective. One possibility 
is that PNNs in SDPS animals are more resistant to metalloproteinase-
mediated degradation, which could result from differences in sulfation 
patterns of the glycosaminoglycan chains of CSPGs259. Increasing 
evidence shows that loss of C6-sulfation and increase in the expression 
of C4-sulfation is detrimental for memory342. Interestingly, a recent study 
showed that age-related memory decline, accompanied with a loss of 
the C6-sulfation, was prevented by restoring C6-sulfation levels in the 
perirhinal cortex343. This represents an interesting topic for future studies 
as stress could modulate the sulfation of CSPGs, subsequently affecting 
their assembly and degradation. 
Aberrant inhibitory neurotransmission 
as target for therapeutic interventions
Parvalbumin interneurons are crucial for proper excitatory / inhibitory 
balance in the brain, sustaining cognitive processing and affective 
behavior99,344. Our results on decreased sIPSC frequency onto pyramidal 
CA1 cells in SDPS and reduced excitatory puncta on PNN-covered PV+ 
interneurons suggest that PNN build-up results in reduced inhibitory output 
from PV+ cells, although electrophysiological recordings are required to 
confirm this hypothesis. If true, then interventions targeted to increase 
activity of PV+ cells, for example by opto- or chemogenetic tools, could be 
effective in restoring the SDPS-induced memory impairment. Although the 
time-frame of intervention is different, recent studies have demonstrated 
that PV-targeted manipulations prior to or during stress prevent the 
emergence of stress-induced behavioral effects. As an example, in the 
barrel cortex selective activation of PV neurons during the restraint stress 
paradigm prevented early development of stress-driven sensory deficit271. 
Furthermore, restoring PV+ hyperactivity in the ventral pallidum, a brain 
region involved in reward behavior, promoted stress resilience against 
defeat-induced social withdrawal and behavioral despair in mice345. Similarly, 
evidence of hyperactive PV+ cells in the immediate response to restraint 
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stress have been reported in the hippocampus346. Collectively, these data 
indicate that PV+-mediated control of network function is vulnerable to 
stress across brain regions. Importantly, PV+-targeted interventions display 
potential in protecting from stress effects. Although the role of the PNNs 
were not explored in all these studies, it is tempting to speculate that PNN-
related mechanisms contribute to the observed abnormalities and to the 
observed therapeutic effects.
An interesting question involves around the specific role of perisynaptic 
ECM versus PNNs in the restoration of cognitive function in SDPS. This 
can be challenging as many of the ECM proteins are associated with both 
types of the ECM. Yet, PNN-specific interventions could shed some light 
on this, e.g. by conditional/local depletion of aggrecan, which is enriched 
in PNNs vs. perisynaptic ECM. Furthermore, it would be of interest to 
study whether manipulations targeted specifically to disrupt PV-associated 
PNNs347 could restore memory in SDPS animals. SDPS induces an 
increase in the population of PNN-coated PV+ interneurons in the CA1 
in the long-term, which receive less excitatory input, presumably due to 
the non-permissive environment supported by PNNs presence. Hence, 
degradation of PV-specific PNNs could relieve cognitive symptoms, by 
enabling remodeling of synaptic inputs onto PV cells74,348. Furthermore, 
PNNs can regulate intrinsic excitability of PV interneurons74,221,349, and 
they may be crucial both in synaptic and intrinsic excitability homeostasis. 
Homeostatic regulation aims at restoring balanced neuronal activity after 
disruption350. As such, this regulation is not only the mechanism that leads 
to the maladaptive state of depression as evoked by stress, but it might 
also be key in ensuring appropriate PV-activity to escape such a state. 
However, as changes in PNNs can affect PV+ activity74,221 and, conversely, 
PV+ activity can modulate PNNs351, the directionality of SDPS-induced 
changes is challenging to dissect. Speculatively, loss of PNN integrity in 
response to social stress, as observed early after stress, could alter PV+ 
cell activity. Likewise, stress-induced changes in PV+ activity could result 
in loss or accumulation of PNNs around them, consequently modulating 
network function. Shifts in PV+ network plasticity states were recently 
demonstrated to be integral to optimal learning and memory processes 
in the hippocampus89. Moreover, it was shown that ChABC administration 
induced a change from high- to low- PV+ plasticity state via reshuffling 
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of synapses onto PV-cells89, indicating that ECM remodeling is key in 
modulating PV+-mediated experience-dependent plasticity. The observed 
rescue of inhibitory neurotransmission after ChABC treatment in SDPS 
animals could thus result from similar homeostatic mechanisms, including 
remodeling of synaptic inputs onto PV+ neurons218.
It should be noted that not all CA1 PV+ cells are surrounded by a PNN. 
In our studies, we have observed that around 50-80% of PV+ cells show 
co-localization with a PNN in the CA1 pyramidal layer (Chapters 2 and 5). 
Indeed, a comparison of the intrinsic properties and activity of PNN+ vs. 
PNN- PV+ cells in or ex vivo would be critical in understanding the complex 
cross talk between PNNs and PV+ cells, a mechanism that is currently 
largely unknown. 
Development of ECM-associated changes following stress
In chapter 3, we showed that the transition from stress to depression-
like state is characterized by bidirectional changes in hippocampal ECM 
composition and PNN density. In particular, 72 h after the last of five defeat 
episodes, both perisynaptic and pericellular hippocampal ECM undergo 
extensive downregulation, an effect that is accompanied by a severe 
reduction in hippocampus-dependent spatial memory performance. 
Subsequent temporal profiling of ECM remodeling at 2 to 4 weeks after 
stress exposure, showed a transient recovery of ECM proteins expression 
levels, and the number of CA1 PNN+-PV+ interneurons. During this period, 
no memory disturbances could be observed. Finally, at week 8 post-defeat, 
we reported an increase in the expression of ECM components, in parallel 
with an increase in the density of PV-associated PNNs and re-occurrence 
of disrupted memory. Together, this profile highlights the differences 
between early stress effects and the endpoint effects that emerge much 
later, and suggest that neurobiological adaptations continue to occur long 
after the active response to stress exposure, reminiscent of long-term 
neuroadaptations after transient exposure to drugs of abuse94,97. In support 
of our findings, a recent study demonstrated a biphasic regulation of PNNs 
in the mPFC in response to chronic stress in adolescent rats212. In particular, 
after 7 days of stress exposure, an increase in PNN numbers was reported, 
which was followed by a decrease after when stress continued for a total 
of 35 days. This was in contrast to non-stressed controls, that showed 
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a time-dependent gradual increase in mPFC PNNs, highlighting normal 
brain development. The differential pattern of cortical PNN maturation 
after stress co-occurred with changes in executive function, namely an 
initial increase followed by a reduction in working memory (spontaneous 
alteration) performance after chronic stress, mirroring the changes in 
PNN density. Together with our findings, these observations suggest that 
homeostatic changes involving ECM remodeling take weeks to months. 
Hence, time-dependent effects of stress are observed at the molecular 
level, similar to what is observed with SDPS-induced behavioral changes. 
Altogether, these findings exemplify the importance of stress recency in 
determining the phenotypic endpoint. Yet, the molecular mechanisms 
supporting these lasting and dynamic changes remain unknown. 
A recent study suggested a role for homeoprotein OTX2-mediated signaling 
mediating the effects of early life stress on ECM lasting until adulthood. In this 
study, maternal deprivation and early weaning induced long-lasting changes 
in PNN-enwrapped interneurons of the ventral HPC in adult mice352. These 
animals, which displayed increased anxiety and increased hippocampal 
oscillations (theta power and theta-gamma coupling), showed increased 
PNN+-PV+ staining intensity but reduced PV+ density in the dentate gyrus. 
Notably, this was parallel to an increase in OTX2 accumulated in double 
immunoreactive PNN+-PV+ interneurons. During critical developmental 
periods, OTX2 in the visual cortex is specifically internalized by PV+ cells, 
facilitating PNN assembly353,354. In turn, PNN maturation further promotes 
accumulation of the homeoprotein, creating a positive feedback loop that 
is maintained throughout adulthood, thereby limiting plasticity. Notably, 
OTX2 methylation has been shown to confer increased risk of depression 
in children with early maltreatment, supporting the translational value of 
these preclinical findings355. Furthermore, a recent study showed that 
OTX2 regulates anxiety-like behavior in mice356. In particular, heterozygous 
OTX2 mice displayed a hypo-anxious phenotype, whereas overexpression 
of OTX2 in the choroid plexus reversed this behavior. Moreover, the hypo-
anxious phenotype was accompanied with reduced number of PV cells in 
the mPFC and could be reversed by overexpressing OTX2 in the choroid 
plexus356. Although it has not yet been explored whether stress regulates 
OTX2 levels, it is plausible that OTX2 modulates the stress-response on 
PNNs and PVs in several brain regions, in turn impacting on the expression 
of anxiety- and depression-like symptoms.
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To gain more insight into the development of the depressive-like state, it 
would be important to assess the functional implication of the initial ECM 
downregulation early after stress and how this relates to the long-term 
effects of stress. Hypothetically, since ECM downregulation allows for 
increased structural and synaptic plasticity, this re-organization during and 
shortly after stress might represent a well-adapted response to stressful 
stimuli, for example, promoting memory of the adverse event and its 
associated cues and context, with manifold evolutionary advantages. Yet, 
once initiated, or due to continuation of stressful events (e.g. isolation / 
environmental impoverishment), these initially adaptive changes may 
become maladaptive, facilitating the emergence and maintenance of 
behavioral deficits later on. It is then possible that late increases in ECM 
and PNNs create a non-permissive environment, characterized by low 
plasticity that sustains maladaptive responses to stress, such as the 
formation of persistent traumatic memories43.
More studies are needed to understand the complex mechanisms 
underlying ECM production and breakdown and relate these processes 
to physiological changes at the molecular, cellular and network level. Our 
initial experiments showing that IPR-179 was effective in preventing stress-
induced memory impairment, suggest that metalloproteinase-mediated 
processes play an important role in acute stress response, as supported 
by others152. We and others152 assessed the potential of MMP inhibition 
to prevent stress-induced hippocampal dependent memory impairment. It 
would be of interest to assess stress-induced metalloproteinase activity 
in other brain regions, and to study whether metalloproteinase-mediated 
processes underlie other stress-induced behavioral deficits, such as 
defeat-induced social avoidance. Furthermore, in order to shed light on the 
causality between early and late-emerging deficits, experiments assessing 
whether early rescue prevents the re-emergence of the molecular and 
behavioral deficits should be conducted. 
Importantly, we found decreased MMP-2 activity to coincide with increased 
ECM levels, months following the last stress exposure, suggesting that 
metalloproteinase-mediated regulation sustains aberrant ECM assembly 
during the chronic depressive-like state. Interestingly, there is some clinical 
evidence linking MMP regulation and mood disorders. As an example, 
reduced serum MMP-2 levels were observed in MDD patients and shown to 
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be restored after electroconvulsive treatment (ECT), which also regulates 
serum MMP-9 levels357. Furthermore, increased serum levels of MMP-
9 were found in patients suffering from bipolar disorder358. Although the 
correlation between serum and brain MMP levels remains unknown, these 
studies hint to the involvement of protease-mediated ECM remodeling in 
major depression pathology and in antidepressant response. Given the 
heterogeneity of MMPs in regard to their cellular origin and targets, more 
research is needed to dissect their individual contribution. 
Extracellular matrix and PV-interneurons 
as targets of antidepressants
Our studies underscore the antidepressant potential of ECM-targeted 
manipulations, which is also now supported by others341. Vice versa, we 
demonstrated that antidepressant treatment restores SDPS-induced 
increase in synaptic ECM levels in rats187. Although the antidepressant 
potential of ECM-targeted interventions is still scarcely explored, several 
studies support our findings and demonstrate that antidepressant agents 
act on ECM and modulate PV+ cell plasticity. As an example, Fluoxetine 
(Flx), one of the most common antidepressants, has been shown to 
modulate PNN+/PV+ density and plasticity across brain regions, both in 
health and disease. A general observation is that chronic Flx treatment 
results in decreased PNN density in naïve animals, as shown in the 
basolateral amygdala, hippocampus and mPFC63,93,155. 
Our own data support ECM remodeling as an important substrate for the 
depression-relieving properties of the tricyclic antidepressant imipramine. 
Our results showed that imipramine restored SDPS-induced increase in 
hippocampal ECM protein levels in rats187. This antidepressant-mediated 
decrease in ECM likely renders the perisynaptic environment more 
permissive and boosts rewiring of neural circuitries affected in SDPS. 
Although the mechanisms by which antidepressants exert ECM remodeling 
are poorly understood, increasing evidence points to the involvement of 
metalloproteinases in this process. A recent study showed that venlafaxine, 
a serotonin-norepinephrine reuptake inhibitor (SNRI) commonly prescribed 
against depression, increased the expression of hippocampal pro-MMP-9, 
while reducing both the density and intensity of hippocampal PNNs 
after corticosteroid treatment359. These changes were accompanied by 
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increased gamma power in the hippocampus, assessed by local field 
potential recordings. Notably, the authors showed that venlafaxine effects 
on PNNs and hippocampal oscillations were abolished in MMP-9 KO 
mice, pinpointing to ECM-targeting proteinases as a tangible molecular 
substrate for the antidepressant properties of SNRIs. Intriguingly, analysis 
of post-mortem samples found increased MMP-9 levels in prefrontal cortex 
of MDD patients treated with monoamine antidepressants359, supporting 
these preclinical findings.  
Furthermore, antidepressant-induced changes in PNNs are often found to 
coincide with altered PV+ expression. For example, reduced PV+ expression 
following chronic Flx treatment has been observed in hippocampus and 
mPFC156. Changes in parvalbumin expression following Flx may reflect 
the drug’s ability to regulate intrinsic properties of PV+ cells and synaptic 
inputs onto these cells, as demonstrated by Knowland et al. (2017)345. 
Importantly, the authors showed that defeat-induced aberrant PV-activity 
was rescued by chronic Flx treatment, when the treatment was started 
acutely after defeat. Furthermore, both Flx and imipramine have been 
shown to alter PV-mediated GABA release, thereby regulating gamma-
oscillations158, supporting the ability of antidepressants to modulate 
hippocampal network activity. Assuming that PV interneurons are altered 
in SDPS animals, antidepressant-induced restoration of PV activity could 
be important in promoting healthy hippocampal function in our model. Yet, 
in mice there might be a critical treatment window, after which intervention 
with antidepressants is no longer effective (Chapter 5). It is possible that PV 
interneurons, similar to ECM remodeling, follow time-dependent modulation 
after stress. Therefore, there might be a critical time-window during which 
hippocampal PV interneurons, together with the ECM, optimally respond 
to antidepressants. Depending on the state of the hippocampal network, 
antidepressant-induced changes may be beneficial and promote optimal 
E/I balance, while at other times they may promote imbalanced network 
activity, and thereby sustain hippocampal dysfunction. Finally, whether 
antidepressants act on PV cells via PNN-dependent or -independent 
mechanisms remains to be established. Indeed, it would be interesting to 
experimentally test this, for example by assessing whether (in)activation of 
PV+ cells sustain antidepressant effects in animals devoid of PNNs. 
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Evidence also points to the involvement of PNNs and PV+ cells in the 
antidepressant effects of rapidly acting antidepressants that do not target 
the brain’s monoaminergic system. As an example, chemogenetic activation 
of PV+ cells during exposure to restraint stress mimicked ketamine’s 
protective effect, and diminished dendritic spine elimination in the frontal 
cortex, a mechanism associated with ketamine’s antidepressant actions360. 
Furthermore, ketamine was found to increase the activity of PV+ cells, while 
inhibition of PV+ cells abolished ketamine’s protective effect against spine 
elimination, demonstrating the involvement of PV+ activity in ketamine-
induced spine remodeling. Another study demonstrated the involvement of 
PNNs in mediating the sustained antidepressant effects of ketamine361. In 
particular, the authors showed that ChABC-mediated disruption of ventral 
hippocampus ECM prior to a single ketamine administration abolished 
ketamine-induced reduction in immobility in the forced swim test, which 
assesses amongst others behavioral despair. Notably, the requirement 
of intact ECM for ketamine’s antidepressant actions was seen at one-
week post-administration, but not when tested acutely, indicating that the 
sustained downstream effects of ketamine involve the ECM.
Collectively, the above-mentioned studies together with our own findings 
suggest that the ability to regulate ECM composition and PNN formation 
is a common feature shared by different types of antidepressant agents, 
further highlighting the therapeutic potential of ECM-targeting interventions. 
Whether this is achieved via facilitation of ECM-targeting proteolytic 
processes or yet unknown signaling pathways, ECM-associated effects 
of antidepressants often result in restoration of aberrant PV+ circuitry and 
recovery from depression-like behavioral phenotypes. More research is 
needed to corroborate the role of ECM and PV-interneurons in the effects 
of antidepressant. 
CONCLUTIONS
The investigation of complex human psychiatric disorders, such as MDD, 
using rodent models is challenging, as many of the core symptoms are 
human-like and are based on subjective experience rather than objective 
measures. Furthermore, it is increasingly acknowledged that neurobiological 
mechanisms underlying MDD are complex and heterogeneous. Due 
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to our limited understanding of the molecular mechanisms underlying 
MDD, therapeutic approaches against this debilitating disorder remain 
inadequate. My work aimed at increasing our understanding of the neural 
underpinnings contributing to depression-related pathology that could 
provide novel therapeutic targets. 
In my work, I employed the SDPS/PVDPS models as valuable tools to study 
depression-associated pathology that recapitulate individual components 
of depression, including affective and cognitive deficits. Importantly, both 
models enable the investigation of chronicity of depression. The SDPS 
model in rats allows for the examination of prolonged affective symptoms, 
as this feature of the depressive-like state can be maintained by coupling 
the defeat stress with a prolonged social isolation. Similary, the PVDPS 
paradigm in mice allows for specific examination of persistent cognitive 
decline, that could be mediated by a combinatory effect of physical and 
psychosocial stress. My findings also underscore differences between rats 
and mice in their response to social defeat stress. In particular, fundamental 
differences in affective behavior are found, likely mirroring innate 
differences between these species in their social behavior that should be 
taken into consideration in study designs. Importantly, the hippocampal 
ECM is identified as an crucial substrate for cognitive impairment in both 
models, with ECM regulation being associated with stress pathology and 
as well as serving as a substrate for antidepressants. Together, ECM 
targeted interventions may offer novel therapeutic avenues against MDD.
In conclusion, my studies highlight the importance of stress recency, 
determining both the behavioral and molecular end phenotypes of social 
stress. In rats, cognitive deficits, together with ECM remodeling, developed 
in a biphasic manner, while affective deficit emerged gradually. Conversely, 
in mice stress-induced affective disturbance was transient, while cognitive 
impairment only emerged later on. Although more work is needed to 
understand the underlying mechanisms driving these dynamic outcomes, 
time-dependence of stress effects should not be overlooked when studying 
a perpetual and recurring disorder, such as MDD. 
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